"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,WO,A1,WO 2022/043078 A1,077-542-948-905-534,2022-03-03,2022,EP 2021072491 W,2021-08-12,GB 202013310 A,2020-08-26,SUBSEA DUMMY INSERT,"A dummy insert (20) for a plug (12) of a connector assembly (11), the dummy insert (20) comprises a forward end (45) and a rearward end (46), an insert body (22), an array of shuttle pin assemblies (24), a retention plate (26). The insert body (22) has an internal wall (42) and a plurality of guide tubes (36). The plurality of guide tubes (36) extends generally forwardly from the internal wall (42). The retention plate (26) is located rearwardly of the internal wall (42). Each shuttle pin assembly (24) is located at least partly in one guide tube (36) and is retained by the retention plate (26). The insert body (22), the internal wall (42) and the plurality of guide tubes (36) is a monolithic structure.",SIEMENS ENERGY LTD,BRENNAN CAMERON,,https://lens.org/077-542-948-905-534,Patent Application,yes,2,0,4,4,0,H01R13/523;;H01R13/443;;H01R13/5216;;H01R13/5213;;H01R13/5219;;H01R13/2421;;H01R43/20;;H01R13/443;;H01R13/5213;;H01R13/523,E21B33/038;;H01R13/52;;H01R13/24;;H01R13/443;;H01R13/523;;H01R43/20,,0,0,,,,PENDING
2,EP,A1,EP 4186128 A1,129-435-787-144-025,2023-05-31,2023,EP 21762442 A,2021-08-12,GB 202013310 A;;EP 2021072491 W,2020-08-26,SUBSEA DUMMY INSERT,,SIEMENS ENERGY LTD,BRENNAN CAMERON,,https://lens.org/129-435-787-144-025,Patent Application,yes,0,0,4,4,0,H01R13/523;;H01R13/443;;H01R13/5216;;H01R13/5213;;H01R13/5219;;H01R13/2421;;H01R43/20;;H01R13/443;;H01R13/5213;;H01R13/523,H01R13/52;;E21B33/038;;H01R13/24;;H01R13/443;;H01R13/523;;H01R43/20,,0,0,,,,PENDING
3,US,A1,US 2023/0361499 A1,197-568-302-393-783,2023-11-09,2023,US 202118040267 A,2021-08-12,GB 202013310 A;;EP 2021072491 W,2020-08-26,SUBSEA DUMMY INSERT,"A dummy insert ( 20 ) for a plug ( 12 ) of a connector assembly ( 11 ), the dummy insert ( 20 ) comprises a forward end ( 45 ) and a rearward end ( 46 ), an insert body ( 22 ), an array of shuttle pin assemblies ( 24 ), a retention plate ( 26 ). The insert body ( 22 ) has an internal wall ( 42 ) and a plurality of guide tubes ( 36 ). The plurality of guide tubes ( 36 ) extends generally forwardly from the internal wall ( 42 ). The retention plate ( 26 ) is located rearwardly of the internal wall ( 42 ). Each shuttle pin assembly ( 24 ) is located at least partly in one guide tube ( 36 ) and is retained by the retention plate ( 26 ). The insert body ( 22 ), the internal wall ( 42 ) and the plurality of guide tubes ( 36 ) is a monolithic structure. [ FIG. 2 ]",SIEMENS ENERGY LTD,BRENNAN CAMERON,SIEMENS ENERGY LIMITED (2023-01-23),https://lens.org/197-568-302-393-783,Patent Application,yes,0,0,4,4,0,H01R13/523;;H01R13/443;;H01R13/5216;;H01R13/5213;;H01R13/5219;;H01R13/2421;;H01R43/20;;H01R13/443;;H01R13/5213;;H01R13/523,H01R13/443;;H01R13/52;;H01R13/523,,0,0,,,,PENDING
4,NZ,A,NZ 523152 A,185-600-065-201-718,2003-02-28,2003,NZ 52315202 A,2002-12-13,NZ 52315202 A,2002-12-13,Car window shade where the attachment means is applied to the car door and not the car window,"A sun shade, comprising of a length adjustable filamentary sheet material (preferably of a mesh form), support rods and a distinct attachment means that is attachable to a motor vehicle door frame as opposed to the glass window of the door such that the sheet material substantially covers the window of the door whether the door is open or closed and wherein the sheet material is substantially on only one side of the door.",SAMTARA HOLDINGS LTD,REYNOLDS CHARLES JAMES;;ROBINSON CAMERON BRENNAN,,https://lens.org/185-600-065-201-718,Patent Application,no,0,0,1,1,0,,B60J1/20;;B60J3/00,,0,0,,,,PENDING
5,NZ,A,NZ 523153 A,063-998-668-455-273,2003-02-28,2003,NZ 52315302 A,2002-12-13,NZ 52315302 A,2002-12-13,"Attachment means having malleable portion connected to a hook means, allowing bending and maintaining of bent shape","An attachment means comprising a substantially malleable portion (preferably of elongate metallic or plastic substance) fitted in a flexible sheath of material, which is attached to a hook portion. The attachment means can be employed to hold a sun shade adjacent to the inside of the window of a vehicle door, wherein a number of attachment means are engaged to the vehicle sun shade.",SAMTARA HOLDINGS LTD,REYNOLDS CHARLES JAMES;;ROBINSON CAMERON BRENNAN,,https://lens.org/063-998-668-455-273,Patent Application,no,0,0,1,1,0,,B60R7/00;;B60R7/04;;B60R11/00,,0,0,,,,PENDING
6,CN,A,CN 117321445 A,152-103-287-920-916,2023-12-29,2023,CN 202280034837 A,2022-02-17,US 202117201724 A;;CA 2022050228 W,2021-03-15,Generating and displaying metric of interest based on motion data,"In a general aspect, a metric of interest is generated and displayed based on motion data. In some aspects, a method includes obtaining channel information based on wireless signals communicated through a space over a time period by a wireless communication network. The space includes a plurality of locations. The method includes generating motion data based on the channel information. The motion data includes motion indication values and motion localization values for a plurality of locations. The method further includes identifying an actual value of the metric of interest for the time period based on the motion data; identifying a reference value for the metric of interest for the time period based on user input data; and providing the actual value of the metric of interest and the reference value of the metric of interest for display on a user interface of a user device.",COGNITIVE SYSTEMS CORP,A FORSYTH;;BRENNAN CAMERON;;MANKU SAURABH,,https://lens.org/152-103-287-920-916,Patent Application,no,0,0,6,6,0,A61B5/4806;;A61B5/4809;;A61B5/4818;;A61B5/0507;;A61B5/1113;;A61B5/746;;G06F3/04847;;G06F3/04886;;G09G2380/08;;G06F3/14;;G09G2354/00;;G09G5/36;;H04W4/38;;H04W4/029;;A61B5/4815;;G06F3/04847;;G06F3/14;;H04W4/38;;A61B5/7278;;A61B5/4809;;A61B5/0004;;A61B5/742;;A61B5/7475;;A61B5/1118,G01S11/00,,0,0,,,,PENDING
7,EP,A4,EP 1774043 A4,196-126-684-834-69X,2009-09-02,2009,EP 05804854 A,2005-05-27,US 2005/0018850 W;;US 57579504 P;;US 58033704 P,2004-05-28,"COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF CANCER",,DANA FARBER CANCER INST INC,CHIN LYNDA;;AGUIRRE ANDREW J;;BRENNAN CAMERON,,https://lens.org/196-126-684-834-69X,Search Report,no,4,0,8,8,0,C12Q2600/136;;C12Q2600/154;;C12Q1/6886;;A61P35/00;;C12Q2600/136;;C12Q2600/154;;C12Q1/6886,C12Q1/68,,2,1,079-932-272-026-957,10616197,"O'LEARY T ET AL: ""Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors."", LABORATORY INVESTIGATION; A JOURNAL OF TECHNICAL METHODS AND PATHOLOGY DEC 1999, vol. 79, no. 12, December 1999 (1999-12-01), pages 1461 - 1467, XP009120348, ISSN: 0023-6837;;DATABASE Geneseq [online] 8 February 2001 (2001-02-08), ""Human cancer associated gene sequence SEQ ID NO:226."", XP002538173, retrieved from EBI accession no. GSN:AAC77832 Database accession no. AAC77832",DISCONTINUED
8,EP,A2,EP 1774043 A2,008-294-702-663-536,2007-04-18,2007,EP 05804854 A,2005-05-27,US 2005/0018850 W;;US 57579504 P;;US 58033704 P,2004-05-28,"COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF CANCER",,DANA FARBER CANCER INST INC,CHIN LYNDA;;AGUIRRE ANDREW J;;BRENNAN CAMERON,,https://lens.org/008-294-702-663-536,Patent Application,yes,0,0,8,8,0,A61P35/00;;C12Q1/6886;;C12Q1/6886;;C12Q2600/136;;C12Q2600/136;;C12Q2600/154;;C12Q2600/154,C12Q1/68,,0,0,,,,DISCONTINUED
9,US,A1,US 2009/0134105 A1,069-488-729-389-731,2009-05-28,2009,US 28835108 A,2008-10-17,NZ 56273207 A,2007-10-19,Textile sampling,An apparatus is disclosed for displaying a plurality of textile or fabric samples. The apparatus includes a plurality of elongate rail members configured to receive and engage at least one sample member. The at least one or each sample member holds at least one sample and is adapted to slidably and/or pivotally engage at least one rail member by way of one or more corresponding apertures or channels provided therein.,MOKUM TEXTILES LTD,RYSENBRY EDWIN;;REYNOLDS CHARLES JAMES;;ROBINSON CAMERON BRENNAN,BALDWINS (2008-12-16),https://lens.org/069-488-729-389-731,Patent Application,yes,24,1,4,4,0,G09F5/02;;G09F5/04;;G09F2005/045;;G09F2005/048;;G09F5/02;;G09F5/04;;G09F2005/045;;G09F2005/048,A47F5/00,211/184,0,0,,,,DISCONTINUED
10,EP,A3,EP 2056276 A3,131-622-395-648-860,2009-09-30,2009,EP 08253378 A,2008-10-17,NZ 56273207 A,2007-10-19,Textile sampling,"An apparatus is disclosed for displaying a plurality of textile or fabric samples. The apparatus includes a plurality of elongate rail members configured to receive and engage at least one sample member. The or each sample member holds at least one sample and is adapted to slidably and/or pivotally engage at least one rail member by way of one or more corresponding apertures or channels provided therein.
",MOKUM TEXTILES LTD,RYSENBRY EDWIN;;GRIFFIN CHARLES JAMES REYNOLDS;;ROBINSON CAMERON BRENNAN,,https://lens.org/131-622-395-648-860,Search Report,yes,8,0,4,4,0,G09F5/02;;G09F5/04;;G09F2005/045;;G09F2005/048;;G09F5/02;;G09F5/04;;G09F2005/045;;G09F2005/048,G09F5/02;;G09F5/04,,0,0,,,,DISCONTINUED
11,AU,A1,AU 2008/230001 A1,058-494-887-318-463,2009-05-07,2009,AU 2008/230001 A,2008-10-17,NZ 56273207 A,2007-10-19,Textile sampling,,MOKUM TEXTILES LTD,GRIFFIN CHARLES JAMES REYNOLDS;;ROBINSON CAMERON BRENNAN;;RYSENBRY EDWIN,,https://lens.org/058-494-887-318-463,Patent Application,no,0,0,4,4,0,G09F5/02;;G09F5/04;;G09F2005/045;;G09F2005/048;;G09F5/02;;G09F5/04;;G09F2005/045;;G09F2005/048,G09F5/04;;B65D73/00,,0,0,,,,DISCONTINUED
12,EP,A2,EP 2056276 A2,085-052-684-213-590,2009-05-06,2009,EP 08253378 A,2008-10-17,NZ 56273207 A,2007-10-19,Textile sampling,"An apparatus is disclosed for displaying a plurality of textile or fabric samples. The apparatus includes a plurality of elongate rail members configured to receive and engage at least one sample member. The or each sample member holds at least one sample and is adapted to slidably and/or pivotally engage at least one rail member by way of one or more corresponding apertures or channels provided therein.
",MOKUM TEXTILES LTD,RYSENBRY EDWIN;;GRIFFIN CHARLES JAMES REYNOLDS;;ROBINSON CAMERON BRENNAN,,https://lens.org/085-052-684-213-590,Patent Application,yes,2,0,4,4,0,G09F5/02;;G09F5/04;;G09F2005/045;;G09F2005/048;;G09F5/02;;G09F5/04;;G09F2005/045;;G09F2005/048,G09F5/02;;G09F5/04,,0,0,,,,DISCONTINUED
13,US,B2,US 9461954 B2,073-100-563-307-441,2016-10-04,2016,US 201213692006 A,2012-12-03,US 201213692006 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, one or more computer systems of a social-networking system query a social graph of the social-networking system for social content associated with particular media content. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system determine a time associated with each of the social content, determine, using the determined time of each of the social content, a particular point within the particular media content that the social content was generated, and present a content visualization graph for display on a display device. The content visualization graph is a visual indication of the particular points within the particular media content that the social content was generated.",CAMPBELL COLIN CAMERON BRENNAN;;HEYNEN MARK;;KRAUSZ BRIAN;;TSENG ERICK;;FACEBOOK INC,CAMPBELL COLIN CAMERON BRENNAN;;HEYNEN MARK;;KRAUSZ BRIAN;;TSENG ERICK,META PLATFORMS INC (2012-12-04),https://lens.org/073-100-563-307-441,Granted Patent,yes,111,14,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N7/173;;G06F3/00;;G06F3/048;;G06F3/0481;;G06F13/00;;G06F15/16;;G06F17/30;;H04L12/58;;H04L29/06;;H04N5/445;;H04N21/23;;H04N21/258;;H04N21/41;;H04N21/4227;;H04N21/433;;H04N21/439;;H04N21/44;;H04N21/472;;H04N21/478;;H04N21/4788;;H04N21/63;;H04N21/6543;;H04N21/81;;H04W4/50;;H04W4/80,,19,0,,,"U.S. Appl. No. 13/602,011, filed Aug. 31, 2012, Cameron A. Marlow.;;U.S. Appl. No. 13/688,736, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,035, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/688,850, filed Nov. 29, 2012, Sean M. Bruich.;;U.S. Appl. No. 13/689,285, filed Nov. 29, 2012, David H. Garcia.;;U.S. Appl. No. 13/689,355, filed Nov. 29, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/688,905, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13/690,769, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/690,892, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,122, filed Nov. 30, 2012, Mark Heynen.;;U.S. Appl. No. 13/692,122, filed Dec. 3, 2012, Colin C. Brennan.;;U.S. Appl. No. 13/691,269, filed Nov. 30, 2012, David H. Garcia.;;U.S. Appl. No. 13/692,675, filed Dec. 3, 2012, Ime Archibong.;;U.S. Appl. No. 13/692,598, filed Dec. 3, 2012, Gregory J. Badros.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013, date of mailing Dec. 11, 2013.;;Martin, R. et al. ""neXream: A Multi-Device, Social Approach to Video Content Consumption."" Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010, 1-5.;;U.S. Appl. No. 14/930,072, filed Nov. 2, 2015, Archibong.;;U.S. Appl. No. 15/046,179, filed Feb. 17, 2016, Archibong.;;EPO Germany, Communication-Extended European Search Report dated Apr. 5, 2016; Application No./Patent No. 13833399.2-1905/2891322 PCT/US2013057449; Ref. FABOO276-PCT/EP May 4, 2016.",ACTIVE
14,WO,A1,WO 2021/116323 A1,193-276-488-052-249,2021-06-17,2021,EP 2020085603 W,2020-12-10,GB 201918323 A,2019-12-12,SUBSEA CONNECTOR,"An independently mountable sensor system (1) for a wet-mateable subsea connector or a dry-mateable subsea connector comprising at least one of a receptacle connector body or a plug connector body (41) comprises a pressure vessel (2); one or more sensors (7a, 7b), a power source (25), a transmitter (27), a processor and a memory (24) within the pressure vessel. The pressure inside the pressure vessel is maintained at a predetermined pressure and an antenna (10) is provided in the sensor system. The pressure vessel (2) comprises an electromagnetically transparent section (40) to permit electromagnetic waves to pass between the sensor system and an external receiver. The sensor system (1) is configured to be mounted between a back end and a front end of the receptacle connector body, or between a back end and a front end of the plug connector body; or configured to be mounted to the connector body back end.",SIEMENS AG,BARRETT WESLEY;;BRENNAN CAMERON;;BURROW CHRISTOPHER;;HARDISTY JONATHAN;;HENRY PETER,,https://lens.org/193-276-488-052-249,Patent Application,yes,7,0,7,7,0,E21B33/038;;E21B33/0355;;G01R31/66;;G01L1/22;;G01P15/00;;H01R13/6683,E21B33/038;;E21B33/035,,0,0,,,,PENDING
15,EP,A1,EP 4073345 A1,017-221-185-246-855,2022-10-19,2022,EP 20828980 A,2020-12-10,GB 201918323 A;;EP 2020085603 W,2019-12-12,SUBSEA CONNECTOR,,SIEMENS ENERGY GLOBAL GMBH & CO KG,BARRETT WESLEY;;BRENNAN CAMERON;;BURROW CHRISTOPHER;;HARDISTY JONATHAN;;HENRY PETER,,https://lens.org/017-221-185-246-855,Patent Application,yes,0,0,7,7,0,E21B33/038;;E21B33/0355;;G01R31/66;;G01L1/22;;G01P15/00;;H01R13/6683,E21B33/038;;E21B33/035,,0,0,,,,ACTIVE
16,WO,A3,WO 2005/118869 A3,158-530-428-642-900,2009-01-29,2009,US 2005/0018850 W,2005-05-27,US 57579504 P;;US 58033704 P,2004-05-28,"COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF CANCER","The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human cancer. A variety of chromosomal regions (MCRs) and markers corresponding thereto, are provided, wherein alterations in the copy number of one or more of the MCRs and/or alterations in the amount, structure, and/or activity of one or more of the markers is correlated with the presence of cancer.",DANA FARBER CANCER INST INC;;CHIN LYNDA;;DEPINHO RONALD A;;BRENNAN CAMERON;;AGUIRRE ANDREW J,CHIN LYNDA;;DEPINHO RONALD A;;BRENNAN CAMERON;;AGUIRRE ANDREW J,,https://lens.org/158-530-428-642-900,Search Report,yes,0,0,8,8,0,A61P35/00;;C12Q1/6886;;C12Q1/6886;;C12Q2600/136;;C12Q2600/136;;C12Q2600/154;;C12Q2600/154,C12Q1/68,,9,8,079-932-272-026-957;;028-194-746-291-479;;082-071-398-120-697;;026-019-394-114-311;;075-014-892-357-978;;064-319-008-237-405;;013-381-721-133-983;;035-431-301-766-718,10616197;;10913674;;10.1016/s0165-4608(99)00249-6;;10.1002/(sici)1098-2264(200005)28:1<121::aid-gcc14>3.0.co;2-o;;10738310;;10.1038/75985;;10835626;;10453739;;10.1007/s004390050994;;9927061;;12081210;;10.1002/path.1101;;11066075;;10.1002/1098-2264(2000)9999:9999<::aid-gcc1047>3.0.co;2-e,"O'LEARY ET AL.: ""Loss of Heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors"", LABORATORY INVESTIGATION, vol. 79, no. 12, 1999, pages 1461 - 1467;;BELLO ET AL.: ""High-Resolution analysis of Chromosome Arm 1p alterations in Meningioma"", CANCER GENET. CYTOGENET., vol. 120, 2000, pages 30 - 36, XP003024730;;SMEDLEY ET AL.: ""Characterization of Chromosome 1 Abnormalities in Malignant melanomas"", GENES, CHROMOSOMES, CANCER, vol. 28, 2000, pages 121 - 125, XP003024731;;WATNICK ET AL.: ""Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene"", NATURE GENETICS, vol. 25, June 2000 (2000-06-01), pages 144 - 146, XP003024732;;MATSUMOTO ET AL.: ""Molecular Cloning and Characterization of the human NUDC gene"", HUM. GENET., vol. 104, 1999, pages 498 - 504, XP003024733;;BALSARA ET AL.: ""Comparative Genomic Hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma"", CANCER RESEARCH, vol. 59, 1999, pages 450 - 454, XP003024734;;KOGA ET AL.: ""Frequent genomic imbalances in chromosomes 17, 19 and 22q in peripheral nerve sheath tumors detected by comparative genomic hybridization analysis"", J. PATHOLOGY, vol. 197, 2002, pages 98 - 107, XP003024735;;FUKUDA ET AL.: ""CD44 is a potential target of amplification within the 11p13 amplicon detected in gastric cancer cell lines"", GENES, CHROMOSOMES & CANCER, vol. 29, 2000, pages 315 - 324, XP003024736;;See also references of EP 1774043A4",PENDING
17,US,A1,US 2023/0009735 A1,009-569-401-639-547,2023-01-12,2023,US 202017782647 A,2020-12-10,GB 201918323 A;;EP 2020085603 W,2019-12-12,SUBSEA CONNECTOR,"An independently mountable sensor system for a wet-mateable subsea connector or a dry-mateable subsea connector having at least one of a receptacle connector body or a plug connector body with a pressure vessel; one or more sensors, a power source, a transmitter, a processor and a memory within the pressure vessel. The pressure inside the pressure vessel is maintained at a predetermined pressure and an antenna is provided in the sensor system. The pressure vessel includes an electromagnetically transparent section to permit electromagnetic waves to pass between the sensor system and an external receiver. The sensor system is configured to be mounted between a back end and a front end of the receptacle connector body, or between a back end and a front end of the plug connector body; or configured to be mounted to the connector body back end.",SIEMENS ENERGY GLOBAL GMBH & CO KG,BARRETT WESLEY;;BRENNAN CAMERON;;BURROW CHRISTOPHER;;HARDISTY JONATHAN;;HENRY PETER,SIEMENS AKTIENGESELLSCHAFT (2022-06-01);;SIEMENS ENERGY LIMITED (2022-06-01);;SIEMENS ENERGY GLOBAL GMBH & CO. KG (2022-06-15);;SIEMENS PLC (2022-05-31),https://lens.org/009-569-401-639-547,Patent Application,yes,0,0,7,7,0,E21B33/038;;E21B33/0355;;G01R31/66;;G01L1/22;;G01P15/00;;H01R13/6683,G01R31/66;;G01L1/22;;G01P15/00;;H01R13/66,,0,0,,,,PENDING
18,CA,A1,CA 2568413 A1,045-485-262-409-481,2005-12-15,2005,CA 2568413 A,2005-05-27,US 57579504 P;;US 58033704 P;;US 2005/0018850 W,2004-05-28,"COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF CANCER",,DANA FARBER CANCER INST INC,CHIN LYNDA;;BRENNAN CAMERON;;DEPINHO RONALD A;;AGUIRRE ANDREW J,,https://lens.org/045-485-262-409-481,Patent Application,no,0,0,8,8,0,A61P35/00;;C12Q1/6886;;C12Q1/6886;;C12Q2600/136;;C12Q2600/136;;C12Q2600/154;;C12Q2600/154,C12Q1/68,,0,0,,,,DISCONTINUED
19,BR,A2,BR 112022010133 A2,016-702-852-045-899,2022-08-09,2022,BR 112022010133 A,2020-12-10,EP 2020085603 W;;GB 201918323 A,2019-12-12,CONECTOR SUBMARINO,"CONECTOR SUBMARINO. A presente invenção refere-se a um sistema de sensor independentemente montável (1) em um conector submarino de acoplamento úmido ou em um conector submarino de acoplamento seco compreendendo pelo menos um dentre um corpo de conector de receptáculo ou um corpo de conector de plugue (41) e que compreende um vaso de pressão (2); um ou mais sensores (7a, 7b), uma fonte de alimentação (25), um transmissor (27), um processador e uma memória (24) dentro do vaso de pressão. A pressão dentro do vaso de pressão é mantida a uma predeterminada pressão, e uma antena (10) é provida no sistema de sensor. O vaso de pressão (2) compreende uma seção eletromagnética transparente (40) a fim de permitir a passagem de ondas eletromagnéticas entre o sistema de sensor e um receptor externo. O sistema de sensor (1) é configurado para ser montado entre uma extremidade traseira e uma extremidade dianteira do corpo de conector de receptáculo, ou entre uma extremidade traseira e uma extremidade dianteira do corpo de conector de plugue; ou configurado para ser montado em uma extremidade traseira do corpo de conector.",SIEMENS ENERGY GLOBAL GMBH & CO KG,WESLEY BARRETT;;CAMERON BRENNAN;;CHRISTOPHER BURROW;;JONATHAN HARDISTY;;PETER HENRY,,https://lens.org/016-702-852-045-899,Patent Application,no,0,0,7,7,0,E21B33/038;;E21B33/0355;;G01R31/66;;G01L1/22;;G01P15/00;;H01R13/6683,E21B33/038;;E21B33/035,,0,0,,,,PENDING
20,CN,A,CN 114829738 A,193-575-080-598-723,2022-07-29,2022,CN 202080086146 A,2020-12-10,GB 201918323 A;;EP 2020085603 W,2019-12-12,Subsea connector,"An independently mountable sensor system (1) for a wet-plug or dry-plug subsea connector, the subsea connector comprising at least one of a receptacle connector body and a plug connector body (41), the sensor system comprising a pressure vessel (2); one or more sensors (7a, 7b) located within the pressure vessel, a power source (25), a transmitter (27), a processor and a memory (27). The pressure in the pressure vessel is maintained at a predetermined pressure, and an antenna (10) is arranged in the sensor system. The pressure vessel (2) comprises a portion (40) permeable to electromagnetic waves to allow transmission of electromagnetic waves between the sensor system and an external receiver. The sensor system (1) is configured to be mounted between the rear end and the front end of the receptacle connector body or between the rear end and the front end of the plug connector body; or is configured to be mounted on the rear end of the receptacle connector body or the plug connector body.",SIEMENS ENERGY GLOBAL GMBH & CO KG,BARRETT WILLIAM;;BRENNAN CAMERON;;BRAU CHRISTOPHER;;HARDISTY JONATHAN;;HENRY PATRICK,,https://lens.org/193-575-080-598-723,Patent Application,no,22,0,7,7,0,E21B33/038;;E21B33/0355;;G01R31/66;;G01L1/22;;G01P15/00;;H01R13/6683,E21B33/038;;E21B33/035,,0,0,,,,PENDING
21,US,A1,US 2014/0067948 A1,117-508-295-885-096,2014-03-06,2014,US 201213692006 A,2012-12-03,US 201213692006 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming Through Social Networking,"In particular embodiments, one or more computer systems of a social-networking system query a social graph of the social-networking system for social content associated with particular media content. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system determine a time associated with each of the social content, determine, using the determined time of each of the social content, a particular point within the particular media content that the social content was generated, and present a content visualization graph for display on a display device. The content visualization graph is a visual indication of the particular points within the particular media content that the social content was generated.",CAMPBELL COLIN CAMERON BRENNAN;;HEYNEN MARK;;KRAUSZ BRIAN;;TSENG ERICK,CAMPBELL COLIN CAMERON BRENNAN;;HEYNEN MARK;;KRAUSZ BRIAN;;TSENG ERICK,META PLATFORMS INC (2012-12-04),https://lens.org/117-508-295-885-096,Patent Application,yes,8,14,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04L29/06;;H04W4/50;;H04W4/80,709/204,0,0,,,,ACTIVE
22,US,B2,US 9854303 B2,011-647-366-938-965,2017-12-26,2017,US 201615244685 A,2016-08-23,US 201615244685 A;;US 201213692006 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, one or more computer systems query a social graph for social content associated with particular media content, present a content visualization graph for display on a display device, determine a plurality of interesting points of the particular media content based on an amount of social content generated, and provide indications on the content visualization graph of at least some of the determined plurality of interesting points. The content visualization graph provides a visual indication of particular points within the particular media content that the social content was generated. Determining the plurality of interesting points includes determining a respective amount of social content generated for each of a plurality of time periods and selecting, as the plurality of interesting points, a pre-determined number of the plurality of time periods that have the largest amount of generated social content.",FACEBOOK INC,CAMPBELL COLIN CAMERON BRENNAN;;HEYNEN MARK;;KRAUSZ BRIAN;;TSENG ERICK,META PLATFORMS INC (2021-10-28),https://lens.org/011-647-366-938-965,Granted Patent,yes,190,0,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N7/173;;G06F3/00;;G06F3/048;;G06F3/0481;;G06F13/00;;G06F15/16;;G06F17/30;;G06Q30/02;;G06Q50/00;;H04L12/58;;H04L29/06;;H04L29/08;;H04L29/12;;H04N5/445;;H04N21/23;;H04N21/234;;H04N21/235;;H04N21/258;;H04N21/278;;H04N21/41;;H04N21/4147;;H04N21/4227;;H04N21/433;;H04N21/434;;H04N21/4363;;H04N21/439;;H04N21/44;;H04N21/4402;;H04N21/472;;H04N21/478;;H04N21/4788;;H04N21/482;;H04N21/488;;H04N21/63;;H04N21/6334;;H04N21/6543;;H04N21/81;;H04N21/84;;H04N21/8547;;H04W4/50;;H04W4/80,,12,1,001-019-759-270-089,10.1109/ccnc.2010.5421599,"U.S. Appl. No. 15/175,159, filed Jun. 7, 2016, Archibong.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013, dated Dec. 11, 2013.;;Martin, R. et al. “neXtream: A Multi-Device, Social Approach to Video Content Consumption.” Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5, 2010.;;EPO Germany, Communication—Extended European Search Report, dated May 4, 2016; Application No. / Patent No. 1383339.2-1905 / 2891322 PCT/US2013057449; Ref. FABOO276-PCT/EP, dated May 4, 2016.;;U.S. Appl. No. 15/283,908, filed Oct. 3, 2016, Archibong.;;U.S. Appl. No. 15/295,497, filed Oct. 17, 2016, Badros.;;U.S. Appl. No. 15/376,902, filed Dec. 13, 2016, Campbell.;;U.S. Appl. No. 15/393,449, filed Dec. 29, 2016, Garcia.;;U.S. Appl. No. 15/495,508, filed Apr. 24, 2017, Archibong.;;U.S. Appl. No. 15/498,015, filed Apr. 26, 2017, Archibong.;;U.S. Appl. No. 15/612,169, filed Jun. 2, 2017, Garcia.;;U.S. Appl. No. 15/618,816, filed Jun. 9, 2017, Marlow.",ACTIVE
23,US,A1,US 2016/0366090 A1,041-577-749-728-217,2016-12-15,2016,US 201615244685 A,2016-08-23,US 201615244685 A;;US 201213692006 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming through Social Networking,"In particular embodiments, one or more computer systems query a social graph for social content associated with particular media content, present a content visualization graph for display on a display device, determine a plurality of interesting points of the particular media content based on an amount of social content generated, and provide indications on the content visualization graph of at least some of the determined plurality of interesting points. The content visualization graph provides a visual indication of particular points within the particular media content that the social content was generated. Determining the plurality of interesting points includes determining a respective amount of social content generated for each of a plurality of time periods and selecting, as the plurality of interesting points, a pre-determined number of the plurality of time periods that have the largest amount of generated social content.",FACEBOOK INC,CAMPBELL COLIN CAMERON BRENNAN;;HEYNEN MARK;;KRAUSZ BRIAN;;TSENG ERICK,META PLATFORMS INC (2021-10-28),https://lens.org/041-577-749-728-217,Patent Application,yes,0,20,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04L12/58;;H04L29/06;;H04L29/08;;H04N21/23;;H04N21/258;;H04N21/41;;H04N21/4227;;H04N21/433;;H04N21/439;;H04N21/44;;H04N21/472;;H04N21/4788;;H04N21/63;;H04N21/6543;;H04N21/81;;H04W4/50;;H04W4/80,,0,0,,,,ACTIVE
24,EP,B1,EP 4073345 B1,054-701-249-899-949,2024-01-31,2024,EP 20828980 A,2020-12-10,GB 201918323 A;;EP 2020085603 W,2019-12-12,SUBSEA CONNECTOR,,SIEMENS ENERGY GLOBAL GMBH & CO KG,BARRETT WESLEY;;BRENNAN CAMERON;;BURROW CHRISTOPHER;;HARDISTY JONATHAN;;HENRY PETER,,https://lens.org/054-701-249-899-949,Granted Patent,yes,10,0,7,7,0,E21B33/038;;E21B33/0355;;G01R31/66;;G01L1/22;;G01P15/00;;H01R13/6683,E21B33/038;;E21B33/035,,0,0,,,,ACTIVE
25,AU,B2,AU 2017/291702 B2,061-849-085-799-857,2022-04-28,2022,AU 2017/291702 A,2017-06-28,US 201662359684 P;;US 2017/0039620 W,2016-07-07,"Imaging systems and methods for particle-driven, knowledge-based, and predictive cancer radiogenomics","Described herein are particle-driven radiogenomics systems and methods that can be used to identify imaging features for prediction of intratumoral and interstitial nanoparticle distributions in cancers (e.g., in low grade and/or high-grade brain cancers (e.g., gliomas, e.g., primary gliomas)). In certain embodiments, the systems and methods described herein extract and combine quantitative multi-dimensional data generated from structural, functional, and/or metabolic imaging. In certain embodiments, the combined multidimensional data is linked to intratumoral and interstitial nanoparticle distributions. For example, this linked data can be used to determine quantitative functional-metabolic multimodality particle-based imaging features and to predict treatment efficacy. These techniques provide an improved quantitative ability to measure treatment response and determine tumor progressions compared to traditional size-based imaging methods.",UNIV CORNELL;;MEMORIAL SLOAN KETTERING CANCER CENTER,BRADBURY MICHELLE S;;BRENNAN CAMERON;;GONEN MITHAT;;PAULIAH MOHAN;;WIESNER ULRICH,,https://lens.org/061-849-085-799-857,Granted Patent,no,3,0,11,11,0,A61B6/03;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;G06T7/0012;;G06T7/40;;G06T2207/10072;;G06T2207/30096;;A61K49/0002;;G16H50/30;;A61B1/000094;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;A61K49/0002;;G06T7/0012;;G06T7/40;;G06T2207/30096;;G06T2207/10072;;A61B5/0042;;A61B5/4848;;A61B6/037;;A61B6/481;;A61B6/501;;A61B6/5247;;G06T7/0012;;G06T7/40;;G06T2207/30096;;A61B6/03;;A61B5/1075;;A61B8/481;;A61B5/4842;;A61B5/1072;;A61B6/5217;;A61B8/5223;;A61B8/085;;A61B8/5261;;A61B6/4417;;A61B8/4416;;G06T2207/10072;;A61B1/000094;;A61K49/0002;;A61B5/0035;;A61B5/055;;A61K49/1818;;A61K51/082;;A61K51/088;;A61K51/1244;;G01R33/481;;G01R33/4812;;G01R33/4814;;G01R33/5601;;G01R33/56341;;G01T1/1642;;G01T1/2985;;G06T2207/10088,A61B1/04;;A61B5/00;;A61B6/03;;A61K49/00,,0,0,,,,ACTIVE
26,BR,A2,BR 112019000143 A2,004-403-626-388-193,2019-04-16,2019,BR 112019000143 A,2017-06-28,US 2017/0039620 W;;US 201662359684 P,2016-07-07,"sistemas de imagem e métodos para radiogenomia de câncer conduzido por partícula, baseado no conhecimento e preditivo","a presente invenção refere-se aos sistemas radiogênicos e métodos com base em partículas que podem ser usados para identificar as características de imagem para predizer as distribuições de nanopartículas intratumorais e intersticiais em cânceres (por exemplo, em cânceres cerebrais de baixo grau e/ou de alto grau (por exemplo, gliomas, por exemplo, gliomas primários)). em certas modalidades, os sistemas e métodos descritos na presente invenção extraem e combinam os dados multidimensionais quantitativos gerados a partir de imagiologia estrutural, funcional e/ou metabólica. em certas modalidades, os dados multidimensionais combinados estão ligados a distribuições de nanopartículas intratumorais e intersticiais. por exemplo, estes dados ligados podem ser usados para determinar as características de imagiologia com base em partículas de multimodalidade funcional metabólica funcional e para prever a eficácia do tratamento. estas técnicas proporcionam uma capacidade quantitativa melhorada para medir a resposta ao tratamento e determinar as progressões do tumor em comparação com os métodos tradicionais de imagiologia com base no tamanho.",UNIV CORNELL;;MEMORIAL SLOAN KETTERING CANCER CENTER,CAMERON BRENNAN;;MICHELLE S BRADBURY;;MITHAT GONEN;;MOHAN PAULIAH;;ULRICH WIESNER,,https://lens.org/004-403-626-388-193,Patent Application,no,0,0,11,11,0,A61B6/03;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;G06T7/0012;;G06T7/40;;G06T2207/10072;;G06T2207/30096;;A61K49/0002;;G16H50/30;;A61B1/000094;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;A61K49/0002;;G06T7/0012;;G06T7/40;;G06T2207/30096;;G06T2207/10072;;A61B5/0042;;A61B5/4848;;A61B6/037;;A61B6/481;;A61B6/501;;A61B6/5247;;G06T7/0012;;G06T7/40;;G06T2207/30096;;A61B6/03;;A61B5/1075;;A61B8/481;;A61B5/4842;;A61B5/1072;;A61B6/5217;;A61B8/5223;;A61B8/085;;A61B8/5261;;A61B6/4417;;A61B8/4416;;G06T2207/10072;;A61B1/000094;;A61K49/0002;;A61B5/0035;;A61B5/055;;A61K49/1818;;A61K51/082;;A61K51/088;;A61K51/1244;;G01R33/481;;G01R33/4812;;G01R33/4814;;G01R33/5601;;G01R33/56341;;G01T1/1642;;G01T1/2985;;G06T2207/10088,A61B1/04;;A61B5/00;;A61B6/03;;A61K49/00,,0,0,,,,DISCONTINUED
27,EP,A4,EP 3481272 A4,182-663-331-118-44X,2020-03-11,2020,EP 17824714 A,2017-06-28,US 201662359684 P;;US 2017/0039620 W,2016-07-07,"IMAGING SYSTEMS AND METHODS FOR PARTICLE-DRIVEN, KNOWLEDGE-BASED, AND PREDICTIVE CANCER RADIOGENOMICS",,MEMORIAL SLOAN KETTERING CANCER CENTER;;UNIV CORNELL,BRADBURY MICHELLE S;;BRENNAN CAMERON;;GONEN MITHAT;;PAULIAH MOHAN;;WIESNER ULRICH,,https://lens.org/182-663-331-118-44X,Search Report,no,2,0,11,11,0,A61B6/03;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;G06T7/0012;;G06T7/40;;G06T2207/10072;;G06T2207/30096;;A61K49/0002;;G16H50/30;;A61B1/000094;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;A61K49/0002;;G06T7/0012;;G06T7/40;;G06T2207/30096;;G06T2207/10072;;A61B5/0042;;A61B5/4848;;A61B6/037;;A61B6/481;;A61B6/501;;A61B6/5247;;G06T7/0012;;G06T7/40;;G06T2207/30096;;A61B6/03;;A61B5/1075;;A61B8/481;;A61B5/4842;;A61B5/1072;;A61B6/5217;;A61B8/5223;;A61B8/085;;A61B8/5261;;A61B6/4417;;A61B8/4416;;G06T2207/10072;;A61B1/000094;;A61K49/0002;;A61B5/0035;;A61B5/055;;A61K49/1818;;A61K51/082;;A61K51/088;;A61K51/1244;;G01R33/481;;G01R33/4812;;G01R33/4814;;G01R33/5601;;G01R33/56341;;G01T1/1642;;G01T1/2985;;G06T2207/10088,A61B1/04;;A61B1/00;;A61B5/00;;A61B5/107;;A61B6/00;;A61B6/03;;A61B8/00;;A61B8/08;;A61K49/00;;G06T7/00;;G06T7/40,,7,6,043-251-313-533-200;;098-297-396-213-93X;;014-909-378-722-64X;;036-823-837-584-76X;;167-449-337-034-991;;088-731-302-600-100,10.1126/scitranslmed.3009524;;25355699;;pmc4426391;;10.1002/adma.200802366;;10.1021/acs.bioconjchem.5b00213;;25971846;;pmc5378316;;22281669;;10.1016/j.neuroimage.2012.01.070;;pmc3971916;;10.1039/c6nr00147e;;27029509;;10.1007/s00138-013-0499-8,"E. PHILLIPS ET AL: ""Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe"", SCIENCE TRANSLATIONAL MEDICINE, vol. 6, no. 260, 29 October 2014 (2014-10-29), US, pages 260ra149 - 260ra149, XP055254613, ISSN: 1946-6234, DOI: 10.1126/scitranslmed.3009524;;HYON BIN NA ET AL: ""Inorganic Nanoparticles for MRI Contrast Agents"", ADVANCED MATERIALS, vol. 21, no. 21, 5 June 2009 (2009-06-05), DE, pages 2133 - 2148, XP055251674, ISSN: 0935-9648, DOI: 10.1002/adma.200802366;;MOSES Q. WILKS ET AL: ""Imaging PEG-Like Nanoprobes in Tumor, Transient Ischemia, and Inflammatory Disease Models"", BIOCONJUGATE CHEMISTRY, vol. 26, no. 6, 17 June 2015 (2015-06-17), US, pages 1061 - 1069, XP055283192, ISSN: 1043-1802, DOI: 10.1021/acs.bioconjchem.5b00213;;JOSEPH B MANDEVILLE ED - JOHANSEN-BERG HEIDI ET AL: ""IRON fMRI measurements of CBV and implications for BOLD signal"", NEUROIMAGE, ELSEVIER, AMSTERDAM, NL, vol. 62, no. 2, 9 January 2012 (2012-01-09), pages 1000 - 1008, XP028502194, ISSN: 1053-8119, [retrieved on 20120116], DOI: 10.1016/J.NEUROIMAGE.2012.01.070;;HENG LIU ET AL: ""Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside"", NANOSCALE, vol. 8, no. 15, 1 January 2016 (2016-01-01), United Kingdom, pages 7808 - 7826, XP055661398, ISSN: 2040-3364, DOI: 10.1039/C6NR00147E;;TRAN LOC ET AL: ""High-dimensional MRI data analysis using a large-scale manifold learning approach"", MACHINE VISION AND APPLICATIONS, SPRINGER VERLAG, DE, vol. 24, no. 5, 19 April 2013 (2013-04-19), pages 995 - 1014, XP035368617, ISSN: 0932-8092, [retrieved on 20130419], DOI: 10.1007/S00138-013-0499-8;;See also references of WO 2018009379A1",PENDING
28,US,B2,US 8999633 B2,021-592-802-747-370,2015-04-07,2015,US 59782509 A,2009-06-16,US 59782509 A;;US 57579504 P;;US 58033704 P;;US 2005/0018850 W,2004-05-28,"Compositions, kits, and methods for identification, assessment, prevention and treatment of pancreatic adenocarcinoma in humans","The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human pancreatic adenocarcinoma. A variety of chromosomal regions (MCRs) and markers in the MCRs, are provided that are correlated with cancer. In particular, chromosomal regions and markers in the MCR 50.06-62.89 Mb of human chromosome 19, are provided, wherein alterations in the copy number of the MCR and/or alterations in the amount, structure, and/or activity of one or more of the markers in the MCR is correlated with the presence of pancreatic adenocarcinoma.",CHIN LYNDA;;BRENNAN CAMERON W;;DEPINHO RONALD A;;AGUIRRE ANDREW J;;DANA FARBER CANCER INST INC,CHIN LYNDA;;BRENNAN CAMERON W;;DEPINHO RONALD A;;AGUIRRE ANDREW J,DANA-FARBER CANCER INSTITUTE INC (2007-09-24),https://lens.org/021-592-802-747-370,Granted Patent,yes,17,3,8,8,1528,A61P35/00;;C12Q1/6886;;C12Q1/6886;;C12Q2600/136;;C12Q2600/136;;C12Q2600/154;;C12Q2600/154,C12Q1/68,435/6.1;;435/6.14,79,76,142-600-738-286-438;;037-500-079-365-559;;035-873-700-483-131;;075-421-931-310-223;;030-593-846-723-97X;;020-178-040-162-13X;;064-319-008-237-405;;028-194-746-291-479;;035-431-301-766-718;;013-381-721-133-983;;079-932-272-026-957;;075-014-892-357-978;;082-071-398-120-697;;026-019-394-114-311;;141-552-307-773-701;;124-069-226-874-803;;026-019-394-114-311;;076-139-734-348-158;;039-514-080-975-979;;004-738-078-948-368;;140-939-463-940-161;;098-036-108-277-651;;089-520-638-381-227;;016-077-783-232-998;;021-735-298-714-662;;001-289-663-547-397;;083-169-263-029-572;;051-425-933-870-758;;037-920-584-212-490;;018-404-105-056-33X;;043-781-583-966-151;;105-535-811-037-682;;113-297-468-619-528;;029-742-983-481-795;;031-898-723-593-793;;053-393-466-133-052;;076-314-967-087-118;;029-888-766-849-786;;048-401-146-964-224;;057-165-463-943-202;;072-007-995-074-685;;087-871-690-717-906;;141-189-916-837-818;;083-655-016-998-003;;035-094-562-115-791;;022-634-280-119-21X;;013-248-779-960-102;;012-664-627-298-304;;036-110-529-854-852;;033-204-109-356-628;;093-107-238-632-854;;102-300-777-333-609;;139-294-904-335-434;;044-051-410-207-79X;;007-948-924-640-739;;040-588-351-398-075;;008-722-170-833-554;;017-746-642-715-189;;004-184-985-742-257;;035-507-566-489-857;;034-483-080-138-002;;036-598-026-051-46X;;105-031-147-566-543;;033-490-550-941-721;;035-555-391-941-931;;033-963-799-295-451;;112-511-549-386-621;;051-346-920-381-327;;011-448-154-520-207;;114-831-710-525-364;;094-221-271-392-413;;003-322-393-947-183;;087-328-357-959-675;;022-844-593-669-795;;020-645-394-475-942;;035-078-343-015-846,11850545;;10.1038/modpathol.3880508;;10.1056/nejm199407283310401;;8015568;;12124348;;10673336;;10.1006/geno.1999.6087;;12750293;;10.1073/pnas.0402932101;;15199222;;pmc428474;;9927061;;10913674;;10.1016/s0165-4608(99)00249-6;;11066075;;10.1002/1098-2264(2000)9999:9999<::aid-gcc1047>3.0.co;2-e;;12081210;;10.1002/path.1101;;10616197;;10453739;;10.1007/s004390050994;;10.1002/(sici)1098-2264(200005)28:1<121::aid-gcc14>3.0.co;2-o;;10738310;;10.1038/75985;;10835626;;10.1002/(sici)1098-2264(199905)25:1<60::aid-gcc9>3.3.co;2-p;;10.1002/(sici)1098-2264(199905)25:1<60::aid-gcc9>3.0.co;2-y;;10221341;;10.1093/nar/gkh013;;10.1038/75985;;10835626;;10.1016/s0165-4608(99)00118-1;;10640145;;12610533;;10.1038/ng1107;;pmc1968474;;8494707;;10.1038/bjc.1993.203;;12086841;;10.1016/s1535-6108(02)00061-2;;12142370;;10.1093/clinchem/48.8.1178;;10.1158/0008-5472.can-04-1241;;15256441;;7726912;;10.1038/ng0994-27;;pmc311107;;10.1101/gr.174301;;10.1101/gr.gr1743r;;11381030;;10939410;;10.1021/ac0002386;;10.1006/geno.1998.5405;;9787076;;10.1038/nature00766;;12068308;;9218997;;10.1002/(sici)1098-2264(199707)19:3<161::aid-gcc5>3.0.co;2-w;;pmc1868131;;10.1016/s0002-9440(10)64315-5;;12759238;;pmc1850008;;10027410;;10.1016/s0002-9440(10)65298-4;;12063017;;10.1016/s0301-472x(02)00806-8;;11034080;;10.1126/science.286.5439.531;;10521349;;10.1002/(sici)1098-2264(199810)23:2<81::aid-gcc1>3.0.co;2-0;;9739011;;8605114;;10.1002/gcc.2870140404;;10.1093/carcin/21.3.443;;10688864;;10.1006/gyno.2002.6677;;12586079;;7513550;;10.1002/gcc.2870090204;;7757992;;7553647;;12414653;;8521410;;12610534;;10.1038/ng1089;;10.1002/1097-0142(19920401)69:7<1674::aid-cncr2820690706>3.0.co;2-l;;1551052;;12042769;;10.1038/nrg816;;10.1126/science.1359641;;1359641;;10.3892/ijmm.12.5.727;;14533001;;10.1002/(sici)1098-2264(199610)17:2<88::aid-gcc3>3.3.co;2-3;;10.1002/(sici)1098-2264(199610)17:2<88::aid-gcc3>3.0.co;2-x;;8913725;;15154013;;10.1038/modpathol.3800180;;pmc314163;;14673087;;10.1073/pnas.2536758100;;7849743;;10.1093/hmg/3.suppl_1.1487;;10.1007/978-3-642-59696-4_8;;10802942;;9176885;;10.1016/s1357-4310(97)01019-8;;10.1038/nrc1045;;12671664;;15034871;;10.1002/gcc.20016;;8438152;;10.1126/science.8438152;;12975311;;10.1101/gr.1349003;;pmc403708;;10.1002/(sici)1098-2264(199712)20:4<383::aid-gcc10>3.0.co;2-o;;9408755;;10.1002/gcc.10122;;12378529;;12398888;;10.1016/s1535-6108(02)00158-7;;14961574;;10.1002/ijc.11716;;10.1038/2524;;9771718;;11861394;;10.1038/12640;;10471496;;10.1073/pnas.162471999;;pmc130569;;12297621;;9135016;;10.1126/science.270.5235.467;;7569999;;8168108;;8706027;;11034075;;10.1073/pnas.1232418100;;12788976;;pmc164650;;10.1158/0008-5472.can-03-2570;;14729609;;10.1593/neo.03439;;pmc1502104;;15153336;;10.1593/neo.3439;;12355068;;10.1038/ng1007;;15126342;;10.1158/0008-5472.can-03-3308,"DePreter et al (2002) Mod. Pathol. vol. 15(2): 159-66.;;Jen et al. (1994) The New England Journal of Medicine vol. 331 No. 4 pp. 213-221.;;Hartmann et al. (2002) Cancer Research vol. 62: pp. 4100-4108.;;Pohl et al. (2000) Genomics vol. 63: pp. 255-262.;;Logsdon et al. (2003) Cancer Research 63: pp. 2649-2657.;;Table 2 of Depinho et al. from U.S. Appl. No. 11/503,499, filed Aug. 11, 2006.;;Aguirre et al. (Jun. 15, 2004) PNAS vol. 101 No. 24 pp. 9067-9072.;;Balsara et al., Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma, Cancer Research, 1999, vol. 59, pp. 450-454.;;Bello et al., High-Resolution analysis of chromosome Arm 1p alterations in meningioma, Cancer Genet Cytogenet, 2000, vol. 120, pp. 30-36.;;Fukuda et al., CD44 is a potential target of amplification within the 11p13 amplicon detected in gastric cancer cell lines, Genes, Chromosomes & Cancer. 2000, vol. 29, pp. 315-324.;;Koga et al., Frequent genomic imbalances in chromosomes 17, 19 and 22q in peripheral nerve sheath tumors detected by comparative genomic hybridization analysis, J. Pathology, 2002, vol. 197, pp. 98-107.;;O'Leary et al., Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors, Laboratory Investigation. 1999, vol. 79, No. 12, pp. 1461-1467.;;Matsumoto et al., Molecular cloning and characterization of the human NUDC gene. Hum. Genet. 1999, vol. 104, p. 498-504.;;Smedley et al., Characterization of chromosome 1 abnormalities in malignant melanomas, Genes, Chromosomes, Cancer, 2000, vol. 28, pp. 121-125.;;Watnick et al., Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene, Nature Genetics, 2000, vol. 25, pp. 144-146.;;International Search Report dated Aug. 21, 2008 from PCT/US05/18850.;;Abe, T., et al., ""Identification of Three Commonly Deleted Regions on Chromosome Arm 6q in Human Pancreatic Cancer,"" Genes Chromosomes Cancer 25:60-4 (1999).;;Akagi, K., et al., ""RTCGD: retroviral tagged cancer gene database,"" Nucl. Acids Res. 32:D523-D527 (2004).;;Albertson, D. G., et al., ""Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene,"" Nature Genetics 25, 144-146 (2000).;;Armengol, G., et al., ""DNA Copy Number Changes and Evaluation of MYC, IGF1R, and FES Amplification in Xenografts of Pancreatic Adenocarcinoma,"" Cancer Genet. Cytogenet. 116: 133-141 (2000).;;Balmain, A. et al., ""The genetics and genomics of cancer,"" Nat. Genet. 33:238-244 (2003).;;Bardi, G., et al., ""Karyotypic abnormalities in tumours of the pancreas,"" Br J Cancer 67:1106-1112 (1993).;;Baylin, S. and Bestor, T.H., ""Altered methylation patterns in cancer cell genomes: Cause or consequence?,"" Cancer Cell 1:299-305 (2002).;;Bernard, P.S. and Wittwer, C.T., ""Real-Time PCR Technology for Cancer Diagnostics,"" Clin. Chem. 48(8):1178-1185 (2002).;;Brennan, C. et al., ""High-Resolution Global Profiling of Genomic Alterations with Long Oligonucleotide Microarray,"" Cancer Res. 64(14):4744-4748 (2004).;;Caldas, C., et al., ""Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma,"" Nature Genetics 8:27-32 (1994).;;Collins, C. et al., ""Comprehensive Genome Sequence Analysis of a Breast Cancer Amplicon,"" Genome Res. 11(6):1034-1042 (2001).;;Conrads, T. P. et al., ""Utility of Accurate Mass Tags for Proteome-Wide Protein Identification,"" Anal. Chem. 72:3349-3354 (2000).;;Curtis, L. J., et al., ""Amplification of DNA Sequences from Chromosome 19q13.1 in Human Pancreatic Cell Lines,"" Genomics 53:42-55 (1998).;;Davies et al., ""Mutations of the BRAF gene in human cancer,"" Nature 417(6892):949-954 (2002).;;Fukushige, S., et al., ""Frequent Gain of Copy Number on the Long Arm of Chromosome 20 in Human Pancreatic Adenocarcinoma,"" Genes Chromosomes Cancer 19:161-9 (1997).;;Furukawa, T., et al., ""Potential Tumor Suppressive Pathway Involving DUSP6/NKP-3 in Pancreatic Cancer,"" Am J Pathology 162:1807-15 (2003).;;Ghadimi, B. M., et al., ""Specific Chromosomal Aberrations and Amplification of the AIB1 Nuclear Receptor Coactivator Gene in Pancreatic Carcinomas,"" Am. J. Pathol. 154:525-36 (1999).;;Ginzinger, D. G. ""Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream,"" Exp. Hematol. 30:503-512 (2002).;;Ginzinger, D. G. et al., ""Measurement of DNA Copy Number at Microsatellite Loci Using Quantitative PCR Analysis,"" Cancer Res. 60:5405-5409 (2000).;;Golub, T. R., et al., ""Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring,"" Science 286:531-537 (1999).;;Gorunova, L., et al., ""Cytogenetic Analysis of Pancreatic Carcinomas: Intratumor Heterogeneity and Nonrandom Pattern of Chromosome Aberrations,"" Genes Chromosomes Cancer 23:81-99 (1998).;;Gorunova, L., et al., ""Massive Cytogenetic Heterogeneity in a Pancreatic Carcinoma: Fifty-Four Karyotypically Unrelated Clones,"" Genes Chromosomes Cancer 14:259-266 (1995).;;Gray, J. W. and Collins, C., ""Genome changes and gene expression in human solid tumors,"" Carcinogenesis 21(3):443-452 (2000).;;Gray, J. W. et al., ""Specific Keynote: Genome Copy Number Abnormalities in Ovarian Cancer,"" Gyn. Oncol. 88:S16-S21 (2003).;;Griffin, C. A., et al., ""Chromosome Abnormalities in Pancreatic Adenocarcinoma,"" Genes Chromosomes Cancer 9:93-100 (1994).;;Griffin, C. A., et al., ""Consistent Chromosome Abnormalities in Adenocarcinoma of the Pancreas,"" Cancer Res. 55:2394-2399 (1995).;;Hahn, S. A., et al., ""Allelotype of Pancreatic Adenocarcinoma Using Xenograft Enrichment,"" Cancer Res. 55:4670-4675 (1995).;;Hyman, E., et al., ""Impact of DNA Amplification on Gene Expression Patterns in Breast Cancer,"" Cancer Res. 62:6240-6245 (2002).;;Iwabuchi, H. et al., ""Genetic Analysis of Benign, Low-Grade, and High-Grade Ovarian Tumors,"" Cancer Res. 55:6172-6180 (1995).;;Jaenisch, R. and Bird, A., ""Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals,"" Nature Genetics, 33:245-254 (2003).;;Johansson, B., et al., ""Nonrandom Chromosomal Rearrangements in Pancreatic Carcinomas,"" Cancer 69:1674-1681 (1992).;;Jones, P. A. and Baylin, S. B., ""The Fundamental Role of Epigenetic Events in Cancer,"" Nat. Rev. Genet. 3(6):415-428 (2002).;;Kallioniemi, A. et al., ""Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors,"" Science 258:818-821 (1992).;;Kawasaki, K. et al., ""11q23-24 loss is associated with chromosomal instability in endometrial cancer,"" Int. J. Mol. Med. 12(5):727-731 (2003).;;Kimura, M., et al., ""Detailed Deletion Mapping on Chromosome Arm 12q in Human Pancreatic Adenocarcinoma: Identification of a 1-cM Region of Common Allelic Loss,"" Genes Chromosomes Cancer 17:88-93 (1996).;;Kimura Y, et al., ""Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression,"" Mod. Pathol., 17:1328-1337 (2004).;;Laird, C. D. et al., ""Hairpin-bisulfite PCR: Assessing epigenetic methylation patterns on complementary strands of individual DNA molecules,"" Proc. Natl. Acad. Sci. USA 101(1):204-209 (2004).;;Laird, P. W. and Jaenisch, R., ""DNA methylation and cancer,"" Hum. Mol. Genet. 3:1487-1495 (1994).;;Laird, P. W., ""Mouse Models in DNA-Methylation Research,"" Curr. Top. Microbiol. Immunol. 249:119-134 (2000).;;Laird, P. W., ""Oncogenic mechanisms mediated by DNA methylation,"" Mol. Med. Today 3(5):223-229 (1997).;;Laird, P. W., ""The Power and the Promise of DNA Methylation Markers,"" Nat. Rev. Cancer 3(4):253-266 (2003).;;Lapuk et al., ""Computational BAC Clone Contig Assembly for Comprehensive Genome Analysis,"" Genes Chrom. Cancer 40:66-71 (2004).;;Lisitsyn, N. et al., ""Cloning the Differences Between Two Complex Genomes,"" Science 259:946-951 (1993).;;Lucito, R., et al., ""Representational Oligonucleotide Microarray Analysis: A High-Resolution Method to Detect Genome Copy Number Variation,"" Genome Res. 13,2291-305 (2003).;;Mahlamaki, E. H., et al., ""Comparative Genomic Hybridization Reveals Frequent Gains of 20q, 8q, 11q, 12q, and 17q, and Losses of 18q, 9q, and 15q in Pancreatic Cancer,"" Genes Chromosomes Cancer 20:383-91 (1997).;;Mahlamaki, E. H., et al., ""Frequent Amplification of 8q24, 11q, 17q, and 20q-Specific Genes in Pancreatic Cancer,"" Genes Chromosomes Cancer 35:353-358 (2002).;;Neil, J. C. & Cameron, E. R., ""Retroviral insertion sites and cancer: Fountain of all knowledge?,"" Cancer Cell 2:253-255 (2002).;;Nilsson, M. et al., ""Amplification of Chromosome 1 Sequences in Lipomatous Tumors and Other Sarcomas,"" Int. J. Cancer 109(3):363-369 (2004).;;Olshen, A. B., and Venkatraman, E. S., ""Change-Point Analysis of Array-Based Comparative Genomic Hybridization Data,"" ASA Proceedings of the Joint Statistical Meetings 2530-2535 (2002).;;Pinkel, D. et al., ""High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays,"" Nature Genetics 20:207-21I (1998).;;Platzer, P., et al., ""Silence of Chromosomal Amplifications in Colon Cancer,"" Cancer Res. 62:1134-1138 (2002).;;Pollack, J. R., et al., ""Genome-wide analysis of DNA copy-number changes using cDNA microarrays,"" Nat. Genet. 23:41-46 (1999).;;Pollack, J. R., et al., ""Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors,"" Proc. Natl. Acad. Sci. USA 99(20):12963-12968 (2002).;;Rozenblum, E., et al., ""Tumor-suppressive Pathways in Pancreatic Carcinoma,"" Cancer Res. 57:1731-1734 (1997).;;Schena, M. et al., ""Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray,"" Science 270:467-470 (1995).;;Seymour, A. B., et al., ""Allelotype of Pancreatic Adenocarcinoma,"" Cancer Res. 54: 2761-2764 (1994).;;Solinas-Toldo, S., et al., ""Mapping of Chromosomal Imbalances in Pancreatic Carcinoma by Comparative Genomic Hybridization,"" Cancer Res. 56:3803-3807 (1996).;;Suzuki, S. et al., ""An Approach to Analysis of Large-Scale Correlations between Genome Changes and Clinical Endpoints in Ovarian Cancer,"" Cancer Res. 60(19):5382-5385 (2000).;;Volik, S., ""End-sequence profiling: Sequence-based analysis of aberrant genomes,"" Proc. Natl. Acad. Sci. USA 100(13):7696-7701 (2003).;;Wang Z. C. et al., ""Loss of Heterozygosity and Its Correlation with Expression Profiles in Subclasses of Invasive Breast Cancers,"" Cancer Res 64(1):64-71 (2004).;;Wolf, M et al., ""High-Resolution Analysis of Gene Copy Number Alterations in Human Prostate Cancer Using CGH on cDNA Microarrays: Impact of Copy Number on Gene Expression,"" Neoplasia 6(3):240-247 (2004).;;Zardo, G. et al., ""Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors,"" Nat. Genet. 32(3):453-458 (2002).;;Zhao et al., ""An Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays,"" Cancer Res. 64:3060-3071 (2004).",INACTIVE
29,KR,A,KR 20190028723 A,057-657-455-604-498,2019-03-19,2019,KR 20197003434 A,2017-06-28,US 201662359684 P;;US 2017/0039620 W,2016-07-07,"입자-구동, 지식-기반, 및 예측성 암 방사선유전체학을 위한 영상화 시스템 및 방법","암에서(예를 들어, 저-악성도 및/또는 고-악성도 뇌암(예를 들어, 신경아교종, 예를 들어, 원발성 신경아교종)에서) 종양내 및 간질성 나노입자 분포를 예측하기 위해 영상화 특징을 확인하는데 사용될 수 있는 입자-구동 방사선유전체학 시스템 및 방법이 본원에 개시된다. 특정 구체예에서, 본원에 기재된 시스템 및 방법은 구조적, 기능적 및/또는 대사적 영상화로부터 생성된 정량적인 다차원 데이터를 추출 및 조합시킨다. 특정 구체예에서, 조합된 다차원 데이터는 종양내 및 간질성 나노입자 분포에 관련된다. 예를 들어, 이 관련된 데이터는 정량적인 기능성-대사성 멀티모달리티 입자-기반 영상화 특징을 결정하고 치료 효능을 예측하는데 사용될 수 있다. 이러한 기술은 전통적인 크기-기반 영상화 방법에 비해 치료 반응을 측정하고 종양 진행을 결정하는 개선된 정량 능력을 제공한다.",MEMORIAL SLOAN KETTERING CANCER CENTER;;UNIV CORNELL,BRADBURY MICHELLE S;;BRENNAN CAMERON;;GONEN MITHAT;;PAULIAH MOHAN;;WIESNER ULRICH,,https://lens.org/057-657-455-604-498,Patent Application,no,0,0,11,11,0,A61B6/03;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;G06T7/0012;;G06T7/40;;G06T2207/10072;;G06T2207/30096;;A61K49/0002;;G16H50/30;;A61B1/000094;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;A61K49/0002;;G06T7/0012;;G06T7/40;;G06T2207/30096;;G06T2207/10072;;A61B5/0042;;A61B5/4848;;A61B6/037;;A61B6/481;;A61B6/501;;A61B6/5247;;G06T7/0012;;G06T7/40;;G06T2207/30096;;A61B6/03;;A61B5/1075;;A61B8/481;;A61B5/4842;;A61B5/1072;;A61B6/5217;;A61B8/5223;;A61B8/085;;A61B8/5261;;A61B6/4417;;A61B8/4416;;G06T2207/10072;;A61B1/000094;;A61K49/0002;;A61B5/0035;;A61B5/055;;A61K49/1818;;A61K51/082;;A61K51/088;;A61K51/1244;;G01R33/481;;G01R33/4812;;G01R33/4814;;G01R33/5601;;G01R33/56341;;G01T1/1642;;G01T1/2985;;G06T2207/10088,A61B5/00;;A61B5/107;;A61B6/00;;A61B6/03;;A61B8/00;;A61B8/08;;A61K49/00;;G06T7/00;;G06T7/40,,0,0,,,,PENDING
30,CN,A,CN 109475279 A,192-259-341-558-666,2019-03-15,2019,CN 201780045361 A,2017-06-28,US 201662359684 P;;US 2017/0039620 W,2016-07-07,"IMAGING SYSTEMS AND METHODS FOR PARTICLE-DRIVEN, KNOWLEDGE-BASED, AND PREDICTIVE CANCER RADIOGENOMICS","Described herein are particle-driven radiogenomics systems and methods that can be used to identify imaging features for prediction of intratumoral and interstitial nanoparticle distributions in cancers (e.g., in low grade and/or high-grade brain cancers (e.g., gliomas, e.g., primary gliomas)). In certain embodiments, the systems and methods described herein extract and combine quantitative multi-dimensional data generated from structural, functional, and/or metabolic imaging. In certain embodiments, the combined multidimensional data is linked to intratumoral and interstitial nanoparticle distributions. For example, this linked data can be used to determine quantitative functional-metabolic multimodality particle-based imaging features and to predict treatment efficacy. These techniques provide an improved quantitative ability to measure treatment response and determine tumor progressions compared to traditional size-based imaging methods.",MEMORIAL SLOAN KETTERING CANCER CENTER;;UNIV CORNELL,BRADBURY MICHELLE S;;BRENNAN CAMERON;;GONEN MITHAT;;PAULIAH MOHAN;;WIESNER ULRICH,,https://lens.org/192-259-341-558-666,Patent Application,no,5,3,11,11,0,A61B6/03;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;G06T7/0012;;G06T7/40;;G06T2207/10072;;G06T2207/30096;;A61K49/0002;;G16H50/30;;A61B1/000094;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;A61K49/0002;;G06T7/0012;;G06T7/40;;G06T2207/30096;;G06T2207/10072;;A61B5/0042;;A61B5/4848;;A61B6/037;;A61B6/481;;A61B6/501;;A61B6/5247;;G06T7/0012;;G06T7/40;;G06T2207/30096;;A61B6/03;;A61B5/1075;;A61B8/481;;A61B5/4842;;A61B5/1072;;A61B6/5217;;A61B8/5223;;A61B8/085;;A61B8/5261;;A61B6/4417;;A61B8/4416;;G06T2207/10072;;A61B1/000094;;A61K49/0002;;A61B5/0035;;A61B5/055;;A61K49/1818;;A61K51/082;;A61K51/088;;A61K51/1244;;G01R33/481;;G01R33/4812;;G01R33/4814;;G01R33/5601;;G01R33/56341;;G01T1/1642;;G01T1/2985;;G06T2207/10088,A61B1/04;;A61B5/00;;A61B6/03;;A61K49/00,,0,0,,,,PENDING
31,AU,A1,AU 2017/291702 A1,081-555-247-200-766,2019-01-17,2019,AU 2017/291702 A,2017-06-28,US 201662359684 P;;US 2017/0039620 W,2016-07-07,"Imaging systems and methods for particle-driven, knowledge-based, and predictive cancer radiogenomics","Described herein are particle-driven radiogenomics systems and methods that can be used to identify imaging features for prediction of intratumoral and interstitial nanoparticle distributions in cancers (e.g., in low grade and/or high-grade brain cancers (e.g., gliomas, e.g., primary gliomas)). In certain embodiments, the systems and methods described herein extract and combine quantitative multi-dimensional data generated from structural, functional, and/or metabolic imaging. In certain embodiments, the combined multidimensional data is linked to intratumoral and interstitial nanoparticle distributions. For example, this linked data can be used to determine quantitative functional-metabolic multimodality particle-based imaging features and to predict treatment efficacy. These techniques provide an improved quantitative ability to measure treatment response and determine tumor progressions compared to traditional size-based imaging methods.",UNIV CORNELL;;MEMORIAL SLOAN KETTERING CANCER CENTER,BRADBURY MICHELLE S;;BRENNAN CAMERON;;GONEN MITHAT;;PAULIAH MOHAN;;WIESNER ULRICH,,https://lens.org/081-555-247-200-766,Patent Application,no,0,0,11,11,0,A61B6/03;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;G06T7/0012;;G06T7/40;;G06T2207/10072;;G06T2207/30096;;A61K49/0002;;G16H50/30;;A61B1/000094;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;A61K49/0002;;G06T7/0012;;G06T7/40;;G06T2207/30096;;G06T2207/10072;;A61B5/0042;;A61B5/4848;;A61B6/037;;A61B6/481;;A61B6/501;;A61B6/5247;;G06T7/0012;;G06T7/40;;G06T2207/30096;;A61B6/03;;A61B5/1075;;A61B8/481;;A61B5/4842;;A61B5/1072;;A61B6/5217;;A61B8/5223;;A61B8/085;;A61B8/5261;;A61B6/4417;;A61B8/4416;;G06T2207/10072;;A61B1/000094;;A61K49/0002;;A61B5/0035;;A61B5/055;;A61K49/1818;;A61K51/082;;A61K51/088;;A61K51/1244;;G01R33/481;;G01R33/4812;;G01R33/4814;;G01R33/5601;;G01R33/56341;;G01T1/1642;;G01T1/2985;;G06T2207/10088,A61B1/04;;A61B5/00;;A61B6/03;;A61K49/00,,0,0,,,,ACTIVE
32,CA,A1,CA 3029994 A1,164-699-734-752-80X,2018-01-11,2018,CA 3029994 A,2017-06-28,US 201662359684 P;;US 2017/0039620 W,2016-07-07,"IMAGING SYSTEMS AND METHODS FOR PARTICLE-DRIVEN, KNOWLEDGE-BASED, AND PREDICTIVE CANCER RADIOGENOMICS","Described herein are particle-driven radiogenomics systems and methods that can be used to identify imaging features for prediction of intratumoral and interstitial nanoparticle distributions in cancers (e.g., in low grade and/or high-grade brain cancers (e.g., gliomas, e.g., primary gliomas)). In certain embodiments, the systems and methods described herein extract and combine quantitative multi-dimensional data generated from structural, functional, and/or metabolic imaging. In certain embodiments, the combined multidimensional data is linked to intratumoral and interstitial nanoparticle distributions. For example, this linked data can be used to determine quantitative functional-metabolic multimodality particle-based imaging features and to predict treatment efficacy. These techniques provide an improved quantitative ability to measure treatment response and determine tumor progressions compared to traditional size-based imaging methods.",UNIV CORNELL;;MEMORIAL SLOAN KETTERING CANCER CENTER,BRADBURY MICHELLE S;;BRENNAN CAMERON;;GONEN MITHAT;;PAULIAH MOHAN;;WIESNER ULRICH,,https://lens.org/164-699-734-752-80X,Patent Application,no,0,0,11,11,0,A61B6/03;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;G06T7/0012;;G06T7/40;;G06T2207/10072;;G06T2207/30096;;A61K49/0002;;G16H50/30;;A61B1/000094;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;A61K49/0002;;G06T7/0012;;G06T7/40;;G06T2207/30096;;G06T2207/10072;;A61B5/0042;;A61B5/4848;;A61B6/037;;A61B6/481;;A61B6/501;;A61B6/5247;;G06T7/0012;;G06T7/40;;G06T2207/30096;;A61B6/03;;A61B5/1075;;A61B8/481;;A61B5/4842;;A61B5/1072;;A61B6/5217;;A61B8/5223;;A61B8/085;;A61B8/5261;;A61B6/4417;;A61B8/4416;;G06T2207/10072;;A61B1/000094;;A61K49/0002;;A61B5/0035;;A61B5/055;;A61K49/1818;;A61K51/082;;A61K51/088;;A61K51/1244;;G01R33/481;;G01R33/4812;;G01R33/4814;;G01R33/5601;;G01R33/56341;;G01T1/1642;;G01T1/2985;;G06T2207/10088,A61B1/04;;A61B5/00;;A61B6/03;;A61K49/00,,0,0,,,,PENDING
33,US,A1,US 2009/0297536 A1,011-631-701-680-003,2009-12-03,2009,US 59782509 A,2009-06-16,US 59782509 A;;US 57579504 P;;US 58033704 P;;US 2005/0018850 W,2004-05-28,"Compositions, kits, and methods for identification, assessment, prevention and therapy of cancer","The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human cancer. A variety of chromosomal regions (MCRs) and markers corresponding thereto, are provided, wherein alterations in the copy number of one or more of the MCRs and/or alterations in the amount, structure, and/or activity of one or more of the markers is correlated with the presence of cancer.",DANA FARBER CANCER INST INC,CHIN LYNDA;;BRENNAN CAMERON W;;DEPINHO RONALD A;;AGUIRRE ANDREW J,DANA-FARBER CANCER INSTITUTE INC (2007-09-24),https://lens.org/011-631-701-680-003,Patent Application,yes,17,9,8,8,1528,A61P35/00;;C12Q1/6886;;C12Q1/6886;;C12Q2600/136;;C12Q2600/136;;C12Q2600/154;;C12Q2600/154,A61K39/395;;A01K67/00;;A61K31/7052;;A61K38/02;;A61K38/16;;A61P35/00;;C07H21/00;;C07K14/00;;C07K16/00;;C12Q1/68;;C40B30/00,424/172.1;;435/6;;506/7;;800/10;;424/183.1;;424/178.1;;X514 44  A;;514/2;;514/12;;530/350;;536/23.1;;530/389.1,7,6,142-600-738-286-438;;037-500-079-365-559;;035-873-700-483-131;;075-421-931-310-223;;030-593-846-723-97X;;020-178-040-162-13X,11850545;;10.1038/modpathol.3880508;;10.1056/nejm199407283310401;;8015568;;12124348;;10673336;;10.1006/geno.1999.6087;;12750293;;10.1073/pnas.0402932101;;15199222;;pmc428474,"DePreter et al (2002) Mod. Pathol. Vol. 15(2): 159-66.;;Jen et al. (1994) The New England Journal of Medicine vol 331 no 4 pp 213-221.;;Hartmann et al. (2002) Cancer Research Vol. 62: pp 4100-4108;;Pohl et al. (2000) Genomics vol. 63: pp 255-262.;;Logsdon et al. (2003) Cancer Research 63: pp 2649-2657;;Table 2 of Depinho et al. from US application 11503499 filed 2006-08-11;;Aguirre et al. (June 15, 2004) PNAS vol. 101 no 24 pp 9067-9072",INACTIVE
34,WO,A1,WO 2018/009379 A1,156-075-099-842-359,2018-01-11,2018,US 2017/0039620 W,2017-06-28,US 201662359684 P,2016-07-07,"IMAGING SYSTEMS AND METHODS FOR PARTICLE-DRIVEN, KNOWLEDGE-BASED, AND PREDICTIVE CANCER RADIOGENOMICS","Described herein are particle-driven radiogenomics systems and methods that can be used to identify imaging features for prediction of intratumoral and interstitial nanoparticle distributions in cancers (e.g., in low grade and/or high-grade brain cancers (e.g., gliomas, e.g., primary gliomas)). In certain embodiments, the systems and methods described herein extract and combine quantitative multi-dimensional data generated from structural, functional, and/or metabolic imaging. In certain embodiments, the combined multidimensional data is linked to intratumoral and interstitial nanoparticle distributions. For example, this linked data can be used to determine quantitative functional-metabolic multimodality particle-based imaging features and to predict treatment efficacy. These techniques provide an improved quantitative ability to measure treatment response and determine tumor progressions compared to traditional size-based imaging methods.",MEMORIAL SLOAN KETTERING CANCER CENTER;;UNIV CORNELL,BRADBURY MICHELLE S;;BRENNAN CAMERON;;GONEN MITHAT;;PAULIAH MOHAN;;WIESNER ULRICH,,https://lens.org/156-075-099-842-359,Patent Application,yes,21,5,11,11,0,A61B6/03;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;G06T7/0012;;G06T7/40;;G06T2207/10072;;G06T2207/30096;;A61K49/0002;;G16H50/30;;A61B1/000094;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;A61K49/0002;;G06T7/0012;;G06T7/40;;G06T2207/30096;;G06T2207/10072;;A61B5/0042;;A61B5/4848;;A61B6/037;;A61B6/481;;A61B6/501;;A61B6/5247;;G06T7/0012;;G06T7/40;;G06T2207/30096;;A61B6/03;;A61B5/1075;;A61B8/481;;A61B5/4842;;A61B5/1072;;A61B6/5217;;A61B8/5223;;A61B8/085;;A61B8/5261;;A61B6/4417;;A61B8/4416;;G06T2207/10072;;A61B1/000094;;A61K49/0002;;A61B5/0035;;A61B5/055;;A61K49/1818;;A61K51/082;;A61K51/088;;A61K51/1244;;G01R33/481;;G01R33/4812;;G01R33/4814;;G01R33/5601;;G01R33/56341;;G01T1/1642;;G01T1/2985;;G06T2207/10088,A61B1/04;;A61B5/00;;A61B6/03;;A61K49/00,,10,8,043-251-313-533-200;;126-859-414-816-167;;060-065-125-323-879;;042-530-637-812-439;;067-908-625-714-566;;011-313-925-442-246;;007-348-260-535-24X;;103-075-327-952-865,10.1126/scitranslmed.3009524;;25355699;;pmc4426391;;10.1038/81192;;11062440;;10.1038/nbt0198-49;;9447593;;10946975;;10.1097/00004424-200008000-00004;;10.1038/86707;;11283589;;10.1117/1.1352748;;11375721;;9336985;;10.1021/bp970088t;;9359110;;10.1038/nbt1197-1271,"E. PHILLIPS ET AL.: ""Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe"", SCIENCE TRANSLATIONAL MEDICINE, US, vol. 6, no. 260, 29 October 2014 (2014-10-29), XP055254613, DOI: 10.1126/scitranslmed.3009524;;TYAGI ET AL., NAT. BIOTECHNOL., vol. 18, 2000, pages 1191 - 1196;;TYAGI ET AL., NAT. BIOTECHNOL., vol. 16, 1998, pages 49 - 53;;ACHILEFU ET AL., INVEST. RADIOL., vol. 35, 2000, pages 479 - 485;;BECKER ET AL., NATURE BIOTECH, vol. 19, 2001, pages 327 - 331;;BUJAI ET AL., J. BIOMED. OPT., vol. 6, 2001, pages 122 - 133;;BALLOU ET AL., BIOTECHNOL. PROG., vol. 13, 1997, pages 649 - 658;;NERI ET AL., NATURE BIOTECH, vol. 15, 1997, pages 1271 - 1275;;LACKOWICZ: ""Principles of Fluorescence Spectroscopy"", 1999, KLUWAR ACADEMIC;;See also references of EP 3481272A4",PENDING
35,US,A1,US 2019/0231903 A1,002-289-008-898-04X,2019-08-01,2019,US 201716315401 A,2017-06-28,US 201716315401 A;;US 201662359684 P;;US 2017/0039620 W,2016-07-07,"IMAGING SYSTEMS AND METHODS FOR PARTICLE-DRIVEN, KNOWLEDGE-BASED, AND PREDICTIVE CANCER RADIOGENOMICS","Described herein are particle-driven radiogenomics systems and methods that can be used to identify imaging features for prediction of intratumoral and interstitial nanoparticle distributions in cancers (e.g., in low grade and/or high-grade brain cancers (e.g., gliomas, e.g., primary gliomas)). In certain embodiments, the systems and methods described herein extract and combine quantitative multi-dimensional data generated from structural, functional, and/or metabolic imaging. In certain embodiments, the combined multidimensional data is linked to intratumoral and interstitial nanoparticle distributions. For example, this linked data can be used to determine quantitative functional-metabolic multimodality particle-based imaging features and to predict treatment efficacy. These techniques provide an improved quantitative ability to measure treatment response and determine tumor progressions compared to traditional size-based imaging methods.",MEMORIAL SLOAN KETTERING CANCER CENTER;;UNIV CORNELL,BRADBURY MICHELLE S;;BRENNAN CAMERON;;GONEN MITHAT;;PAULIAH MOHAN;;WIESNER ULRICH,CORNELL UNIVERSITY (2017-07-19);;MEMORIAL SLOAN KETTERING CANCER CENTER (2017-08-11),https://lens.org/002-289-008-898-04X,Patent Application,yes,0,2,11,11,0,A61B6/03;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;G06T7/0012;;G06T7/40;;G06T2207/10072;;G06T2207/30096;;A61K49/0002;;G16H50/30;;A61B1/000094;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;A61K49/0002;;G06T7/0012;;G06T7/40;;G06T2207/30096;;G06T2207/10072;;A61B5/0042;;A61B5/4848;;A61B6/037;;A61B6/481;;A61B6/501;;A61B6/5247;;G06T7/0012;;G06T7/40;;G06T2207/30096;;A61B6/03;;A61B5/1075;;A61B8/481;;A61B5/4842;;A61B5/1072;;A61B6/5217;;A61B8/5223;;A61B8/085;;A61B8/5261;;A61B6/4417;;A61B8/4416;;G06T2207/10072;;A61B1/000094;;A61K49/0002;;A61B5/0035;;A61B5/055;;A61K49/1818;;A61K51/082;;A61K51/088;;A61K51/1244;;G01R33/481;;G01R33/4812;;G01R33/4814;;G01R33/5601;;G01R33/56341;;G01T1/1642;;G01T1/2985;;G06T2207/10088,A61K49/00;;A61B5/00;;A61B5/055;;A61B6/00;;A61B6/03;;A61K49/18;;A61K51/08;;A61K51/12;;G01R33/48;;G01R33/56;;G01R33/563;;G01T1/164;;G01T1/29;;G06T7/00;;G06T7/40,,0,0,,,,PENDING
36,EP,A1,EP 3481272 A1,095-232-835-084-361,2019-05-15,2019,EP 17824714 A,2017-06-28,US 201662359684 P;;US 2017/0039620 W,2016-07-07,"IMAGING SYSTEMS AND METHODS FOR PARTICLE-DRIVEN, KNOWLEDGE-BASED, AND PREDICTIVE CANCER RADIOGENOMICS",,MEMORIAL SLOAN KETTERING CANCER CENTER;;UNIV CORNELL,BRADBURY MICHELLE S;;BRENNAN CAMERON;;GONEN MITHAT;;PAULIAH MOHAN;;WIESNER ULRICH,,https://lens.org/095-232-835-084-361,Patent Application,yes,0,0,11,11,0,A61B6/03;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;G06T7/0012;;G06T7/40;;G06T2207/10072;;G06T2207/30096;;A61K49/0002;;G16H50/30;;A61B1/000094;;A61B5/0042;;A61B5/1072;;A61B5/1075;;A61B5/4842;;A61B5/4848;;A61B6/037;;A61B6/4417;;A61B6/481;;A61B6/501;;A61B6/5217;;A61B6/5247;;A61B8/085;;A61B8/4416;;A61B8/481;;A61B8/5223;;A61B8/5261;;A61K49/0002;;G06T7/0012;;G06T7/40;;G06T2207/30096;;G06T2207/10072;;A61B5/0042;;A61B5/4848;;A61B6/037;;A61B6/481;;A61B6/501;;A61B6/5247;;G06T7/0012;;G06T7/40;;G06T2207/30096;;A61B6/03;;A61B5/1075;;A61B8/481;;A61B5/4842;;A61B5/1072;;A61B6/5217;;A61B8/5223;;A61B8/085;;A61B8/5261;;A61B6/4417;;A61B8/4416;;G06T2207/10072;;A61B1/000094;;A61K49/0002;;A61B5/0035;;A61B5/055;;A61K49/1818;;A61K51/082;;A61K51/088;;A61K51/1244;;G01R33/481;;G01R33/4812;;G01R33/4814;;G01R33/5601;;G01R33/56341;;G01T1/1642;;G01T1/2985;;G06T2207/10088,A61B1/04;;A61B5/00;;A61B6/03;;A61K49/00,,0,0,,,,PENDING
37,US,S,US D0725665 S,037-775-275-559-978,2015-03-31,2015,US 201329450198 F,2013-03-15,US 201329450198 F,2013-03-15,Display screen with graphical user interface,,TSENG ERICK;;WONG YOON KEAN;;CAMPBELL COLIN CAMERON BRENNAN;;KRAUSZ BRIAN;;PAPAKIPOS MATTHEW NICHOLAS;;FACEBOOK INC,TSENG ERICK;;WONG YOON KEAN;;CAMPBELL COLIN CAMERON BRENNAN;;KRAUSZ BRIAN;;PAPAKIPOS MATTHEW NICHOLAS,META PLATFORMS INC (2013-05-02),https://lens.org/037-775-275-559-978,Design Right,no,0,37,1,1,0,,,1404;;D14/486,0,0,,,,ACTIVE
38,US,A1,US 2021/0220494 A1,185-178-398-755-03X,2021-07-22,2021,US 201716095780 A,2017-04-28,US 201716095780 A;;US 201662330029 P;;US 2017/0030056 W,2016-04-29,"COMPOSITIONS AND METHODS FOR TARGETED PARTICLE PENETRATION, DISTRIBUTION, AND RESPONSE IN MALIGNANT BRAIN TUMORS","Described herein are nanoparticle conjugates that demonstrate enhanced penetration of tumor tissue (e.g., brain tumor tissue) and diffusion within the tumor interstitium, e.g., for treatment of cancer. Further described are methods of targeting tumor-associated macrophages, microglia, and/or other cells in a tumor microenvironment using such nanoparticle conjugates. Moreover, diagnostic, therapeutic, and theranostic (diagnostic and therapeutic) platforms featuring such nanoparticle conjugates are described for treating targets in both the tumor and surrounding microenvironment, thereby enhancing efficacy of cancer treatment. Use of the nanoparticle conjugates described herein with other conventional therapies, including chemotherapy, radiotherapy, immunotherapy, and the like, is also envisaged.",MEMORIAL SLOAN KETTERING CANCER CENTER;;UNIV CORNELL,BRADBURY MICHELLE S;;OVERHOLTZER MICHAEL;;BRENNAN CAMERON;;YOO BARNEY;;WOLCHOK JEDD D;;WIESNER ULRICH,CORNELL UNIVERSITY (2017-05-12);;MEMORIAL SLOAN KETTERING CANCER CENTER (2017-07-10),https://lens.org/185-178-398-755-03X,Patent Application,yes,1,5,12,12,0,A61K47/6923;;A61P11/00;;A61P25/00;;A61P35/00;;A61P35/04;;A61P43/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K45/06;;A61K51/0474;;A61K51/1244;;A61K2123/00;;A61K2121/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K51/0474;;A61K51/1244;;A61K2121/00,A61K51/12;;A61K47/69;;A61K51/04;;A61P35/00,,2,2,054-588-053-303-742;;037-796-365-534-486,10.1021/am405219u;;24417514;;12438511;;10.1124/jpet.102.039669,"Liu et al. (ACS Appl. Mater. Interfaces 2014, 6, 2131-2136);;Brigger et al. (J. Pharmocol. Exper. Ther. 2002, 303, 928-936)",DISCONTINUED
39,BR,A2,BR 112018069133 A2,189-175-083-665-787,2019-01-22,2019,BR 112018069133 A,2017-04-28,US 2017/0030056 W;;US 201662330029 P,2016-04-29,"composições e métodos para penetração direcionada de partículas, distribuição, e resposta em tumores cerebrais malignos","a presente invenção refere-se a conjugados de nanopartículas que demonstram penetração aumentada no tecido tumoral (p. ex., tecido tumoral cerebral) e difusão dentro do interstício tumoral, p. ex., para o tratamento de câncer. refere-se ainda a métodos de direcionamento para macrófagos associados a tumores, micróglia e/ou outras células em um microambiente tumoral utilizando tais conjugados de nanopartículas. além disso, são descritas plataformas diagnósticas, terapêuticas e teragnósticas (diagnósticas e terapêuticas) apresentando tais conjugados de nanopartículas para o tratamento de alvos no tumor e no microambiente ao redor, aumentando, assim, a eficácia do tratamento contra o câncer. prevê-se também o uso dos conjugados de nanopartículas aqui descritos com outras terapias convencionais, incluindo quimioterapia, radioterapia, imunoterapia e outras semelhantes.",UNIV CORNELL;;MEMORIAL SLOAN KETTERING CANCER CENTER,BARNEY YOO;;CAMERON BRENNAN;;JEDD D WOLCHOK;;MICHAEL OVERHOLTZER;;MICHELLE S BRADBURY;;ULRICH WIESNER,,https://lens.org/189-175-083-665-787,Patent Application,no,0,0,12,12,0,A61K47/6923;;A61P11/00;;A61P25/00;;A61P35/00;;A61P35/04;;A61P43/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K45/06;;A61K51/0474;;A61K51/1244;;A61K2123/00;;A61K2121/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K51/0474;;A61K51/1244;;A61K2121/00,A61P35/00;;A61K47/69;;B82Y5/00,,0,0,,,,PENDING
40,CN,A,CN 109069666 A,128-580-635-941-185,2018-12-21,2018,CN 201780026280 A,2017-04-28,US 2017/0030056 W;;US 201662330029 P,2016-04-29,"Compositions and methods for targeted particle penetration, distribution, and response in malignant brain tumors","Described herein are nanoparticle conjugates that demonstrate enhanced penetration of tumor tissue (e.g., brain tumor tissue) and diffusion within the tumor interstitium, e.g., for treatment of cancer. Further described are methods of targeting tumor-associated macrophages, microglia, and/or other cells in a tumor microenvironment using such nanoparticle conjugates. Moreover, diagnostic, therapeutic, and theranostic (diagnostic and therapeutic) platforms featuring such nanoparticle conjugates are described for treating targets in both the tumor and surrounding microenvironment, thereby enhancing efficacy of cancer treatment. Use of the nanoparticle conjugates described herein with other conventional therapies, including chemotherapy, radiotherapy, immunotherapy, and the like, is also envisaged.",MEMORIAL SLOAN KETTERING CANCER CENTER;;UNIV CORNELL,BRADBURY MICHELLE S;;OVERHOLTZER MICHAEL;;BRENNAN CAMERON;;YOO BARNEY;;WOLCHOK JEDD D;;WIESNER ULRICH,,https://lens.org/128-580-635-941-185,Patent Application,no,10,1,12,12,0,A61K47/6923;;A61P11/00;;A61P25/00;;A61P35/00;;A61P35/04;;A61P43/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K45/06;;A61K51/0474;;A61K51/1244;;A61K2123/00;;A61K2121/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K51/0474;;A61K51/1244;;A61K2121/00,A61K47/69;;A61P35/00;;B82Y5/00,,13,0,,,"JONGJIN JUNG等: ""Selective Inhibition of Human Brain Tumor Cells through Multifunctional Quantum-Dot-Based siRNA Delivery"", 《ANGEWANDTE CHEMIE》;;BARNEY YOO等: ""Ultrasmall dual-modality silica nanoparticle drug conjugates: Design, synthesis, and characterization"", 《BIOORGANIC & MEDICINAL CHEMISTRY》;;HEMANT SARIN等: ""Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells"", 《JOURNAL OF TRANSLATIONAL MEDICINE》;;REMANT BAHADUR K.C.等: ""Redox Potential Ultrasensitive Nanoparticle for the Targeted Delivery of Camptothecin to HER2-Positive Cancer Cells"", 《MOL. PHARMACEUTICS》;;CHEOL AM HONG等: ""Functional Nanostructures for Effective Delivery of Small Interfering RNA Therapeutics"", 《THERANOSTICS》;;李蠡: ""α-黑素细胞刺激素对恶性黑色素瘤细胞的生物学作用"", 《万方学位论文》;;郭秋均等: ""肿瘤相关巨噬细胞在重塑肿瘤免疫微环境中的作用"", 《肿瘤》;;YANNA CUI等: ""Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment"", 《BIOMATERIALS》;;EUNYOUNG LEE等: ""Erlotinib Versus Gefitinib for Control of Leptomeningeal Carcinomatosis in Non–Small-Cell Lung Cancer"", 《J. THORACIC ONCOL.》;;HALINA RUDNICKA等: ""Rakowatość opon mózgu i rdzenia u pacjentki z rakiem piersi — próba leczenia liposomalną doksorubicyną"", 《ONCOL. CLIN. PRACTICE》;;EVAN PHILLIPS等: ""Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe"", 《SCIENCE TRANSLATIONAL MEDICINE 》;;VIORICA BRANISTE等: ""The gut microbiota influences blood-brain barrier permeability in mice"", 《SCI. TRANSL. MED.》;;AARON C. ANSELMO等: ""A Review of Clinical Translation of Inorganic Nanoparticles"", 《THE AAPS JOURNAL》",ACTIVE
41,AU,B2,AU 2017/258415 B2,057-263-304-381-109,2023-03-30,2023,AU 2017/258415 A,2017-04-28,US 201662330029 P;;US 2017/0030056 W,2016-04-29,"Compositions and methods for targeted particle penetration, distribution, and response in malignant brain tumors","Described herein are nanoparticle conjugates that demonstrate enhanced penetration of tumor tissue (e.g., brain tumor tissue) and diffusion within the tumor interstitium, e.g., for treatment of cancer. Further described are methods of targeting tumor-associated macrophages, microglia, and/or other cells in a tumor microenvironment using such nanoparticle conjugates. Moreover, diagnostic, therapeutic, and theranostic (diagnostic and therapeutic) platforms featuring such nanoparticle conjugates are described for treating targets in both the tumor and surrounding microenvironment, thereby enhancing efficacy of cancer treatment. Use of the nanoparticle conjugates described herein with other conventional therapies, including chemotherapy, radiotherapy, immunotherapy, and the like, is also envisaged.",UNIV CORNELL;;MEMORIAL SLOAN KETTERING CANCER CENTER,BRADBURY MICHELLE S;;OVERHOLTZER MICHAEL;;BRENNAN CAMERON;;YOO BARNEY;;WOLCHOK JEDD D;;WIESNER ULRICH,,https://lens.org/057-263-304-381-109,Granted Patent,no,4,0,12,12,0,A61K47/6923;;A61P11/00;;A61P25/00;;A61P35/00;;A61P35/04;;A61P43/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K45/06;;A61K51/0474;;A61K51/1244;;A61K2123/00;;A61K2121/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K51/0474;;A61K51/1244;;A61K2121/00,A61K47/69;;A61P35/00;;B82Y5/00,,6,5,054-588-053-303-742;;013-734-996-960-110;;012-940-865-032-93X;;002-733-110-798-609;;072-371-919-859-350,10.1021/am405219u;;24417514;;pmc4842310;;10.1016/j.bmc.2015.09.050;;26462054;;pmc4334268;;24779647;;10.1021/mp5000482;;pmc4183999;;25285170;;10.7150/thno.8491;;pmc2639552;;19094226;;10.1186/1479-5876-6-80,"JONGJIN JUNG ET AL: ""Selective Inhibition of Human Brain Tumor Cells through Multifunctional Quantum-Dot-Based siRNA Delivery"", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 49, no. 1,  (2010), pages 103 - 107, DOI: 10.1002/anie.200905126;;Liu, D, et al. ""In vitro and in vivo studies on the transport of PEGylated silica nanoparticles across the blood–brain barrier."" ACS applied materials & interfaces, vol. 6, no. 3 (2014): pages 2131-2136.;;BARNEY YOO ET AL: ""Ultrasmall dual-modality silica nanoparticle drug conjugates: Design, synthesis, and characterization"", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 23, no. 22, (2015), pages 7119 - 7130, DOI: 10.1016/j.bmc.2015.09.050;;REMANT BAHADUR K.C. ET AL: ""Redox Potential Ultrasensitive Nanoparticle for the Targeted Delivery of Camptothecin to HER2-Positive Cancer Cells"", MOLECULAR PHARMACEUTICS, vol. 11, no. 6, (2014), pages 1897 - 1905, DOI: 10.1021/mp5000482;;CHEOL AM HONG ET AL: ""Functional Nanostructures for Effective Delivery of Small Interfering RNA Therapeutics"", THERANOSTICS, vol. 4, no. 12, 19 September 2014 (2014-09-19), pages 1211 - 1232, DOI: 10.7150/thno.8491;;Hemant Sarin et al., ""Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells"", Journal of Translational Medicine, (2008), vol. 6, no. 80, pages 1-15",ACTIVE
42,WO,A1,WO 2017/189961 A1,188-845-554-484-59X,2017-11-02,2017,US 2017/0030056 W,2017-04-28,US 201662330029 P,2016-04-29,"COMPOSITIONS AND METHODS FOR TARGETED PARTICLE PENETRATION, DISTRIBUTION, AND RESPONSE IN MALIGNANT BRAIN TUMORS","Described herein are nanoparticle conjugates that demonstrate enhanced penetration of tumor tissue (e.g., brain tumor tissue) and diffusion within the tumor interstitium, e.g., for treatment of cancer. Further described are methods of targeting tumor-associated macrophages, microglia, and/or other cells in a tumor microenvironment using such nanoparticle conjugates. Moreover, diagnostic, therapeutic, and theranostic (diagnostic and therapeutic) platforms featuring such nanoparticle conjugates are described for treating targets in both the tumor and surrounding microenvironment, thereby enhancing efficacy of cancer treatment. Use of the nanoparticle conjugates described herein with other conventional therapies, including chemotherapy, radiotherapy, immunotherapy, and the like, is also envisaged.",MEMORIAL SLOAN KETTERING CANCER CENTER;;UNIV CORNELL,BRADBURY MICHELLE S;;OVERHOLTZER MICHAEL;;BRENNAN CAMERON;;YOO BARNEY;;WOLCHOK JEDD D;;WIESNER ULRICH,,https://lens.org/188-845-554-484-59X,Patent Application,yes,11,12,12,12,0,A61K47/6923;;A61P11/00;;A61P25/00;;A61P35/00;;A61P35/04;;A61P43/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K45/06;;A61K51/0474;;A61K51/1244;;A61K2123/00;;A61K2121/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K51/0474;;A61K51/1244;;A61K2121/00,A61K47/69;;A61P35/00;;B82Y5/00,,8,7,001-658-895-033-10X;;013-734-996-960-110;;012-940-865-032-93X;;002-733-110-798-609;;076-559-452-737-615;;000-703-849-901-467;;028-433-217-712-499,19950159;;pmc2849006;;10.1002/anie.200905126;;pmc4842310;;10.1016/j.bmc.2015.09.050;;26462054;;pmc4334268;;24779647;;10.1021/mp5000482;;pmc4183999;;25285170;;10.7150/thno.8491;;10.1038/nm.3394;;pmc3954707;;24202395;;pmc3840724;;10.1038/nm.3337;;24056773;;pmc3223088;;21865399;;10.1093/neuonc/nor121,"JONGJIN JUNG ET AL: ""Selective Inhibition of Human Brain Tumor Cells through Multifunctional Quantum-Dot-Based siRNA Delivery"", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 49, no. 1, 4 January 2010 (2010-01-04), pages 103 - 107, XP055386349, ISSN: 1433-7851, DOI: 10.1002/anie.200905126;;BARNEY YOO ET AL: ""Ultrasmall dual-modality silica nanoparticle drug conjugates: Design, synthesis, and characterization"", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 23, no. 22, 1 November 2015 (2015-11-01), pages 7119 - 7130, XP055282453, ISSN: 0968-0896, DOI: 10.1016/j.bmc.2015.09.050;;REMANT BAHADUR K.C. ET AL: ""Redox Potential Ultrasensitive Nanoparticle for the Targeted Delivery of Camptothecin to HER2-Positive Cancer Cells"", MOLECULAR PHARMACEUTICS, vol. 11, no. 6, 29 April 2014 (2014-04-29), pages 1897 - 1905, XP055385930, ISSN: 1543-8384, DOI: 10.1021/mp5000482;;CHEOL AM HONG ET AL: ""Functional Nanostructures for Effective Delivery of Small Interfering RNA Therapeutics"", THERANOSTICS, vol. 4, no. 12, 19 September 2014 (2014-09-19), pages 1211 - 1232, XP055342474, ISSN: 1838-7640, DOI: 10.7150/thno.8491;;DANIELA QUAIL; JOHANNA JOYCE: ""Microenvironmental regulation of tumor progression and metastasis"", NATURE MEDICINE, vol. 19, no. 11, November 2013 (2013-11-01);;PYONTECK ET AL.: ""CSF-1R inhibition alters macrophage polarization and blocks glioma progression"", NATURE MEDICINE, vol. 19, no. 10, October 2013 (2013-10-01);;YOO ET AL., BIOORG MED CHEM, 2015;;GROMMES ET AL., NEURO ONCOL., vol. 13, no. 12, December 2011 (2011-12-01), pages 1364 - 1369",PENDING
43,US,S,US D0725666 S,113-959-365-082-211,2015-03-31,2015,US 201329450205 F,2013-03-15,US 201329450205 F,2013-03-15,Display screen with graphical user interface,,TSENG ERICK;;WONG YOON KEAN;;CAMPBELL COLIN CAMERON BRENNAN;;KRAUSZ BRIAN;;PAPAKIPOS MATTHEW NICHOLAS;;FACEBOOK INC,TSENG ERICK;;WONG YOON KEAN;;CAMPBELL COLIN CAMERON BRENNAN;;KRAUSZ BRIAN;;PAPAKIPOS MATTHEW NICHOLAS,META PLATFORMS INC (2013-05-02),https://lens.org/113-959-365-082-211,Design Right,no,0,117,1,1,0,,,1404;;D14/486,0,0,,,,ACTIVE
44,KR,A,KR 20190003630 A,018-402-591-385-315,2019-01-09,2019,KR 20187034236 A,2017-04-28,US 201662330029 P;;US 2017/0030056 W,2016-04-29,"악성 뇌 종양에서의 표적화된 입자 침투, 분포, 및 반응을 위한 조성물 및 방법","종양 조직(예컨대, 뇌 종양 조직)의 강화된 침투 및 종양 사이질 내에서의 확산을 나타내는, 예를 들어, 암의 치료를 위한 나노입자 컨쥬게이트가 본원에 기재된다. 그러한 나노입자 컨쥬게이트를 사용하여 종양 미세환경에서 종양-관련 대식세포, 미세아교세포, 및/또는 다른 세포를 표적화하는 방법이 추가로 기재된다. 또한, 그러한 나노입자 컨쥬게이트를 특징으로 하는 진단, 치료, 및 테라노스틱(theranostic)(진단 및 치료) 플랫폼은 종양 및 주변 미세환경 둘 모두에서 표적을 치료하여, 암 치료의 효능을 향상시키는 것으로 기술된다. 화학요법, 방사선요법, 면역요법 등을 포함하는 다른 통상적인 요법과 함께 본원에 기재된 나노입자 컨쥬게이트의 사용이 또한 고려된다.",MEMORIAL SLOAN KETTERING CANCER CENTER;;UNIV CORNELL,BRADBURY MICHELLE S;;OVERHOLTZER MICHAEL;;BRENNAN CAMERON;;YOO BARNEY;;WOLCHOK JEDD D;;WIESNER ULRICH,,https://lens.org/018-402-591-385-315,Patent Application,no,0,0,12,12,0,A61K47/6923;;A61P11/00;;A61P25/00;;A61P35/00;;A61P35/04;;A61P43/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K45/06;;A61K51/0474;;A61K51/1244;;A61K2123/00;;A61K2121/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K51/0474;;A61K51/1244;;A61K2121/00,A61K47/69;;A61K45/06;;A61K51/04;;A61K51/12;;A61P35/00,,0,0,,,,DISCONTINUED
45,EP,A1,EP 3448436 A1,095-087-625-559-64X,2019-03-06,2019,EP 17722642 A,2017-04-28,US 201662330029 P;;US 2017/0030056 W,2016-04-29,"COMPOSITIONS AND METHODS FOR TARGETED PARTICLE PENETRATION, DISTRIBUTION, AND RESPONSE IN MALIGNANT BRAIN TUMORS",,MEMORIAL SLOAN KETTERING CANCER CENTER;;UNIV CORNELL,BRADBURY MICHELLE S;;OVERHOLTZER MICHAEL;;BRENNAN CAMERON;;YOO BARNEY;;WOLCHOK JEDD D;;WIESNER ULRICH,,https://lens.org/095-087-625-559-64X,Patent Application,yes,0,0,12,12,0,A61K47/6923;;A61P11/00;;A61P25/00;;A61P35/00;;A61P35/04;;A61P43/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K45/06;;A61K51/0474;;A61K51/1244;;A61K2123/00;;A61K2121/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K51/0474;;A61K51/1244;;A61K2121/00,A61K47/69;;A61P35/00;;B82Y5/00,,0,0,,,,PENDING
46,CA,A1,CA 3017954 A1,053-027-765-287-529,2017-11-02,2017,CA 3017954 A,2017-04-28,US 201662330029 P;;US 2017/0030056 W,2016-04-29,"COMPOSITIONS AND METHODS FOR TARGETED PARTICLE PENETRATION, DISTRIBUTION, AND RESPONSE IN MALIGNANT BRAIN TUMORS","Described herein are nanoparticle conjugates that demonstrate enhanced penetration of tumor tissue (e.g., brain tumor tissue) and diffusion within the tumor interstitium, e.g., for treatment of cancer. Further described are methods of targeting tumor-associated macrophages, microglia, and/or other cells in a tumor microenvironment using such nanoparticle conjugates. Moreover, diagnostic, therapeutic, and theranostic (diagnostic and therapeutic) platforms featuring such nanoparticle conjugates are described for treating targets in both the tumor and surrounding microenvironment, thereby enhancing efficacy of cancer treatment. Use of the nanoparticle conjugates described herein with other conventional therapies, including chemotherapy, radiotherapy, immunotherapy, and the like, is also envisaged.",MEMORIAL SLOAN KETTERING CANCER CENTER;;UNIV CORNELL,BRADBURY MICHELLE S;;OVERHOLTZER MICHAEL;;BRENNAN CAMERON;;YOO BARNEY;;WOLCHOK JEDD D;;WIESNER ULRICH,,https://lens.org/053-027-765-287-529,Patent Application,no,0,0,12,12,0,A61K47/6923;;A61P11/00;;A61P25/00;;A61P35/00;;A61P35/04;;A61P43/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K45/06;;A61K51/0474;;A61K51/1244;;A61K2123/00;;A61K2121/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K51/0474;;A61K51/1244;;A61K2121/00,A61K47/69;;A61P35/00;;B82Y5/00,,0,0,,,,PENDING
47,AU,A1,AU 2017/258415 A1,177-952-012-136-966,2018-10-04,2018,AU 2017/258415 A,2017-04-28,US 201662330029 P;;US 2017/0030056 W,2016-04-29,"Compositions and methods for targeted particle penetration, distribution, and response in malignant brain tumors","Described herein are nanoparticle conjugates that demonstrate enhanced penetration of tumor tissue (e.g., brain tumor tissue) and diffusion within the tumor interstitium, e.g., for treatment of cancer. Further described are methods of targeting tumor-associated macrophages, microglia, and/or other cells in a tumor microenvironment using such nanoparticle conjugates. Moreover, diagnostic, therapeutic, and theranostic (diagnostic and therapeutic) platforms featuring such nanoparticle conjugates are described for treating targets in both the tumor and surrounding microenvironment, thereby enhancing efficacy of cancer treatment. Use of the nanoparticle conjugates described herein with other conventional therapies, including chemotherapy, radiotherapy, immunotherapy, and the like, is also envisaged.",UNIV CORNELL;;MEMORIAL SLOAN KETTERING CANCER CENTER,BRADBURY MICHELLE S;;OVERHOLTZER MICHAEL;;BRENNAN CAMERON;;YOO BARNEY;;WOLCHOK JEDD D;;WIESNER ULRICH,,https://lens.org/177-952-012-136-966,Patent Application,no,0,0,12,12,0,A61K47/6923;;A61P11/00;;A61P25/00;;A61P35/00;;A61P35/04;;A61P43/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K45/06;;A61K51/0474;;A61K51/1244;;A61K2123/00;;A61K2121/00;;A61K47/6929;;A61K47/6923;;A61P35/00;;A61K51/0474;;A61K51/1244;;A61K2121/00,A61K47/69;;A61P35/00;;B82Y5/00,,0,0,,,,ACTIVE
48,US,A1,US 2014/0067969 A1,091-305-784-531-369,2014-03-06,2014,US 201213688905 A,2012-11-29,US 201213688905 A;;US 201213602011 A,2012-08-31,Sharing Television And Video Programming Through Social Networking,"In particular embodiments, a social networking system identifies a user viewing video content on a first display device, identifies the video content being viewed on the first display device by the user, and determines a second display device associated with the identified user. The social networking system sends one or more instructions to the determined second display device to display one or more chat messages associated with the identified video content.",ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;TSENG ERICK;;WONG YOON KEAN,ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2012-12-04),https://lens.org/091-305-784-531-369,Patent Application,yes,14,21,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04L12/58;;H04W4/50;;H04W4/80,709/206,0,0,,,,ACTIVE
49,US,A1,US 2016/0072758 A1,019-819-990-066-370,2016-03-10,2016,US 201514930072 A,2015-11-02,US 201514930072 A;;US 201213688905 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming Through Social Networking,"In particular embodiments, a social networking system identifies a user viewing video content on a first display device, identifies the video content being viewed on the first display device by the user, and determines a second display device associated with the identified user. The social networking system sends one or more instructions to the determined second display device to display one or more chat messages associated with the identified video content.",FACEBOOK INC,ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2021-10-28),https://lens.org/019-819-990-066-370,Patent Application,yes,0,18,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04L12/58;;H04L29/06;;H04W4/50;;H04W4/80,,0,0,,,,ACTIVE
50,US,B2,US 9674135 B2,002-278-758-580-459,2017-06-06,2017,US 201514930072 A,2015-11-02,US 201514930072 A;;US 201213688905 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, a social networking system identifies a user viewing video content on a first display device, identifies the video content being viewed on the first display device by the user, and determines a second display device associated with the identified user. The social networking system sends one or more instructions to the determined second display device to display one or more chat messages associated with the identified video content.",FACEBOOK INC,ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2021-10-28),https://lens.org/002-278-758-580-459,Granted Patent,yes,163,1,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N7/173;;G06F3/048;;G06F3/0481;;G06F15/16;;G06F17/30;;H04L12/58;;H04L29/06;;H04L29/08;;H04N21/23;;H04N21/258;;H04N21/41;;H04N21/4227;;H04N21/433;;H04N21/434;;H04N21/439;;H04N21/44;;H04N21/472;;H04N21/478;;H04N21/4788;;H04N21/482;;H04N21/63;;H04N21/6543;;H04N21/81;;H04W4/50;;H04W4/80,,8,1,001-019-759-270-089,10.1109/ccnc.2010.5421599,"Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013, date of mailing Dec. 11, 2013.;;Martin, R. et al. “neXtream: A Multi-Device, Social Approach to Video Content Consumption.” Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5.;;EPO Germany, Communication—Extended European Search Report dated Apr. 5, 2016; Application No./Patent No. 13833399.2-1905 / 2891322 PCT/US2013057449, May 4, 2016.;;U.S. Appl. No. 15/046,179, filed Feb. 17, 2016, Archibong.;;U.S. Appl. No. 15/283,908, filed Oct. 3, 2016, Archibong.;;U.S. Appl. No. 15/295,497, filed Oct. 17, 2016, Badros.;;U.S. Appl. No. 15/376,902, filed Dec. 13, 2016, Campbell.;;U.S. Appl. No. 15/393,449, filed Dec. 29, 2016, Garcia.",ACTIVE
51,US,B2,US 9201904 B2,014-445-631-531-490,2015-12-01,2015,US 201213688905 A,2012-11-29,US 201213688905 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, a social networking system identifies a user viewing video content on a first display device, identifies the video content being viewed on the first display device by the user, and determines a second display device associated with the identified user. The social networking system sends one or more instructions to the determined second display device to display one or more chat messages associated with the identified video content.",ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;TSENG ERICK;;WONG YONG KEAN;;FACEBOOK INC,ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;TSENG ERICK;;WONG YONG KEAN,META PLATFORMS INC (2012-12-04),https://lens.org/014-445-631-531-490,Granted Patent,yes,102,17,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N7/173;;G06F3/048;;G06F3/0481;;G06F15/16;;G06F17/30;;H04L12/58;;H04L29/06;;H04N21/23;;H04N21/258;;H04N21/4227;;H04N21/433;;H04N21/472;;H04N21/478;;H04N21/4788;;H04N21/63;;H04N21/6543;;H04N21/81;;H04W4/50;;H04W4/80,,16,1,001-019-759-270-089,10.1109/ccnc.2010.5421599,"U.S. Appl. No. 13/602,011, filed Aug. 31, 2012, Cameron A. Marlow.;;U.S. Appl. No. 13/688,736, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,035, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/688,850, filed Nov. 29, 2012, Sean M. Bruich.;;U.S. Appl. No. 13/689,285, filed Nov. 29, 2012, David H. Garcia.;;U.S. Appl. No. 13/689,355, filed Nov. 29, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/690,769, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/690,892, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,122, filed Nov. 30, 2012, Mark Heynen.;;U.S. Appl. No. 13/692,122, filed Dec. 3, 2012, Colin C. Brennan.;;U.S. Appl. No. 13/691,269, filed Nov. 30, 2012, David H. Garcia.;;U.S. Appl. No. 13/692,675, filed Dec. 3, 2012, Ime Archibong.;;U.S. Appl. No. 13/692,598, filed Dec. 3, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/692,006, filed Dec. 3, 2012, Colin C. Brennan.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013, date of mailing Dec. 11, 2013.;;Martin, R. et al. ""neXtream: A Multi-Device, Social Approach to Video Content Consumption."" Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5.",ACTIVE
52,US,A1,US 2016/0044127 A1,142-560-154-299-776,2016-02-11,2016,US 201414455807 A,2014-08-08,US 201414455807 A,2014-08-08,IDENTIFYING AND CACHING CONTENT FOR OFFLINE USE,"In one embodiment, a method includes identifying candidate content associated with a user of a computing device, selecting, from the candidate content, cache content to be stored in cache storage of the computing device for access by the user when the computing device does not have network connectivity, and storing the cache content in the cache storage of the computing device. The cache content may be based on information associated with a user node that represents the user in a social graph. The cache content may include entities liked by the user, friends of the user, and/or entities of interest to the user. The cache content includes web pages accessed by the user and/or web pages referenced by content created by the user. The cache content may include information related to past, current, and/or predicted actions of the user, such as social network posts, travel itineraries, and geographic locations.",FACEBOOK INC,FILNER AARON SAMUEL;;NAQUIN DEVIN;;LI JOSHUA;;SWANSON KATHERINE L;;CAMPBELL COLIN CAMERON BRENNAN;;MOECK GREGORY JOHN,META PLATFORMS INC (2014-11-06),https://lens.org/142-560-154-299-776,Patent Application,yes,4,26,2,2,0,H04L67/10;;H04L67/535;;H04L67/5681;;H04L67/10;;H04L67/5681;;H04L67/535,H04L29/08,,0,0,,,,ACTIVE
53,US,B2,US 10291737 B2,028-842-968-765-409,2019-05-14,2019,US 201414455807 A,2014-08-08,US 201414455807 A,2014-08-08,Identifying and caching content for offline use,"In one embodiment, a method includes identifying candidate content associated with a user of a computing device, selecting, from the candidate content, cache content to be stored in cache storage of the computing device for access by the user when the computing device does not have network connectivity, and storing the cache content in the cache storage of the computing device. The cache content may be based on information associated with a user node that represents the user in a social graph. The cache content may include entities liked by the user, friends of the user, and/or entities of interest to the user. The cache content includes web pages accessed by the user and/or web pages referenced by content created by the user. The cache content may include information related to past, current, and/or predicted actions of the user, such as social network posts, travel itineraries, and geographic locations.",FACEBOOK INC,FILNER AARON SAMUEL;;NAQUIN DEVIN;;LI JOSHUA;;SWANSON KATHERINE L;;CAMPBELL COLIN CAMERON BRENNAN;;MOECK GREGORY JOHN,META PLATFORMS INC (2014-11-06),https://lens.org/028-842-968-765-409,Granted Patent,yes,8,2,2,2,0,H04L67/10;;H04L67/535;;H04L67/5681;;H04L67/10;;H04L67/5681;;H04L67/535,H04L29/08,,0,0,,,,ACTIVE
54,US,B2,US 9549227 B2,122-204-935-633-021,2017-01-17,2017,US 201213692122 A,2012-12-03,US 201213692122 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, one or more computer systems of a social-networking system provide social content for display in a mobile application running on a mobile device of a user of the social-networking system. The mobile application is configured to display the social content and an interface for selecting media content to view on a display device. The social content is from a social graph of the social-networking system. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system receive an indication from the mobile application that an option to view particular media content has been selected and provide one or more instructions to display the selected particular media content on the display device.",CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN;;FACEBOOK INC,CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2012-12-04),https://lens.org/122-204-935-633-021,Granted Patent,yes,106,16,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N7/173;;G06F3/00;;G06F3/048;;G06F3/0481;;G06F13/00;;G06F15/16;;G06F17/30;;H04L12/58;;H04L29/06;;H04N5/445;;H04N21/23;;H04N21/258;;H04N21/41;;H04N21/4227;;H04N21/433;;H04N21/439;;H04N21/44;;H04N21/472;;H04N21/478;;H04N21/4788;;H04N21/63;;H04N21/6543;;H04N21/81;;H04W4/50;;H04W4/80,,19,1,001-019-759-270-089,10.1109/ccnc.2010.5421599,"Notification of Transmittal International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013.;;Martin, R. et al. ""neXtream: A Multi-Device, Social Approach to Video Content Consumption."" Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5.;;U.S. Appl. No. 13/602,011, filed Aug. 31, 2012, Cameron A. Marlow.;;U.S. Appl. No. 13/688,736, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,035, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/688,850, filed Nov. 29, 2012, Sean M. Bruich.;;U.S. Appl. No. 13/689,285, filed Nov. 29, 2012, David H. Garcia.;;U.S. Appl. No. 13/689,355, filed Nov. 29, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/688,905, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13/690,769, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/690,892, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,122, filed Nov. 30, 2012, Mark Heynen.;;U.S. Appl. No. 13/691,269, filed Nov. 30, 2012, David H. Garcia.;;U.S. Appl. No. 13/692,675, filed Dec. 3, 2012, Ime Archibong.;;U.S. Appl. No. 13,692,598, filed Dec. 3, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/692,006, filed Dec. 3, 2012, Colin C. Brennan.;;U.S. Appl. No. 14/930,072, filed Nov. 2, 2015, Archibong.;;U.S. Appl. No. 15/046,179, filed Feb. 17, 2016, Archibong.;;EPO Germany, Communication-Extended European Search Report dated Apr. 5, 2016; Application No./Patent No. 13833399.2-1905 / 2891322 PCT/US2013057449; Ref. FABOO276-PCT/EP, May 4, 2016.",ACTIVE
55,US,B2,US 9992534 B2,032-072-748-581-735,2018-06-05,2018,US 201615376902 A,2016-12-13,US 201615376902 A;;US 201213692122 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, one or more computer systems of a social-networking system provide social content for display in a mobile application running on a mobile device of a user of the social-networking system. The mobile application is configured to display the social content and an interface for selecting media content to view on a display device. The social content is from a social graph of the social-networking system. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system receive an indication from the mobile application that an option to view particular media content has been selected and provide one or more instructions to display the selected particular media content on the display device.",FACEBOOK INC,CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2021-10-28),https://lens.org/032-072-748-581-735,Granted Patent,yes,202,2,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N7/173;;G06F3/00;;G06F13/00;;G06F15/16;;G06F17/30;;G06Q30/02;;G06Q50/00;;H04L12/58;;H04L29/06;;H04L29/08;;H04L29/12;;H04N5/445;;H04N21/234;;H04N21/235;;H04N21/258;;H04N21/278;;H04N21/41;;H04N21/4147;;H04N21/4227;;H04N21/433;;H04N21/434;;H04N21/4363;;H04N21/439;;H04N21/44;;H04N21/4402;;H04N21/472;;H04N21/4788;;H04N21/482;;H04N21/488;;H04N21/63;;H04N21/6334;;H04N21/6543;;H04N21/81;;H04N21/84;;H04N21/8547;;H04W4/50;;H04W4/80,,10,1,001-019-759-270-089,10.1109/ccnc.2010.5421599,"U.S. Appl. No. 15/495,508, filed Apr. 24, 2017, Archibong.;;U.S. Appl. No. 15/498,015, filed Apr. 26, 2017, Archibong.;;U.S. Appl. No. 15/612,169, filed Jun. 2, 2017, Garcia.;;U.S. Appl. No. 15/618,816, filed Jun. 9, 2017, Marlow.;;U.S. Appl. No. 15/393,449, filed Dec. 29, 2016, Garcia.;;EPO Germany, Communication—Extended European Search Report dated Apr. 5, 2016; Application No./Patent No. 13833399.2-1905 / 2891322 PCT/US2013057449; Ref. FABOO276-PCT/EP, May 4, 2016.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013, dated Dec. 11, 2013.;;Martin, R. et al. “neXtream: A Multi-Device, Social Approach to Video Content Consumption.” Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5, 2010.;;U.S. Appl. No. 15/653,616, filed Jul. 19, 2017, Sean Michael Bruich.;;U.S. Appl. No. 15/680,752, filed Aug. 18, 2017, Ime Archibong.",ACTIVE
56,US,A1,US 2014/0068461 A1,159-956-105-097-754,2014-03-06,2014,US 201213692122 A,2012-12-03,US 201213692122 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming Through Social Networking,"In particular embodiments, one or more computer systems of a social-networking system provide social content for display in a mobile application running on a mobile device of a user of the social-networking system. The mobile application is configured to display the social content and an interface for selecting media content to view on a display device. The social content is from a social graph of the social-networking system. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system receive an indication from the mobile application that an option to view particular media content has been selected and provide one or more instructions to display the selected particular media content on the display device.",CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN,CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2012-12-04),https://lens.org/159-956-105-097-754,Patent Application,yes,7,17,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,G06F3/048;;H04W4/50;;H04W4/80,715/753,0,0,,,,ACTIVE
57,US,A1,US 2017/0094358 A1,031-719-448-935-800,2017-03-30,2017,US 201615376902 A,2016-12-13,US 201615376902 A;;US 201213692122 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming Through Social Networking,"In particular embodiments, one or more computer systems of a social-networking system provide social content for display in a mobile application running on a mobile device of a user of the social-networking system. The mobile application is configured to display the social content and an interface for selecting media content to view on a display device. The social content is from a social graph of the social-networking system. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system receive an indication from the mobile application that an option to view particular media content has been selected and provide one or more instructions to display the selected particular media content on the display device.",FACEBOOK INC,CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2021-10-28),https://lens.org/031-719-448-935-800,Patent Application,yes,0,8,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N21/4788;;H04N21/258;;H04N21/4363;;H04N21/81;;H04W4/50;;H04W4/80,,0,0,,,,ACTIVE
58,US,A1,US 2013/0072392 A1,039-140-599-422-912,2013-03-21,2013,US 201213473969 A,2012-05-17,US 201213473969 A;;US 70615507 A;;US 77307206 P,2006-02-14,"Compositions, Kits, and Methods for Identification, Assessment, Prevention, and Therapy of Cancer","The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human cancer. A variety of chromosomal regions (MCRs) and markers corresponding thereto, are provided, wherein alterations in the copy number of one or more of the MCRs and/or alterations in the amount, structure, and/or activity of one or more of the markers is correlated with the presence of cancer.",DEPINHO RONALD A;;ANDERSON KENNETH C;;CARRASCO RUBEN D;;TONON GIOVANNI;;BRENNAN CAMERON;;SHAUGHNESSY JR JOHN D;;CHIN LYNDA;;UNIV ARKANSAS;;DANA FARBER CANCER INST INC,DEPINHO RONALD A;;ANDERSON KENNETH C;;CARRASCO RUBEN D;;TONON GIOVANNI;;BRENNAN CAMERON;;SHAUGHNESSY JR JOHN D;;CHIN LYNDA,DANA-FARBER CANCER INSTITUTE INC (2010-04-01);;BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (2010-04-01),https://lens.org/039-140-599-422-912,Patent Application,yes,2,1,10,10,713,C12Q1/6841;;C12Q1/6886;;C12Q2600/106;;C12Q2600/118;;C12Q2600/136;;C12Q2600/178;;A61P43/00;;C12Q1/6841;;C12Q1/6886;;C12Q2600/106;;C12Q2600/118;;C12Q2600/136;;C12Q2600/178;;C12Q1/6837,C40B30/06;;C12Q1/68;;G01N33/574,506/9;;435/6.13;;435/6.11;;435/6.12;;435/7.92;;435/7.1;;435/7.4;;435/7.23,10,7,017-973-378-424-648;;002-157-754-525-814;;083-935-013-608-870;;054-816-679-251-632;;084-745-853-442-251;;135-868-584-437-937;;028-511-266-045-275,10.1016/j.drup.2003.10.003;;14744497;;pmc1895907;;10.1182/blood-2005-03-1158;;16234364;;10.1182/blood-2002-10-3146;;12480690;;10.1016/s1359-6446(03)02654-0;;12681939;;15725085;;10.1111/j.1365-2141.2005.05369.x;;15930364;;10.1158/1078-0432.ccr-04-2611;;12786795;;10.1046/j.1365-2141.2003.04368.x,"Lorenzo et al (Drug Resistance Updates, 2003, 6:329-339);;Mitsiades et al (Blood, 2006, 107:1092-1100, published online October 18, 2005);;Chauhan et al (Blood, 2003, 101:3606-3614);;Huang et al (Drug Discovery Today, 2003, 8:356-363);;ADAPT, Paterson Institute for Cancer Research, probesets for PRKCi, printed January 15, 2014;;ADAPT, Paterson Institute for Cancer Research, probesets for SEMA4A, printed January 15, 2014;;ADAPT, Paterson Institute for Cancer Research, probesets for DHX36, printed January 15, 2014;;Zhou et al (British Journal of Haematology, 2005, 128:636-644);;Tassone et al (Clinical Cancer Research, 2005, 11:4251-4258);;Ni et al (British Journal of Haematology, 2003, 121:849-856)",ACTIVE
59,US,A1,US 2017/0318357 A1,143-327-664-901-400,2017-11-02,2017,US 201715653616 A,2017-07-19,US 201715653616 A;;US 201213688850 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming through Social Networking,"In particular embodiments, a social networking system queries a social graph of the social-networking system for social content associated with video content provided to one or more users of the social-networking system and accesses privacy settings associated with each of the one or more users. The privacy settings indicate whether a particular user has authorized the social-networking system to share social content associated with the particular user with one or more third parties. The social networking system provides the social content associated with video content provided to the one or more users to a particular third party if the privacy settings of the one or more users indicate that the one or more users have authorized the social-networking system to share the social content with one or more third parties.",FACEBOOK LNC,BRUICH SEAN MICHAEL;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;KRAUSZ BRIAN;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2021-10-28),https://lens.org/143-327-664-901-400,Patent Application,yes,2,1,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N21/81;;G06F3/048;;G06F3/0481;;G06F15/16;;G06F17/30;;G06Q30/02;;G06Q50/00;;H04L12/58;;H04L29/06;;H04L29/08;;H04N21/23;;H04N21/234;;H04N21/235;;H04N21/258;;H04N21/278;;H04N21/41;;H04N21/4227;;H04N21/433;;H04N21/434;;H04N21/439;;H04N21/44;;H04N21/472;;H04N21/478;;H04N21/4788;;H04N21/482;;H04N21/488;;H04N21/63;;H04N21/6334;;H04N21/6543;;H04W4/50;;H04W4/80,,0,0,,,,ACTIVE
60,US,B2,US 9309564 B2,173-952-280-800-469,2016-04-12,2016,US 201213473969 A,2012-05-17,US 201213473969 A;;US 70615507 A;;US 77307206 P,2006-02-14,"Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer","The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human cancer. A variety of chromosomal regions (MCRs) and markers corresponding thereto, are provided, wherein alterations in the copy number of one or more of the MCRs and/or alterations in the amount, structure, and/or activity of one or more of the markers is correlated with the presence of cancer.",DEPINHO RONALD A;;ANDERSON KENNETH C;;CARRASCO RUBEN D;;TONON GIOVANNI;;BRENNAN CAMERON;;SHAUGHNESSY JR JOHN D;;CHIN LYNDA;;DANA FARBER CANCER INST INC;;UNIV ARKANSAS,DEPINHO RONALD A;;ANDERSON KENNETH C;;CARRASCO RUBEN D;;TONON GIOVANNI;;BRENNAN CAMERON;;SHAUGHNESSY JR JOHN D;;CHIN LYNDA,DANA-FARBER CANCER INSTITUTE INC (2010-04-01);;BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (2010-04-01),https://lens.org/173-952-280-800-469,Granted Patent,yes,11,1,10,10,713,C12Q1/6841;;C12Q1/6886;;C12Q2600/106;;C12Q2600/118;;C12Q2600/136;;C12Q2600/178;;A61P43/00;;C12Q1/6841;;C12Q1/6886;;C12Q2600/106;;C12Q2600/118;;C12Q2600/136;;C12Q2600/178;;C12Q1/6837,G01N33/574;;C12Q1/68,,109,105,017-973-378-424-648;;002-157-754-525-814;;083-935-013-608-870;;054-816-679-251-632;;084-745-853-442-251;;135-868-584-437-937;;028-511-266-045-275;;105-470-213-897-135;;020-178-040-162-13X;;076-139-734-348-158;;076-591-202-219-68X;;010-960-298-556-053;;004-738-078-948-368;;000-428-986-983-872;;052-130-043-164-905;;027-983-179-525-405;;089-470-191-334-21X;;072-034-119-492-741;;047-846-311-940-169;;089-520-638-381-227;;015-987-432-869-758;;058-233-617-169-933;;030-705-259-970-494;;049-666-656-152-47X;;150-043-352-274-566;;027-107-831-426-572;;010-004-899-887-448;;111-053-101-104-380;;034-502-839-980-053;;049-310-031-441-151;;049-081-306-525-711;;083-169-263-029-572;;086-387-340-381-014;;043-971-045-441-945;;059-265-164-882-99X;;064-901-986-903-441;;042-539-445-108-069;;125-372-386-025-788;;073-992-136-342-951;;069-271-192-093-385;;060-776-367-600-526;;037-920-584-212-490;;003-189-791-794-979;;043-781-583-966-151;;105-535-811-037-682;;015-805-796-879-623;;029-742-983-481-795;;031-898-723-593-793;;053-393-466-133-052;;048-401-146-964-224;;057-165-463-943-202;;044-598-633-506-008;;072-007-995-074-685;;018-067-643-463-093;;011-475-664-545-870;;013-124-736-934-786;;087-871-690-717-906;;025-334-710-956-363;;035-094-562-115-791;;002-048-011-717-986;;081-055-619-088-445;;012-664-627-298-304;;099-443-487-510-63X;;005-619-769-553-730;;036-110-529-854-852;;033-204-109-356-628;;005-295-921-298-124;;113-053-074-594-056;;037-310-319-433-702;;008-191-162-175-221;;008-991-621-663-466;;003-045-892-901-355;;017-746-642-715-189;;023-107-068-480-384;;006-846-530-826-211;;013-149-781-143-466;;004-184-985-742-257;;035-507-566-489-857;;038-486-024-514-252;;065-787-595-730-408;;003-113-109-661-25X;;000-592-244-463-75X;;006-530-638-049-054;;036-977-191-704-479;;057-427-209-307-291;;025-190-406-440-805;;036-598-026-051-46X;;010-389-308-492-613;;138-349-623-159-63X;;042-809-844-633-626;;118-268-988-659-792;;026-871-000-838-194;;105-031-147-566-543;;033-490-550-941-721;;033-963-799-295-451;;037-754-112-897-478;;019-911-301-892-485;;050-278-052-812-394;;130-275-898-020-637;;000-231-571-246-126;;051-239-099-295-51X;;014-549-672-381-122;;139-816-723-444-709;;079-337-780-001-944;;011-448-154-520-207,10.1016/j.drup.2003.10.003;;14744497;;pmc1895907;;10.1182/blood-2005-03-1158;;16234364;;10.1182/blood-2002-10-3146;;12480690;;10.1016/s1359-6446(03)02654-0;;12681939;;15725085;;10.1111/j.1365-2141.2005.05369.x;;15930364;;10.1158/1078-0432.ccr-04-2611;;12786795;;10.1046/j.1365-2141.2003.04368.x;;15238243;;10.1016/j.bbcan.2004.05.001;;10.1073/pnas.0402932101;;15199222;;pmc428474;;10.1016/s0165-4608(99)00118-1;;10640145;;9172003;;10.1002/(sici)1098-2264(199706)19:2<124::aid-gcc8>3.0.co;2-0;;10.1038/sj.onc.1205836;;12362270;;pmc1968474;;8494707;;10.1038/bjc.1993.203;;16525139;;10.1056/nejmoa053583;;12969978;;10.1182/blood-2003-04-1045;;15755896;;10.1182/blood-2005-01-0034;;pmc1895118;;10.1038/sj.onc.1204641;;11607813;;16155016;;10.1200/jco.2005.05.021;;pmc2151225;;9460997;;10.1038/bjc.1998.42;;10.1158/0008-5472.can-04-1241;;15256441;;12917690;;10.1038/nature01811;;15016911;;10.1073/pnas.0308531101;;pmc384712;;10.1038/sj.onc.1207973;;15678131;;16112193;;10.1016/j.leukres.2005.07.008;;12041852;;pmc111086;;10.1038/nm1125;;15502842;;15920009;;10.1182/blood-2005-02-0761;;pmc1895145;;10.1182/blood.v91.8.3007.3007_3007_3010;;9531613;;10.4049/jimmunol.174.10.6030;;15879096;;16015333;;10.1038/nature03681;;16001433;;10.1002/gcc.20231;;10.1006/geno.1998.5405;;9787076;;10.1101/gad.1267105;;15681610;;pmc548948;;12592343;;10.1038/sj.leu.2402797;;10.1073/pnas.0505641102;;16116079;;pmc1188258;;12461754;;10.1002/gcc.10140;;10.1139/o04-052;;15284904;;10.1182/blood-2013-08-522011;;12576455;;14989251;;10.1158/0008-5472.can-03-2876;;14696419;;9218997;;10.1002/(sici)1098-2264(199707)19:3<161::aid-gcc5>3.0.co;2-w;;10469215;;10.1046/j.1365-2559.1999.00705.x;;pmc1850008;;10027410;;10.1016/s0002-9440(10)65298-4;;12063017;;10.1016/s0301-472x(02)00806-8;;15763977;;10.1080/10245330400018524;;10.1126/science.286.5439.531;;10521349;;10.1002/(sici)1098-2264(199810)23:2<81::aid-gcc1>3.0.co;2-0;;9739011;;8605114;;10.1002/gcc.2870140404;;7513550;;10.1002/gcc.2870090204;;7757992;;12791393;;10.1016/s0065-2571(02)00032-8;;7553647;;10.1074/jbc.272.39.24631;;9305932;;15944707;;pmc4599349;;10.1038/nature03552;;15090448;;10.1182/blood-2004-01-0037;;12414653;;15375558;;10.1002/1097-0142(19920401)69:7<1674::aid-cncr2820690706>3.0.co;2-l;;1551052;;12874278;;10.1074/jbc.m306324200;;10.3892/ijo.20.6.1247;;12012006;;10.3892/ijmm.12.5.727;;14533001;;10.1038/nri1003;;12563299;;pmc1615642;;15111303;;10.1016/s0002-9440(10)63715-7;;10.1002/(sici)1098-2264(199610)17:2<88::aid-gcc3>3.3.co;2-3;;10.1002/(sici)1098-2264(199610)17:2<88::aid-gcc3>3.0.co;2-x;;8913725;;15154013;;10.1038/modpathol.3800180;;11990854;;10.1038/nrc746;;12374982;;10.1038/nature01037;;15509819;;10.1056/nejmra041875;;10.1056/nejmcibr032650;;14711921;;10.1016/s0165-4608(98)00046-6;;9772911;;16049974;;10.1002/ijc.21353;;12975311;;10.1101/gr.1349003;;pmc403708;;11369051;;10.1016/s0165-4608(00)00363-0;;12623842;;10.1182/blood-2002-11-3385;;15870690;;10.1038/sj.onc.1208708;;10.1002/(sici)1098-2264(199712)20:4<383::aid-gcc10>3.0.co;2-o;;9408755;;10.1002/gcc.10122;;12378529;;10.1038/sj.onc.1208649;;15824735;;10.1038/sj.onc.1206406;;12761501;;10.1038/35008115;;10783894;;15542427;;10.1016/j.ccr.2004.10.020;;15550490;;10.1182/blood-2004-07-2947;;10.1038/ng1180;;12808457;;15024028;;10.1083/jcb.200311011;;pmc2172278;;15840441;;10.1016/j.semcdb.2005.02.010;;14961574;;10.1002/ijc.11716;;15475419;;10.1093/biostatistics/kxh008;;15736465;;10.1002/gcc.1145;;11391799;;15471221;;9192802;;10.1038/2524;;9771718;;11861394;;10.1073/pnas.162471999;;pmc130569;;12297621;;8889243;;10.1007/bf02265051;;pmc1140582;;15923628;;10.1128/mcb.25.12.5119-5133.2005;;15886323;;10.1182/blood-2005-01-0049;;pmc1895227;;10.4065/80.10.1371;;16212152;;16204062;;10.1158/0008-5472.can-05-2372;;10.1074/jbc.m505402200;;15994303;;16026741;;10.1016/j.beha.2005.01.010;;10.1182/blood.v92.11.4269.423k31_4269_4278;;9834233;;10.1126/science.1098918;;15273396;;8168108,"Lorenzo et al (Drug Resistance Updates, 2003, 6:329-339).;;Mitsiades et al (Blood, 2006, 107:1092-1100, published online Oct. 18, 2005).;;Chauhan et al (Blood, 2003, 101:3606-3614).;;Huang et al (Drug Discovery Today, 2003, 8:356-363).;;ADAPT, Paterson Institute for Cancer Research, probesets for PRKCi, printed Jan. 15, 2014.;;ADAPT, Paterson Institute for Cancer Research, probesets for SEMA4A, printed Jan. 15, 2014.;;ADAPT, Paterson Institute for Cancer Research, probesets for DHX36, printed Jan. 15, 2014.;;Zhou et al (British Journal of Haematology, 2005, 128:636-644).;;Tassone et al (Clinical Cancer Research, 2005, 11:4251-4258).;;Ni et al (British Journal of Haematology, 2003, 121:849-856).;;Abdelhaleem, M., ""Do human RNA helicases have a role in cancer?,"" Biochim Biophys Acta 1704:37-46 (2004).;;Aguirre et al., ""High-resolution characterization of the pancreatic adenocarcinoma genome,"" Proc Natl Acad Sci USA 101:9067-9072 (2004).;;Armengol, G., et al., ""DNA Copy Number Changes and Evaluation of MYC, IGF1R, and FES Amplification in Xenografts of Pancreatic Andenocarcinoma,"" Cancer Genet Cytogenet 116:133-41 (2000).;;Avet-Loiseau et al., ""Molecular Cytogenetic Abnormalities in Multiple Myeloma and Plasma Cell Leukemia Measured Using Comparative Genomic Hybridization,"" Genes Chromosomes Cancer 19:124-133 (1997).;;Balsara, B. R. & Testa, J. R., ""Chromosomal imbalances in human lung cancer,"" Oncogene 21:6877-83 (2002).;;Bardi, G., et al., ""Karyotypic abnormalities in tumours of the pancreas,"" Br J Cancer 67:1106-1112 (1993).;;Barlogie et al., ""Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma,"" N Engl J Med 354:1021-1030 (2006).;;Barlogie et al., ""Treatment of multiple myeloma,"" Blood 103, 20-32 (2004).;;Bergsagel et al., ""Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma,"" Blood 106:296-303 (2005).;;Bergsagel and Kuehl., ""Chromosome translocations in multiple myeloma,"" Oncogene 20:5611-5622 (2001).;;Bergsagel and Kuehl, ""Molecular Pathogenesis and a Consequent Classification of Multiple Myeloma,"" J Clin Oncol 23:6333-6338 (2005).;;Bjorkqvist, A.M., et al. ""Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung,"" Br J Cancer 77(2):260-9 (1998).;;Brennan et al., ""High-Resolution Global Profiling of Genomic Alterations with Long Oligonucleotide Microarray,"" Cancer Res 64:4744-4748 (2004).;;Brummelkamp et al., ""Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB,"" Nature 424:797-801 (2003).;;Brunet et al., ""Metagenes and molecular pattern discovery using matrix factorization,"" Proc Natl Acad Sci USA 101:4164-4169 (2004).;;Castro et al., ""The anaphase-promoting complex: a key factor in the regulation of cell cycle,"" Oncogene 24:314-325 (2005).;;Chang et al., ""Analysis of PTEN deletions and mutations in multiple myeloma,"" Leuk Res 30:262-265 (2006).;;Chen, B.H., ""Monoclonal gammopathy of undetermined significance: new insights,"" CMAJ 166(10):1309 (2002).;;Cheng et al., ""The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers,"" Nat Med 10:1251-1256 (2004).;;Chng et al., ""A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS,"" Blood 106:2156-2161 (2005).;;Cigudosa et al., Characterization of Nonrandom Chromosomal Gains and Losses in Multiple Myeloma by Comparative Genomic Hybridization Blood 91:3007-3010 (1998).;;Colgan et al., ""Cyclophilin A-Deficient Mice Are Resistant to Immunosuppression by Cyclosporine,"" J Immunol 174:6030-6038 (2005).;;Collier et al., ""Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse,"" Nature 436, 272-276 (2005).;;Cremer et al., ""Delineation of Distinct Subgroups of Multiple Myeloma and a Model for Clonal Evolution Based on Interphase Cytogenetics,"" Genes Chromosomes Cancer 44:194-203 (2005).;;Curtis, L. J., et al., ""Amplification of DNA Sequences from Chromosome 19q13.1 in Human Pancreatic Cell Lines,"" Genomics 53:42-55 (1998).;;Dai et al., ""The kinase haspin is required for mitotic histone H3 and Thr 3 phosphorylation and normal metaphase chromosome alignment,"" Genes Dev 19:472-488 (2005).;;Debes-Marun et al., ""Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma,"" Leukemia 17:427-436 (2003).;;Eder, A.M., ""Atypical PKCiota contributed to poor prognosis through loss of apical-basal polarity and Cyclin E overexpression in ovarian cancer,"" Proc Natl Acad Sci U S A.102(35):12519-24 (2005).;;Elnenaei et al., ""Delineation of the Minimal Region of Loss at 13q14 in Multiple Myeloma,"" Genes Chromosomes Cancer 36:99-106 (2003).;;Emberley et al., ""S100 proteins and their influence on pro-survival pathways in cancer,"" Biochem Cell Biol 82:508-515 (2004).;;Falini et al., ""A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal enter B cells, plasma cells, and activated T cells,"" Blood, 95(6):2084-2092 (2000).;;Filipits et al., ""Low p27 Kip1 Expression is an Independent Adverse Prognostic Factor in Paatients with Multiple Myeloma,"" Clin Cancer Res 9:820-826 (2003).;;Fonseca et al., ""Genetics and Cytogenetics of Multiple Myeloma: A Workshop Report,"" Cancer Res 64:1546-1558 (2004).;;Fujita et al., ""Chromosome Arm 20q Gains and Other Genomic Alterations in Esophageal Squamous Cell Carcinoma, as Analyzed by Comparative Genomic Hybridization and Fluorescence In Situ Hybridization,"" Hepato-Gastroenterology 50, 1857-1863 (2003).;;Fukushige, S., et al., ""Frequent Gain of Copy Number on the Long Arm of Chromosome 20 in Human Pancreatic Adenocarcinoma,"" Genes Chromosomes Cancer 19:161-9 (1997).;;Furubo et al., ""Protein expression and genetic alterations of p53 and ras in intranepatic cholangiocarcinoma,"" Histopathology 35:230-240 (1999).;;Ghadimi, B. M., et al., ""Specific Chromosomal Aberrations and Amplification of the AIB1 Nuclear Receptor Coactivator Gene in Pancreatic Carcinomas,"" Am J Pathol 154:525-36 (1999).;;Ginzinger, D. G., ""Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream,"" Exp Hematol 30:503-12 (2002).;;Giuliani et al., ""Angiogenic Switch in Multiple Myeloma,"" Hematology 9:377-381 (2004).;;Golub, T. R., et al., ""Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring,"" Science 286:531-7 (1999).;;Gorunova, L., et al., ""Cytogenetic Analysis of Pancreatic Carcinomas: Intratumor Heterogeneity and Nonrandom Pattern of Chromosome Aberrations,"" Genes, Chromosomes & Cancer 23:81-99 (1998).;;Gorunova, L., et al., ""Massive Cytogenetic Heterogeneity in a Pancreatic Carcinoma: Fifty-Four Karyotypically Unrelated Clones,"" Genes Chromosomes Cancer 14:259-266 (1995).;;Griffin, C. A., et al., ""Chromosome Abnormalities in Pancreatic Adenocarcinoma,"" Genes Chromosomes Cancer 9:93-100 (1994).;;Griffin, C. A., et al., ""Consistent Chromosome Abnormalities in Adenocarcinoma of the Pancreas,"" Cancer Res 55:2394-9 (1995).;;Grunicke, H.H., et al., ""Regulation of cell survival by atypical protein kinase C isozymes,"" Advan. Enzyme Regul. 43:213-28 (2003).;;Hahn, S. A., et al., ""Allelotype of Pancreatic Adenocarcinoma Using Xenograft Enrichment,"" Cancer Res 55:4670-5 (1995).;;Harrington, C., et al., ""The Identification and Characterization of a G4-DNA Resolvase Activity,"" Sep. 26, The Journal of Biological Chemistry 272(39):24631-24636 (1997).;;He et al., ""A microRNA polycistron as a potential human oncogene,"" Nature 435:828-833 (2005).;;Hideshima et al., ""Advances in biology of multiple myeloma: clinical applications,"" Blood 104(3):607-618 (2004).;;Hyman, E., et al., ""Impact of DNA Amplification on Gene Expression Patterns in Breast Cancer,"" Cancer Res 62, 6240-5 (2002).;;Isler et al., ""Evidence for transcriptional repression of SPARC-like 1, a gene downregulated in human lung tumors,"" Int J Oncol 25:1073-1079 (2004).;;Johansson, B., et al., ""Nonrandom Chromosomal Rearrangements in Pancreatic Carcinomas,"" Cancer 69:1674-81 (1992).;;Kanamori et al., ""The PDZ Protein Tax-interacting Protein-1 Inhibits beta-Catenin Transcriptional Activity and Growth of Colorectal Cancer Cells,"" J Biol Chem 278:38758-38764 (2003).;;Katoh, M., ""Molecular cloning and characterization of ST7R (ST7-like, ST7L) on human chromosome 1p13, a novel gene homologous to tumor suppressor gene ST7 on human chromosome 7q31,"" Int J Oncol 20:1247-1253 (2002).;;Kawasaki, K et al., ""11q23-24 loss is associated with chromosomal instability in endometrial cancer,"" Int J Mol Med. 12(5):727-35 31 (2003).;;Kikutani, H., ""Semaphorins in interactions between T cells and antigen-presenting cells,"" Nat.Rev. Immunol. 2:159-67 (2003).;;Kim et al., ""Cyclophilin A as a Novel Biphasic Mediator of Endothelial Activation and Dysfunction,"" Am J Pathol 164:1567-1574 (2004).;;Kimura, M., et al., ""Detailed Deletion Mapping on Chromosome Arm 12q in Human Pancreatic Adenocarcinoma: Identification of a 1-cM Region of Common Allelic Loss,"" Genes Chromosomes Cancer 17:88-93 (1996).;;Kimura Y, et al., ""Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression,"" Mod. Pathol., 17:1328-1337 (2004).;;Kuehl and Bergsagel, ""Multiple Myeloma: Evolving Genetic Events and Host Interactions,"" Nat Rev Cancer 2:175-187 (2002).;;Kumanogoh, A., et al., ""Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2,"" H. Nature. 419:629-33 (2002).;;Kyle, R.A., and Rajkumar, S.V., ""Multiple Myeloma,"" N Engl J Med 351:1860-1873 (2004).;;Lakhani, S. R., ""Putting the Brakes on Cylindromatosis?,"" N Engl J Med 350:187-188 (2004).;;Larramendyac, M., et al.; ""Comparative Genomic Hybridization Revearls Differences in DNA Copy Number Changes between Sporadic Gastric Carcinomas and Gastric Carcinomas from Patients with Hereditary Nonpolyposis Colorectal Cancer""; Cancer Genetics and Cytogenetics; vol. 106, Issue 1, pp. 62-65. (Abstract Only).;;Lindsey et al., ""Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours,"" Int J Cancer, 118:346-352 (2006).;;Lucito, R., et al., ""Representational Oligonucleotide Microarray Analysis: A High-Resolution Method to Detect Genome Copy Number Variation,"" Genome Res 13:2291-2305 (2003).;;Luk, C., et al., ""Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization,"" Cancer Genet Cytogenet 125:87-99 (2001).;;Magrangeas et al., ""Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the patheogenesis of the disease,"" Blood, 101(12):4998-5006 (2003).;;Magrassi et al., Shc3 affects human high-grade astrocytomas survival, Oncogene 24:5198-5206 (2005).;;Mahlamaki, E. H., et al., ""Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer,"" Genes, Chromosomes & Cancer 20:383-91 (1997).;;Mahlamaki, E. H., et al., ""Frequent amplification of 8q24, 11q, 17q and 20q-specific genes in pancreatic cancer,"" Genes Chromosomes Cancer 35:353-8 (2002).;;Maina et al., ""Identification of novel VHL target genes and relationship to hypoxic response pathways,"" Oncogene 24:4549-4558 (2005).;;Matsuda, A., ""Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways,"" Oncogene 22 (21):3307-18 (2003).;;Medema et al., ""AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1,"" Nature 404:782-786 (2000).;;Mitsiades et al., ""Focus on multiple myeloma,"" Cancer Cell 6:439-444 (2004).;;Monti et al., ""Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response,"" Blood 105:1851-1861 (2005).;;Mootha et al., ""PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes,"" Nat Genet 34:267-273 (2003).;;Murray, N.R., ""Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo,"" J Cell Biol. 164(6):797-802 (2004).;;Nakayama and Nakayama, ""Regulation of the cell cycle by SCF-type ubiquitin ligases,"" Semin Cell Dev Biol 16:323-333 (2005).;;Nilsson, M et al., ""Amplification of Chromosome 1 Sequences in Lipomatous Tumors and Other Sarcomas,"" Int J Cancer 109(3):363-9 (2004).;;Olshen et al., ""Circular binary segmentation for the analysis of array-based DNA copy number data,"" Biostatistics 5:557-572 (2004).;;Olshen, A. B., and Venkatraman, E. S., ""Change-Point Analysis of Array-Based Comparative Genomic Hybridization Data,"" ASA Proceedings of the Joint Statistical Meetings 2530-2535 (2002).;;Panani et al., ""Cytogenetic Data as a Prognastic Factor in Multiple Myeloma Patients: Involvement of 1p12 Region an Adverse Prognostic Factor,"" Anticancer Res 24:4141-4146 (2004).;;Pei, J., et al., ""Genomic Imbalances in Human Lung Adenocarcinomas and Squamous Cell Carcinomas,"" Genes, Chromosomes & Cancer 31:282-7 (2001).;;Perez-Andres, M., ""Interaction between clonal plasma cells and the immune system in plasma cell dyscrasias,"" J. Biol. Regul. Homeost. Agents 18(2):161-165 (2004).;;Petersen, I., et al., ""Patterns of Chromosomal Imbalances in Adenocarcinoma and Squamous Cell Carcinoma of the Lung,"" Cancer Res 57:2331-5 (1997).;;Pinkel, et al., ""High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays,"" Nature Genetics 20:207-211 (1998).;;Platzer et al., ""Silence of Chromosomal Amplifications in Colon Cancer,"" Cancer Res 62:1134-1138 (2002).;;Pollack et al., ""Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors,"" Proc Natl Acad Sci USA 99:12963-12968 (2002).;;Protopopov et al., ""Human chromosome 3: high-resolution fluorescence in situ hybridization mapping of 40 unique Notl linking clones homologous to genes and cDNAs,"" Chromosome Res 4:443-447 (1996).;;Pullikuth et al., ""The MEK1 Scaffolding Protein MP1 Regulates Cell Spreading by Integrating PAK1 and Rho Signals,"" Mol Cell Biol 25:5119-5133 (2005).;;Qiang et al., ""Wnts induce migration and invasion of myeloma plasma cells,"" Blood 106:1786-1793 (2005).;;Rajkumar, S.V., and Kyle, R.A., ""Multiple Myeloma: Diagnosis and Treatment,"" Mayo Clin Proc 80:1371-1382 (2005).;;Regala et al., ""Atypical Protein Kinase Ciota Is an Oncogene in Human Non-Small Cell Lung Cancer,"" Cancer Res, 65:8905-8911 (2005).;;Regala, R., ""Atypical Protein Kinase Ciota Plays a Critical Role in Human Lung Cancer Cell Growth and Tumorigenicity,"" J Biol Chem. 280(35):31109-15 (2005).;;Richardson et al., ""Novel biological therapies for the treatment of multiple myeloma,"" Best Pract Res Clin Haematol 18:619-634 (2005).;;Sawyer et al., ""Identification of New Nonrandom Translocations in Multiple Myeloma With Multicolor Spectral Karyotyping,"" Blood 92:4269-4278 (1998).;;Sebat et al., ""Large-Scale Copy Number Polymorphism in the Human Genome,"" Science 305:525-528 (2004).;;Seymour, A. B., et al., ""Allelotype of Pancreatic Adenocarcinoma,"" Cancer Res 54:2761-2764 (1994).",ACTIVE
61,US,A1,US 2014/0067946 A1,051-885-432-802-973,2014-03-06,2014,US 201213688850 A,2012-11-29,US 201213688850 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming Through Social Networking,"In particular embodiments, a social networking system queries a social graph of the social-networking system for social content associated with video content provided to one or more users of the social-networking system and accesses privacy settings associated with each of the one or more users. The privacy settings indicate whether a particular user has authorized the social-networking system to share social content associated with the particular user with one or more third parties. The social networking system provides the social content associated with video content provided to the one or more users to a particular third party if the privacy settings of the one or more users indicate that the one or more users have authorized the social-networking system to share the social content with one or more third parties.",BRUICH SEAN MICHAEL;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;KRAUSZ BRIAN;;TSENG ERICH;;WONG YONG KEAN,BRUICH SEAN MICHAEL;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;KRAUSZ BRIAN;;TSENG ERICH;;WONG YONG KEAN,META PLATFORMS INC (2012-12-04),https://lens.org/051-885-432-802-973,Patent Application,yes,15,28,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,G06F15/16;;H04W4/50;;H04W4/80,709/204,0,0,,,,ACTIVE
62,US,B2,US 10405020 B2,074-548-010-497-048,2019-09-03,2019,US 201715653616 A,2017-07-19,US 201715653616 A;;US 201213688850 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, a social networking system queries a social graph of the social-networking system for social content associated with video content provided to one or more users of the social-networking system and accesses privacy settings associated with each of the one or more users. The privacy settings indicate whether a particular user has authorized the social-networking system to share social content associated with the particular user with one or more third parties. The social networking system provides the social content associated with video content provided to the one or more users to a particular third party if the privacy settings of the one or more users indicate that the one or more users have authorized the social-networking system to share the social content with one or more third parties.",FACEBOOK INC,BRUICH SEAN MICHAEL;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;KRAUSZ BRIAN;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2021-10-28),https://lens.org/074-548-010-497-048,Granted Patent,yes,238,8,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,G06F15/16;;G06F16/438;;G06F16/58;;G06Q30/02;;G06Q50/00;;H04L12/58;;H04L29/06;;H04L29/08;;H04L29/12;;H04N21/234;;H04N21/235;;H04N21/25;;H04N21/258;;H04N21/262;;H04N21/278;;H04N21/41;;H04N21/414;;H04N21/4147;;H04N21/4227;;H04N21/433;;H04N21/434;;H04N21/4363;;H04N21/439;;H04N21/44;;H04N21/4402;;H04N21/45;;H04N21/472;;H04N21/4788;;H04N21/482;;H04N21/488;;H04N21/63;;H04N21/6334;;H04N21/6543;;H04N21/81;;H04N21/84;;H04N21/8547;;H04W4/50;;H04W4/80,,10,1,001-019-759-270-089,10.1109/ccnc.2010.5421599,"U.S. Appl. No. 15/680,752, filed Aug. 18, 2017, Ime Archibong.;;U.S. Appl. No. 15/495,508, filed Apr. 24, 2017, Archibong.;;U.S. Appl. No. 15/498,015, filed Apr. 26, 2017, Archibong.;;U.S. Appl. No. 15/612,169, filed Jun. 2, 2017, Garcia.;;U.S. Appl. No. 15/618,816, filed Jun. 9, 2017, Marlow.;;EPO Germany, Communication—Extended European Search Report dated Apr. 5, 2016; Application No./Patent No. 13833399.2-1905 / 2891322 PCT/US2013057449; Ref. FABOO276-PCT/EP, dated May 4, 2016.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013, dated Dec. 11, 2013.;;Martin, R. et al. “neXtream: A Multi-Device, Social Approach to Video Content Consumption.” Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5, 2010.;;Korean Intellectual Property Office, Notice of Allowance, Appln. No. 10-2015-7008259, dated Nov. 15, 2017.;;Australian Government, IP Australia, Examination Report No. 1 for Standard Patent Application No. 2017/210589, dated Aug. 10, 2018.",ACTIVE
63,US,B2,US 9723373 B2,177-182-011-510-794,2017-08-01,2017,US 201213688850 A,2012-11-29,US 201213688850 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, a social networking system queries a social graph of the social-networking system for social content associated with video content provided to one or more users of the social-networking system and accesses privacy settings associated with each of the one or more users. The privacy settings indicate whether a particular user has authorized the social-networking system to share social content associated with the particular user with one or more third parties. The social networking system provides the social content associated with video content provided to the one or more users to a particular third party if the privacy settings of the one or more users indicate that the one or more users have authorized the social-networking system to share the social content with one or more third parties.",FACEBOOK INC,BRUICH SEAN MICHAEL;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;KRAUSZ BRIAN;;TSENG ERICH;;WONG YONG KEAN,META PLATFORMS INC (2012-12-04),https://lens.org/177-182-011-510-794,Granted Patent,yes,167,10,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,G06F15/16;;G06F3/048;;G06F3/0481;;G06F17/30;;G06Q30/02;;G06Q50/00;;H04L12/58;;H04L29/06;;H04L29/08;;H04N21/23;;H04N21/234;;H04N21/235;;H04N21/258;;H04N21/278;;H04N21/41;;H04N21/4227;;H04N21/433;;H04N21/434;;H04N21/439;;H04N21/44;;H04N21/472;;H04N21/478;;H04N21/4788;;H04N21/482;;H04N21/488;;H04N21/63;;H04N21/6334;;H04N21/6543;;H04N21/81;;H04W4/50;;H04W4/80,,23,1,001-019-759-270-089,10.1109/ccnc.2010.5421599,"U.S. Appl. No. 13/602,011, filed Aug. 31, 2012, Cameron A. Marlow.;;U.S. Appl. No. 13/688,736, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,035, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/689,285, filed Nov. 29, 2012, David H. Garcia.;;U.S. Appl. No. 13/689,355, filed Nov. 29, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/688,905, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13/690,769, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/690,892, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,122, filed Nov. 30, 2012, Mark Heynen.;;U.S. Appl. No. 13/692,122, filed Dec. 3, 2012, Colin C. Brennan.;;U.S. Appl. No. 13/691,269, filed Nov. 30, 2012, David H. Garcia.;;U.S. Appl. No. 13/692,675, filed Dec. 3, 2012, Ime Archibong.;;U.S. Appl. No. 13,692,598, filed Dec. 3, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/692,006, filed Dec. 3, 2012, Colin C. Brennan.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013.;;Martin, R. et al. “neXtream: A Multi-Device, Social Approach to Video Content Consumption.” Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5.;;U.S. Appl. No. 14/931,072, filed Nov. 2, 2015, Archibong.;;U.S. Appl. No. 15/046,179, filed Feb. 17, 2016, Archibong.;;EPO Germany, Communication—Extended European Search Report dated Apr. 5, 2016; Application No./Patent No. 13833399.2-1905/2891322 PCT/US2013057449; Ref. FABOO276-PCT/EP May 4, 2016.;;U.S. Appl. No. 15/283,908, filed Oct. 3, 2016, Archibong.;;U.S. Appl. No. 15/295,497, filed Oct. 17, 2016, Badros.;;U.S. Appl. No. 15/376,902, filed Dec. 13, 2016, Campbell.;;U.S. Appl. No. 15/393,449, filed Dec. 29, 2016, Garcia.",ACTIVE
64,US,A1,US 2008/0075722 A1,026-894-850-911-169,2008-03-27,2008,US 70615507 A,2007-02-13,US 70615507 A;;US 77307206 P,2006-02-14,"Compostions, kits, and methods for identification, assessment, prevention, and therapy of cancer","The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human cancer. A variety of chromosomal regions (MCRs) and markers corresponding thereto, are provided, wherein alterations in the copy number of one or more of the MCRs and/or alterations in the amount, structure, and/or activity of one or more of the markers is correlated with the presence of cancer.",DEPINHO RONALD A;;ANDERSON KENNETH C;;CARRESCO RUBEN D;;TONON GIOVANNI;;BRENNAN CAMERON;;SHAUGHNESSY JOHN D JR;;CHIN LYNDA,DEPINHO RONALD A;;ANDERSON KENNETH C;;CARRESCO RUBEN D;;TONON GIOVANNI;;BRENNAN CAMERON;;SHAUGHNESSY JOHN D JR;;CHIN LYNDA,DANA-FARBER CANCER INSTITUTE INC (2010-04-01);;BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (2010-04-01),https://lens.org/026-894-850-911-169,Patent Application,yes,5,85,10,10,713,C12Q1/6841;;C12Q1/6886;;C12Q2600/106;;C12Q2600/118;;C12Q2600/136;;C12Q2600/178;;A61P43/00;;C12Q1/6841;;C12Q1/6886;;C12Q2600/106;;C12Q2600/118;;C12Q2600/136;;C12Q2600/178;;C12Q1/6837,A61K31/70;;A01K67/00;;A61K38/00;;A61K39/395;;A61P43/00;;C07H21/00;;C07K14/00;;C12Q1/68;;C40B30/04;;G01N33/574,424/138.1;;424/178.1;;435/6;;435/7.23;;506/9;;514/2;;514/44;;530/350;;536/23.1;;800/3,0,0,,,,INACTIVE
65,US,B2,US 8211634 B2,133-481-514-206-261,2012-07-03,2012,US 70615507 A,2007-02-13,US 70615507 A;;US 77307206 P,2006-02-14,"Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer","The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human cancer. A variety of chromosomal regions (MCRs) and markers corresponding thereto, are provided, wherein alterations in the copy number of one or more of the MCRs and/or alterations in the amount, structure, and/or activity of one or more of the markers is correlated with the presence of cancer.",DEPINHO RONALD A;;ANDERSON KENNETH C;;CARRASCO RUBEN D;;TONON GIOVANNI;;BRENNAN CAMERON W;;SHAUGHNESSY JR JOHN D;;CHIN LYNDA;;DANA FARBER CANCER INST INC;;UNIV ARKANSAS,DEPINHO RONALD A;;ANDERSON KENNETH C;;CARRASCO RUBEN D;;TONON GIOVANNI;;BRENNAN CAMERON W;;SHAUGHNESSY JR JOHN D;;CHIN LYNDA,DANA-FARBER CANCER INSTITUTE INC (2010-04-01);;BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (2010-04-01),https://lens.org/133-481-514-206-261,Granted Patent,yes,9,35,10,10,713,C12Q1/6841;;C12Q1/6886;;C12Q2600/106;;C12Q2600/118;;C12Q2600/136;;C12Q2600/178;;A61P43/00;;C12Q1/6841;;C12Q1/6886;;C12Q2600/106;;C12Q2600/118;;C12Q2600/136;;C12Q2600/178;;C12Q1/6837,C12Q1/68;;G01N33/53;;G01N33/574,435/6;;434/7.1;;434/7.23,104,103,000-231-571-246-126;;034-134-907-055-024;;006-846-530-826-211;;121-125-137-504-557;;125-372-386-025-788;;105-470-213-897-135;;020-178-040-162-13X;;076-139-734-348-158;;076-591-202-219-68X;;010-960-298-556-053;;004-738-078-948-368;;000-428-986-983-872;;052-130-043-164-905;;027-983-179-525-405;;089-470-191-334-21X;;072-034-119-492-741;;047-846-311-940-169;;089-520-638-381-227;;015-987-432-869-758;;058-233-617-169-933;;030-705-259-970-494;;049-666-656-152-47X;;150-043-352-274-566;;027-107-831-426-572;;010-004-899-887-448;;111-053-101-104-380;;034-502-839-980-053;;049-310-031-441-151;;049-081-306-525-711;;083-169-263-029-572;;086-387-340-381-014;;043-971-045-441-945;;059-265-164-882-99X;;064-901-986-903-441;;042-539-445-108-069;;073-992-136-342-951;;069-271-192-093-385;;060-776-367-600-526;;037-920-584-212-490;;003-189-791-794-979;;043-781-583-966-151;;105-535-811-037-682;;015-805-796-879-623;;029-742-983-481-795;;031-898-723-593-793;;053-393-466-133-052;;048-401-146-964-224;;057-165-463-943-202;;044-598-633-506-008;;072-007-995-074-685;;018-067-643-463-093;;011-475-664-545-870;;013-124-736-934-786;;087-871-690-717-906;;025-334-710-956-363;;035-094-562-115-791;;002-048-011-717-986;;081-055-619-088-445;;012-664-627-298-304;;099-443-487-510-63X;;005-619-769-553-730;;036-110-529-854-852;;033-204-109-356-628;;005-295-921-298-124;;113-053-074-594-056;;037-310-319-433-702;;008-191-162-175-221;;003-045-892-901-355;;017-746-642-715-189;;023-107-068-480-384;;013-149-781-143-466;;004-184-985-742-257;;035-507-566-489-857;;038-486-024-514-252;;065-787-595-730-408;;003-113-109-661-25X;;000-592-244-463-75X;;006-530-638-049-054;;036-977-191-704-479;;057-427-209-307-291;;025-190-406-440-805;;036-598-026-051-46X;;010-389-308-492-613;;138-349-623-159-63X;;042-809-844-633-626;;118-268-988-659-792;;026-871-000-838-194;;105-031-147-566-543;;033-490-550-941-721;;033-963-799-295-451;;037-754-112-897-478;;019-911-301-892-485;;050-278-052-812-394;;130-275-898-020-637;;051-239-099-295-51X;;014-549-672-381-122;;139-816-723-444-709;;079-337-780-001-944;;011-448-154-520-207;;154-619-705-797-739;;000-938-030-958-082;;114-831-710-525-364;;007-581-103-081-206,16204062;;10.1158/0008-5472.can-05-2372;;1563002;;12623842;;10.1182/blood-2002-11-3385;;11861292;;10.1182/blood.v99.5.1745;;10.1182/blood-2013-08-522011;;15238243;;10.1016/j.bbcan.2004.05.001;;10.1073/pnas.0402932101;;15199222;;pmc428474;;10.1016/s0165-4608(99)00118-1;;10640145;;9172003;;10.1002/(sici)1098-2264(199706)19:2<124::aid-gcc8>3.0.co;2-0;;10.1038/sj.onc.1205836;;12362270;;pmc1968474;;8494707;;10.1038/bjc.1993.203;;16525139;;10.1056/nejmoa053583;;12969978;;10.1182/blood-2003-04-1045;;15755896;;10.1182/blood-2005-01-0034;;pmc1895118;;10.1038/sj.onc.1204641;;11607813;;16155016;;10.1200/jco.2005.05.021;;pmc2151225;;9460997;;10.1038/bjc.1998.42;;10.1158/0008-5472.can-04-1241;;15256441;;12917690;;10.1038/nature01811;;15016911;;10.1073/pnas.0308531101;;pmc384712;;10.1038/sj.onc.1207973;;15678131;;16112193;;10.1016/j.leukres.2005.07.008;;12041852;;pmc111086;;10.1038/nm1125;;15502842;;15920009;;10.1182/blood-2005-02-0761;;pmc1895145;;10.1182/blood.v91.8.3007.3007_3007_3010;;9531613;;10.4049/jimmunol.174.10.6030;;15879096;;16015333;;10.1038/nature03681;;16001433;;10.1002/gcc.20231;;10.1006/geno.1998.5405;;9787076;;10.1101/gad.1267105;;15681610;;pmc548948;;12592343;;10.1038/sj.leu.2402797;;10.1073/pnas.0505641102;;16116079;;pmc1188258;;12461754;;10.1002/gcc.10140;;10.1139/o04-052;;15284904;;12576455;;14989251;;10.1158/0008-5472.can-03-2876;;14696419;;9218997;;10.1002/(sici)1098-2264(199707)19:3<161::aid-gcc5>3.0.co;2-w;;10469215;;10.1046/j.1365-2559.1999.00705.x;;pmc1850008;;10027410;;10.1016/s0002-9440(10)65298-4;;12063017;;10.1016/s0301-472x(02)00806-8;;15763977;;10.1080/10245330400018524;;10.1126/science.286.5439.531;;10521349;;10.1002/(sici)1098-2264(199810)23:2<81::aid-gcc1>3.0.co;2-0;;9739011;;8605114;;10.1002/gcc.2870140404;;7513550;;10.1002/gcc.2870090204;;7757992;;12791393;;10.1016/s0065-2571(02)00032-8;;7553647;;10.1074/jbc.272.39.24631;;9305932;;15944707;;pmc4599349;;10.1038/nature03552;;15090448;;10.1182/blood-2004-01-0037;;12414653;;15375558;;10.1002/1097-0142(19920401)69:7<1674::aid-cncr2820690706>3.0.co;2-l;;1551052;;12874278;;10.1074/jbc.m306324200;;10.3892/ijo.20.6.1247;;12012006;;10.3892/ijmm.12.5.727;;14533001;;10.1038/nri1003;;12563299;;pmc1615642;;15111303;;10.1016/s0002-9440(10)63715-7;;10.1002/(sici)1098-2264(199610)17:2<88::aid-gcc3>3.3.co;2-3;;10.1002/(sici)1098-2264(199610)17:2<88::aid-gcc3>3.0.co;2-x;;8913725;;15154013;;10.1038/modpathol.3800180;;11990854;;10.1038/nrc746;;12374982;;10.1038/nature01037;;15509819;;10.1056/nejmra041875;;10.1056/nejmcibr032650;;14711921;;16049974;;10.1002/ijc.21353;;12975311;;10.1101/gr.1349003;;pmc403708;;11369051;;10.1016/s0165-4608(00)00363-0;;15870690;;10.1038/sj.onc.1208708;;10.1002/(sici)1098-2264(199712)20:4<383::aid-gcc10>3.0.co;2-o;;9408755;;10.1002/gcc.10122;;12378529;;10.1038/sj.onc.1208649;;15824735;;10.1038/sj.onc.1206406;;12761501;;10.1038/35008115;;10783894;;15542427;;10.1016/j.ccr.2004.10.020;;15550490;;10.1182/blood-2004-07-2947;;10.1038/ng1180;;12808457;;15024028;;10.1083/jcb.200311011;;pmc2172278;;15840441;;10.1016/j.semcdb.2005.02.010;;14961574;;10.1002/ijc.11716;;15475419;;10.1093/biostatistics/kxh008;;15736465;;10.1002/gcc.1145;;11391799;;15471221;;9192802;;10.1038/2524;;9771718;;11861394;;10.1073/pnas.162471999;;pmc130569;;12297621;;8889243;;10.1007/bf02265051;;pmc1140582;;15923628;;10.1128/mcb.25.12.5119-5133.2005;;15886323;;10.1182/blood-2005-01-0049;;pmc1895227;;10.4065/80.10.1371;;16212152;;10.1074/jbc.m505402200;;15994303;;16026741;;10.1016/j.beha.2005.01.010;;10.1182/blood.v92.11.4269.423k31_4269_4278;;9834233;;10.1126/science.1098918;;15273396;;8168108;;10.1034/j.1600-065x.2003.00054.x;;12846813;;10.1006/geno.1999.6101;;10708517;;8706027;;10822368;;10.1038/sj.onc.1203561,"Regala et al (Cancer Research, Oct. 2005, 65:8905-8911).;;Tockman et al (Cancer Res., 1992, 52:2711s-2718s).;;Magrangeas et al (Blood, Jun. 2003, 101:4998-5006).;;Zhan et al (Blood, 2002, 99:1745-1757).;;Falini et al (Blood, 2000, 95:2084-2092).;;Abdelhaleem, M., ""Do human RNA helicases have a role in cancer?,"" Biochim Biophys Acta 1704:37-46 (2004).;;Aguirre et al., ""High-resolution characterization of the pancreatic adenocarcinoma genome,"" Proc Natl Acad Sci USA 101:9067-9072 (2004).;;Armengol et al., ""DNA Copy Number Changes and Evaluation of MYC, IGF1R, and FES Amplification in Xenografts of Pancreatic Andenocarcinoma,"" Cancer Genet Cytogenet 116:133-41 (2000).;;Avet-Loiseau et al., ""Molecular Cytogenetic Abnormalities in Multiple Myeloma and Plasma Cell Leukemia Measured Using Comparative Genomic Hybridization,"" Genes Chromosomes Cancer 19:124-133 (1997).;;Balsara and Testa, ""Chromosomal imbalances in human lung cancer,"" Oncogene 21:6877-6883 (2002).;;Bardi et al., ""Karyotypic abnormalities in tumours of the pancreas,"" Br J Cancer 67:1106-1112 (1993).;;Barlogie et al., ""Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma,"" N Engl J Med 354:1021-1030 (2006).;;Barlogie et al., ""Treatment of multiple myeloma,"" Blood 103, 20-32 (2004).;;Bergsagel et al.,""Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma,"" Blood 106:296-303 (2005).;;Bergsagel and Kuehl., ""Chromosome translocations in multiple myeloma,"" Oncogene 20:5611-5622 (2001).;;Bergsagel and Kuehl, ""Molecular Pathogenesis and a Consequent Classification of Multiple Myeloma,"" J Clin Oncol 23:6333-6338 (2005).;;Bjorkqvist et al. ""Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung,"" Br J Cancer 77(2):260-269 (1998).;;Brennan et al., ""High-Resolution Global Profiling of Genomic Alterations with Long Oligonucleotide Microarray,"" Cancer Res 64:4744-4748 (2004).;;Brummelkamp et al., ""Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB,"" Nature 424:797-801 (2003).;;Brunet et al., ""Metagenes and molecular pattern discovery using matrix factorization,"" Proc Natl Acad Sci USA 101:4164-4169 (2004).;;Castro et al., ""The anaphase-promoting complex: a key factor in the regulation of cell cycle,"" Oncogene 24:314-325 (2005).;;Chang et al., ""Analysis of PTEN deletions and mutations in multiple myeloma,"" Leuk Res 30:262-265 (2006).;;Chen, B. H., ""Monoclonal gammopathy of undetermined significance: new insights,"" Can Med Assoc J 166(10):1309 (2002).;;Cheng et al., ""The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers,"" Nat Med 10:1251-1256 (2004).;;Chng et al., ""A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS,"" Blood 106:2156-2161 (2005).;;Cigudosa et al., Characterization of Nonrandom Chromosomal Gains and Losses in Multiple Myeloma by Comparative Genomic Hybridization Blood 91:3007-3010 (1998).;;Colgan et al.,""Cyclophilin A-Deficient Mice Are Resistant to Immunosuppression by Cyclosporine,"" J Immunol 174:6030-6038 (2005).;;Collier et al., ""Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse,"" Nature 436, 272-276 (2005).;;Cremer et al., ""Delineation of Distinct Subgroups of Multiple Myeloma and a Model for Clonal Evolution Based on Interphase Cytogenetics,"" Genes Chromosomes Cancer 44:194-203 (2005).;;Curtis et al., ""Amplification of DNA Sequences from Chromosome 19q13.1 in Human Pancreatic Cell Lines,"" Genomics 53:42-55 (1998).;;Dai et al., ""The kinase haspin is required for mitotic histone H3 and Thr3 phosphorylation and normal metaphase chromosome alignment,"" Genes Dev 19:472-488 (2005).;;Debes-Marun et al., ""Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma,"" Leukemia 17:427-436 (2003).;;Eder, A.M., ""Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and Cyclin E overexpression in ovarian cancer,"" Proc Natl Acad Sci U S A.102(35):12519-12524 (2005).;;Elnenaei et al., ""Delineation of the Minimal Region of Loss at 13q14 in Multiple Myeloma,"" Genes Chromosomes Cancer 36:99-106 (2003).;;Emberley et al., ""S100 proteins and their influence on pro-survival pathways in cancer,"" Biochem Cell Biol 82:508-515 (2004).;;Filipits et al., ""Low p27Kip1 Expression Is an Independent Adverse Prognostic Factor in Patients with Multiple Myeloma,"" Clin Cancer Res 9:820-826 (2003).;;Fonseca et al., ""Genetics and Cytogenetics of Multiple Myeloma: A Workshop Report,"" Cancer Res 64:1546-1558 (2004).;;Fujita et al., ""Chromosome Arm 20q Gains and Other Genomic Alterations in Esophageal Squamous Cell Carcinoma, as Analyzed by Comparative Genomic Hybridization and Fluorescence in Situ Hybridization,"" Hepato-Gastroenterology 50, 1857-1863 (2003).;;Fukushige et al., ""Frequent Gain of Copy Number on the Long Arm of Chromosome 20 in Human Pancreatic Adenocarcinoma,"" Genes Chromosomes Cancer 19:161-169 (1997).;;Furubo et al., ""Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma,"" Histopathology 35:230-240 (1999).;;Ghadimi et al., ""Specific Chromosomal Aberrations and Amplification of the AlB1 Nuclear Receptor Coactivator Gene in Pancreatic Carcinomas,"" Am J Pathol 154:525-536 (1999).;;Ginzinger, D. M., ""Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream,"" Exp Hematol 30:503-512 (2002).;;Giuliani et al., ""Angiogenic Switch in Multiple Myeloma,"" Hematology 9:377-381 (2004).;;Golub et al., ""Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring,"" Science 286:531-537 (1999).;;Gorunova et al., ""Cytogenetic Analysis of Pancreatic Carcinomas: Intratumor Heterogeneity and Nonrandom Pattern of Chromosome Aberrations,"" Genes Chromosomes Cancer 23:81-99 (1998).;;Gorunova et al., ""Massive Cytogenetic Heterogeneity in a Pancreatic Carcinoma: Fifty-Four Karyotypically Unrelated Clones,"" Genes Chromosomes Cancer 14:259-266 (1995).;;Griffin et al., ""Chromosome Abnormalities in Pancreatic Adenocarcinoma,"" Genes Chromosomes Cancer 9:93-100 (1994).;;Griffin et al., ""Consistent Chromosome Abnormalities in Adenocarcinoma of the Pancreas,"" Cancer Res 55:2394-2399 (1995).;;Grunicke et al., ""Regulation of cell survival by atypical protein kinase C isozymes,"" Advan. Enzyme Regul. 43:213-228 (2003).;;Hahn et al., ""Allelotype of Pancreatic Adenocarcinoma Using Xenograft Enrichment,"" Cancer Res 55:4670-4675 (1995).;;Harrington et al., ""The Identification and Characterization of a G4-DNA Resolvase Activity,"" J Biol Chem 272(39):24631-24636 (1997).;;He et al., ""A microRNA polycistron as a potential human oncogene,"" Nature 435:828-833 (2005).;;Hideshima et al., ""Advances in biology of multiple myeloma: clinical applications,"" Blood 104(3):607-618 (2004).;;Hyman et al., ""Impact of DNA Amplification on Gene Expression Patterns in Breast Cancer,"" Cancer Res 62, 6240-6245 (2002).;;Isler et al., ""Evidence for transcriptional repression of SPARC-like 1, a gene downregulated in human lung tumors,"" Int J Oncol 25:1073-1079 (2004).;;Johansson et al., ""Nonrandom Chromosomal Rearrangements in Pancreatic Carcinomas,"" Cancer 69:1674-1681 (1992).;;Kanamori et al., ""The PDZ Protein Tax-interacting Protein-1 Inhibits beta-Catenin Transcriptional Activity and Growth of Colorectal Cancer Cells,"" J Biol Chem 278:38758-38764 (2003).;;Katoh, M., ""Molecular cloning and characterization of ST7R (ST7-like, ST7L) on human chromosome 1p13, a novel gene homologous to tumor suppressor gene ST7 on human chromosome 7q31,"" Int J Oncol 20:1247-1253 (2002).;;Kawasaki et al., ""11q23-24 loss is associated with chromosomal instability in endometrial cancer,"" Int J Mol Med 12(5):727-731 (2003).;;Kikutani and Kumanogoh, ""Semaphorins in interactions between T cells and antigen-presenting cells,"" Nat Rev Immunol 3:159-167 (2003).;;Kim et al.,""Cyclophilin A as a Novel Biphasic Mediator of Endothelial Activation and Dysfunction,"" Am J Pathol 164:1567-1574 (2004).;;Kimura et al., ""Detailed Deletion Mapping on Chromosome Arm 12q in Human Pancreatic Adenocarcinoma: Identification of a 1-cM Region of Common Allelic Loss,"" Genes Chromosomes Cancer 17:88-93 (1996).;;Kimura et al., ""Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression,"" Mod Pathol, 17:1328-1337 (2004).;;Kuehl and Bergsagel, ""Multiple Myeloma: Evolving Genetic Events and Host Interactions,"" Nat Rev Cancer 2:175-187 (2002).;;Kumanogoh et al., ""Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2,"" Nature 419:629-633 (2002).;;Kyle and Rajkumar, ""Multiple Myeloma,"" N Engl J Med 351:1860-1873 (2004).;;Lakhani, S. R., ""Putting the Brakes on Cylindromatosis?,"" N Engl J Med 350:187-188 (2004).;;Lindsey et al., ""Epigenetic inactivation of MCJ (DNAJD1) in malignant pediatric brain tumours,"" Int J Cancer, 118:346-352 (2006).;;Lucito et al., ""Representational Oligonucleotide Microarray Analysis: A High-Resolution Method to Detect Genome Copy Number Variation,"" Genome Res 13:2291-2305 (2003).;;Luk et al., ""Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization,"" Cancer Genet Cytogenet 125:87-99 (2001).;;Magrassi et al., ""Shc3 affects human high-grade astrocytomas survival,"" Oncogene 24:5198-5206 (2005).;;Mahlamaki et al., ""Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer,"" Genes Chromosomes Cancer 20:383-391 (1997).;;Mahlamaki et al., ""Frequent amplification of 8q24, 11q, 17q and 20q-specific genes in pancreatic cancer,"" Genes Chromosomes Cancer 35:353-358 (2002).;;Maina et al., ""Identification of novel VHL target genes and relationship to hypoxic response pathways,"" Oncogene 24:4549-4558 (2005).;;Matsuda et al. ""Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways,"" Oncogene 22:3307-3318 (2003).;;Medema et al., ""AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1,"" Nature 404:782-786 (2000).;;Mitsiades et al., ""Focus on multiple myeloma,"" Cancer Cell 6:439-444 (2004).;;Monti et al., ""Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response,"" Blood 105:1851-1861 (2005).;;Mootha et al., ""PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes,"" Nat Genet 34:267-273 (2003).;;Murray et al., ""Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo,"" J Cell Biol 164(6):797-802 (2004).;;Nakayama and Nakayama, ""Regulation of the cell cycle by SCF-type ubiquitin ligases,"" Semin Cell Dev Biol 16:323-333 (2005).;;Nilsson et al., ""Amplification of Chromosome 1 Sequences in Lipomatous Tumors and Other Sarcomas,"" Int J Cancer 109:363-369 (2004).;;Olshen et al., ""Circular binary segmentation for the analysis of array-based DNA copy number data,"" Biostatistics 5:557-572 (2004).;;Olshen and Venkatraman, ""Change-Point Analysis of Array-Based Comparative Genomic Hybridization Data,"" ASA Proc Joint Stat Meetings 2530-2535 (2002).;;Panani et al., ""Cytogenetic Data as a Prognostic Factor in Multiple Myeloma Patients: Involvement of 1p12 Region an Adverse Prognostic Factor,"" Anticancer Res 24:4141-4146 (2004).;;Pei et al., ""Genomic Imbalances in Human Lung Adenocarcinomas and Squamous Cell Carcinomas,"" Genes Chromosomes Cancer 31:282-287 (2001).;;Perez-Andres et al. ""Interaction between clonal plasma cells and the immune system in plasma cell dyscrasias,"" J Biol Regul Homeost Agents 18:161-165 (2004).;;Petersen et al., ""Patterns of Chromosomal Imbalances in Adenocarcinoma and Squamous Cell Carcinoma of the Lung,"" Cancer Res 57:2331-2335 (1997).;;Pinkel et al., ""High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays,"" Nat Genet 20:207-211 (1998).;;Platzer et al., ""Silence of Chromosomal Amplifications in Colon Cancer,"" Cancer Res 62:1134-1138 (2002).;;Pollack et al.,""Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors,"" Proc Natl Acad Sci USA 99:12963-12968 (2002).;;Protopopov et al., ""Human chromosome 3: high-resolution fluorescence in situ hybridization mapping of 40 unique Not linking clones homologous to genes and cDNAs,"" Chromosome Res 4:443-447 (1996).;;Pullikuth et al., ""The MEK1 Scaffolding Protein MP1 Regulates Cell Spreading by Integrating PAK1 and Rho Signals,"" Mol Cell Biol 25:5119-5133 (2005).;;Qiang et al., ""Wnts induce migration and invasion of myeloma plasma cells,"" Blood 106:1786-1793 (2005).;;Rajkumar and Kyle, ""Multiple Myeloma: Diagnosis and Treatment,"" Mayo Clin Proc 80:1371-1382 (2005).;;Regala et al., ""Atypical Protein Kinase Ciota Plays a Critical Role in Human Lung Cancer Cell Growth and Tumorigenicity,"" J Biol Chem 280(35):31109-31115 (2005).;;Richardson et al., ""Novel biological therapies for the treatment of multiple myeloma,"" Best Pract Res Clin Haematol 18:619-634 (2005).;;Sawyer et al., ""Identification of New Nonrandom Translocations in Multiple Myeloma With Multicolor Spectral Karyotyping,"" Blood 92:4269-4278 (1998).;;Sebat et al., ""Large-Scale Copy Number Polymorphism in the Human Genome,"" Science 305:525-528 (2004).;;Seymour et al., ""Allelotype of Pancreatic Adenocarcinoma,"" Cancer Res 54:2761-2764 (1994).;;Shaughnessy, Jr. and Barlogie, ""Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling,"" Immunol Rev 194:140-163 (2003).;;Smith et al., ""A Transcript Map of the Chromosome 19q-Arm Glioma Tumor Suppressor Region,"" Genomics 64:44-50 (2000).;;Solinas-Toldo et al., ""Mapping of Chromosomal Imbalances in Pancreatic Carcinoma by Comparative Genomic Hybridization,"" Cancer Res 56:3803-3807 (1996).;;Stepanova et al., ""Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia,"" Oncogene 19:2186-2193 (2000).",INACTIVE
66,US,A1,US 2014/0067828 A1,161-961-384-589-839,2014-03-06,2014,US 201213691035 A,2012-11-30,US 201213691035 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming Through Social Networking,"In particular embodiments, one or more computer systems of a social-networking system determine identities of one or more users in proximity to a display device and query a social graph of the social-networking system for social content associated with the determined identities. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system identify, using the social content, recommended media content for the one or more users in proximity to the display device and provide a playlist for display on the display device. The playlist includes the recommended media content for the one or more users in proximity to the display device.",ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;SHAFFER JUSTIN ALEXANDER;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YONG KEAN,ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;SHAFFER JUSTIN ALEXANDER;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YONG KEAN,META PLATFORMS INC (2012-12-04),https://lens.org/161-961-384-589-839,Patent Application,yes,22,286,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,G06F17/30;;H04W4/50;;H04W4/80,707/748;;707/770,0,0,,,,ACTIVE
67,US,B2,US 10028005 B2,013-026-167-892-387,2018-07-17,2018,US 201715495508 A,2017-04-24,US 201715495508 A;;US 201213691035 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, one or more computer systems of a social-networking system determine identities of one or more users in proximity to a display device and query a social graph of the social-networking system for social content associated with the determined identities. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system identify, using the social content, recommended media content for the one or more users in proximity to the display device and provide a playlist for display on the display device. The playlist includes the recommended media content for the one or more users in proximity to the display device.",FACEBOOK INC,ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;SHAFFER JUSTIN ALEXANDER;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2021-10-28),https://lens.org/013-026-167-892-387,Granted Patent,yes,204,6,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N7/173;;G06F17/30;;H04N7/025;;H04N7/10;;H04N21/25;;H04N21/258;;H04N21/262;;H04N21/41;;H04N21/4788;;H04W4/50;;H04W4/80,,8,1,001-019-759-270-089,10.1109/ccnc.2010.5421599,"U.S. Appl. No. 15/498,015, filed Apr. 26, 2017, Archibong.;;U.S. Appl. No. 15/612,169, filed Jun. 2, 2017, Garcia.;;U.S. Appl. No. 15/618,816, filed Jun. 9, 2017, Marlow.;;EPO Germany, Communication—Extended European Search Report dated Apr. 5, 2016; Application No./Patent No. 13833399.2-1905 / 2891322 PCT/US2013057449.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013, dated Dec. 11, 2013.;;Martin, R. et al. “neXtream: A Multi-Device, Social Approach to Video Content Consumption.” Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5.;;U.S. Appl. No. 15/653,616, filed Jul. 19, 2017, Sean Michael Bruich.;;U.S. Appl. No. 15/680,752, filed Aug. 18, 2017, Ime Archibong.",ACTIVE
68,US,B2,US 9660950 B2,172-962-338-225-050,2017-05-23,2017,US 201213691035 A,2012-11-30,US 201213691035 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, one or more computer systems of a social-networking system determine identities of one or more users in proximity to a display device and query a social graph of the social-networking system for social content associated with the determined identities. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system identify, using the social content, recommended media content for the one or more users in proximity to the display device and provide a playlist for display on the display device. The playlist includes the recommended media content for the one or more users in proximity to the display device.",ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;SHAFFER JUSTIN ALEXANDER;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YONG KEAN;;FACEBOOK INC,ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;SHAFFER JUSTIN ALEXANDER;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YONG KEAN,META PLATFORMS INC (2012-12-04),https://lens.org/172-962-338-225-050,Granted Patent,yes,160,53,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N7/173;;G06F3/048;;G06F3/0481;;G06F15/16;;G06F17/30;;H04L12/58;;H04L29/06;;H04L29/08;;H04N7/025;;H04N7/10;;H04N21/23;;H04N21/258;;H04N21/41;;H04N21/4227;;H04N21/433;;H04N21/434;;H04N21/439;;H04N21/44;;H04N21/472;;H04N21/478;;H04N21/4788;;H04N21/482;;H04N21/63;;H04N21/6543;;H04N21/81;;H04W4/50;;H04W4/80,,23,1,001-019-759-270-089,10.1109/ccnc.2010.5421599,"Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013.;;Martin, R. et al. “neXtream: A Multi-Device, Social Approach to Video Content Consumption.” Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5.;;U.S. Appl. No. 13/602,011, filed Aug. 31, 2012, Cameron A. Marlow.;;U.S. Appl. No. 13/688,736, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13,688,850, filed Nov. 29, 2012, Sean M. Bruich.;;U.S. Appl. No. 13/689,285, filed Nov. 29, 2012, David H. Garcia.;;U.S. Appl. No. 13/689,355, filed Nov. 29, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/688,905, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13/690,769, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/690,892, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,122, filed Nov. 30, 2012, Mark Heynen.;;U.S. Appl. No. 13/692,122, filed Dec. 3, 2012, Colin C. Brennan.;;U.S. Appl. No. 13/691,269, filed Nov. 30, 2012, David H. Garcia.;;U.S. Appl. No. 13/692,675, filed Dec. 3, 2012, Ime Archibong.;;U.S. Appl. No. 13,692,598, filed Dec. 3, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/692,006, filed Dec. 3, 2012, Colin C. Brennan.;;U.S. Appl. No. 14/930,072, filed Nov. 2, 2015, Archibong.;;U.S. Appl. No. 15/046,179, filed Feb. 17, 2016, Archibong.;;EPO Germany, Communication—Extended European Search Report dated Apr. 5, 2016; Application No./Patent No. 13833399.2-1905 / 2891322 PCT/US2013057449; Ref. FABOO276-PCT/EP May 4, 2016.;;U.S. Appl. No. 15/283,908, filed Oct. 3, 2016, Archibong.;;U.S. Appl. No. 15/295,497, filed Oct. 17, 2016, Badros.;;U.S. Appl. No. 15/376,902, filed Dec. 13, 2016, Campbell.;;U.S. Appl. No. 15/393,449, filed Dec. 29, 2016, Garcia.",ACTIVE
69,US,A1,US 2017/0230700 A1,098-256-067-317-69X,2017-08-10,2017,US 201715495508 A,2017-04-24,US 201715495508 A;;US 201213691035 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming Through Social Networking,"In particular embodiments, one or more computer systems of a social-networking system determine identities of one or more users in proximity to a display device and query a social graph of the social-networking system for social content associated with the determined identities. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system identify, using the social content, recommended media content for the one or more users in proximity to the display device and provide a playlist for display on the display device. The playlist includes the recommended media content for the one or more users in proximity to the display device.",FACEBOOK INC,ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;SHAFFER JUSTIN ALEXANDER;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2021-10-28),https://lens.org/098-256-067-317-69X,Patent Application,yes,0,2,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N21/262;;G06F17/30;;H04N21/25;;H04N21/258;;H04N21/41;;H04N21/4788;;H04W4/50;;H04W4/80,,0,0,,,,ACTIVE
70,US,A1,US 2014/0068692 A1,052-481-354-063-33X,2014-03-06,2014,US 201213690769 A,2012-11-30,US 201213690769 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming Through Social Networking,"In particular embodiments, one or more computer systems of a social-networking system receive a first video stream from a content source, receive social content from a social graph of the social-networking system, and generate an overlay area comprising at least a portion of the social content. The social graph includes a plurality of nodes and edges connecting the nodes, the nodes comprising user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system determine a placement for the overlay area within the first video stream, generate a modified video stream using at least the first video stream and the overlay area, and provide the modified video stream for display on a display device. The overlay area is placed within the modified video stream according to the determined placement.",ARCHIBONG IME;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;UNDERWOOD PATRICK;;WONG YOON KEAN,ARCHIBONG IME;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;UNDERWOOD PATRICK;;WONG YOON KEAN,META PLATFORMS INC (2012-12-04),https://lens.org/052-481-354-063-33X,Patent Application,yes,3,213,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N21/23;;H04W4/50;;H04W4/80,725/116,7,0,,,Angiolillo et al US Pub no 2009/0007179;;Jo US Pub no 2013/0140680;;McMaster et al US Pub no 2009/0083815;;Sloo US Pub no 2006/0139373;;Casagrande US Pub no 20100262992;;Hall et al US Pub no 2010/0199308;;Tidwell et al US Pub no 2011/0016482,ACTIVE
71,US,B2,US 10425671 B2,108-628-426-335-79X,2019-09-24,2019,US 201213690769 A,2012-11-30,US 201213690769 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, one or more computer systems of a social-networking system receive a first video stream from a content source, receive social content from a social graph of the social-networking system, and generate an overlay area comprising at least a portion of the social content. The social graph includes a plurality of nodes and edges connecting the nodes, the nodes comprising user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system determine a placement for the overlay area within the first video stream, generate a modified video stream using at least the first video stream and the overlay area, and provide the modified video stream for display on a display device. The overlay area is placed within the modified video stream according to the determined placement.",FACEBOOK INC,ARCHIBONG IME;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;UNDERWOOD PATRICK;;WONG YOON KEAN,META PLATFORMS INC (2012-12-04),https://lens.org/108-628-426-335-79X,Granted Patent,yes,200,2,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N21/234;;G06F15/16;;G06F16/438;;G06F16/58;;G06Q30/02;;G06Q50/00;;H04L12/58;;H04L29/06;;H04L29/08;;H04L29/12;;H04N21/235;;H04N21/25;;H04N21/258;;H04N21/262;;H04N21/2668;;H04N21/278;;H04N21/41;;H04N21/414;;H04N21/4147;;H04N21/4227;;H04N21/431;;H04N21/433;;H04N21/434;;H04N21/4363;;H04N21/439;;H04N21/44;;H04N21/4402;;H04N21/442;;H04N21/45;;H04N21/458;;H04N21/472;;H04N21/4788;;H04N21/482;;H04N21/488;;H04N21/63;;H04N21/6334;;H04N21/6543;;H04N21/81;;H04N21/84;;H04N21/8547;;H04W4/50;;H04W4/80,,21,0,,,"U.S. Appl. No. 13/602,011, filed Aug. 31, 2012, Cameron A. Marlow.;;U.S. Appl. No. 13/688,736, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,035, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/688,850, filed Nov. 29, 2012, Sean M. Bruich.;;U.S. Appl. No. 13/689,285, filed Nov. 29, 2012, David H. Garcia.;;U.S. Appl. No. 13/689,355, filed Nov. 29, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/688,905, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13/690,892, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,122, filed Nov. 30, 2012, Mark Heynen.;;U.S. Appl. No. 13/692,122, filed Dec. 3, 2012, Colin C. Brennan.;;U.S. Appl. No. 13/691,269, filed Nov. 30, 2012, David H. Garcia.;;U.S. Appl. No. 13/692,675, filed Dec. 3, 2012, Ime Archibong.;;U.S. Appl. No. 13,692,598, filed Dec. 3, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/692,006, filed Dec. 3, 2012, Colin C. Brennan.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013, dated Dec. 11, 2013.;;Martin, R. et al. “neXtreme: A Multi-Device, Social Approach to Video Content Consumption.” Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5.;;EPO Germany, Communication—Extended European Search Report dated May 4, 2016; Application No./Patent No. 13833399.2-1905 / 2891322 PCT/US2013057449; Ref. FABOO276-PCT/EP.;;U.S. Appl. No. 15/175,159, filed Jun. 7, 2016, Archibong.;;Korean Intellectual Property Office, Notice of Allowance, Appln. No. 10-2015-7008259, dated Nov. 15, 2017.;;Australian Government, IP Australia, Examination Report No. 1 for Standard Patent Application No. 2017/210589, dated Aug. 10, 2018.;;KR Office Action received from KIPO for Patent Application No. 10-2017-7003970. (with English Translation), dated Feb. 1, 2019.",ACTIVE
72,US,B2,US 9807454 B2,162-753-180-502-519,2017-10-31,2017,US 201615283908 A,2016-10-03,US 201615283908 A;;US 201213690892 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, one or more computer systems of a social-networking system identify a user viewing video content on a first display device, identify the video content being viewed on the first display device by the user, and determine a second display device associated with the identified user. The one or more computer systems of the social-networking system determine an action related to the video content being viewed by the user on the first display device and provide one or more instructions to the determined second display device to display a call-to-action associated with the determined action.",FACEBOOK INC,ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;SHAFFER JUSTIN ALEXANDER;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;UNDERWOOD PATRICK;;WONG YOON KEAN,META PLATFORMS INC (2021-10-28),https://lens.org/162-753-180-502-519,Granted Patent,yes,190,1,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N7/173;;G06F15/16;;G06F17/30;;G06Q30/02;;G06Q50/00;;H04L12/58;;H04L29/06;;H04L29/08;;H04L29/12;;H04N7/025;;H04N7/10;;H04N21/234;;H04N21/235;;H04N21/258;;H04N21/278;;H04N21/41;;H04N21/4147;;H04N21/4227;;H04N21/433;;H04N21/434;;H04N21/4363;;H04N21/439;;H04N21/44;;H04N21/4402;;H04N21/472;;H04N21/4788;;H04N21/482;;H04N21/488;;H04N21/63;;H04N21/6334;;H04N21/6543;;H04N21/81;;H04N21/84;;H04N21/8547;;H04W4/50;;H04W4/80,,10,1,001-019-759-270-089,10.1109/ccnc.2010.5421599,"U.S. Appl. No. 15/175,159, filed Jun. 7, 2016, Ime Archibong.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013, dated Dec. 11, 2013.;;Martin, R. et al. “neXtream: A Multi-Device, Social Approach to Video Content Consumption.” Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5.;;EPO Germany, Communication—Extended European Search Report, dated May 4, 2016; Application No. / Patent No. 13833399.2-1905 / 2891322 PCT/US2013057449; Ref. FABOO276-PCT/EP.;;U.S. Appl. No. 15/376,902, filed Dec. 13, 2016, Campbell.;;U.S. Appl. No. 15/393,449, filed Dec. 29, 2016, Garcia.;;U.S. Appl. No. 15/495,508, filed Apr. 24, 2017, Archibong.;;U.S. Appl. No. 15/498,015, filed Apr. 26, 2017, Archibong.;;U.S. Appl. No. 15/612,169, filed Jun. 2, 2017, Garcia.;;U.S. Appl. No. 15/618,816, filed Jun. 9, 2017, Marlow.",ACTIVE
73,US,A1,US 2017/0026442 A1,155-968-871-825-434,2017-01-26,2017,US 201615283908 A,2016-10-03,US 201615283908 A;;US 201213690892 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming through Social Networking,"In particular embodiments, one or more computer systems of a social-networking system identify a user viewing video content on a first display device, identify the video content being viewed on the first display device by the user, and determine a second display device associated with the identified user. The one or more computer systems of the social-networking system determine an action related to the video content being viewed by the user on the first display device and provide one or more instructions to the determined second display device to display a call-to-action associated with the determined action.",FACEBOOK INC,ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;SHAFFER JUSTIN ALEXANDER;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;UNDERWOOD PATRICK;;WONG YOON KEAN,META PLATFORMS INC (2021-10-28),https://lens.org/155-968-871-825-434,Patent Application,yes,0,16,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04L29/06;;H04L12/58;;H04L29/08;;H04W4/50;;H04W4/80,,0,0,,,,ACTIVE
74,US,A1,US 2014/0067947 A1,057-784-684-782-011,2014-03-06,2014,US 201213690892 A,2012-11-30,US 201213690892 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming Through Social Networking,"In particular embodiments, one or more computer systems of a social-networking system identify a user viewing video content on a first display device, identify the video content being viewed on the first display device by the user, and determine a second display device associated with the identified user. The one or more computer systems of the social-networking system determine an action related to the video content being viewed by the user on the first display device and provide one or more instructions to the determined second display device to display a call-to-action associated with the determined action.",ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;SHAFFER JUSTIN ALEXANDER;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;UNDERWOOD PATRICK;;WONG YOON KEAN,ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;SHAFFER JUSTIN ALEXANDER;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;UNDERWOOD PATRICK;;WONG YOON KEAN,META PLATFORMS INC (2012-12-04),https://lens.org/057-784-684-782-011,Patent Application,yes,21,19,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04L29/06;;H04W4/50;;H04W4/80,709/204,0,0,,,,ACTIVE
75,US,B2,US 9497155 B2,110-126-493-070-586,2016-11-15,2016,US 201213690892 A,2012-11-30,US 201213690892 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, one or more computer systems of a social-networking system identify a user viewing video content on a first display device, identify the video content being viewed on the first display device by the user, and determine a second display device associated with the identified user. The one or more computer systems of the social-networking system determine an action related to the video content being viewed by the user on the first display device and provide one or more instructions to the determined second display device to display a call-to-action associated with the determined action.",ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;SHAFFER JUSTIN ALEXANDER;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;UNDERWOOD PATRICK;;WONG YOON KEAN;;FACEBOOK INC,ARCHIBONG IME;;BADROS GREGORY JOSEPH;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;HEYNEN MARK;;KRAUSZ BRIAN;;MARLOW CAMERON ALEXANDER;;SHAFFER JUSTIN ALEXANDER;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;UNDERWOOD PATRICK;;WONG YOON KEAN,META PLATFORMS INC (2012-12-04),https://lens.org/110-126-493-070-586,Granted Patent,yes,120,11,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N7/173;;G06F3/048;;G06F3/0481;;G06F15/16;;G06F17/30;;H04L12/58;;H04L29/06;;H04N7/025;;H04N7/10;;H04N21/23;;H04N21/258;;H04N21/41;;H04N21/4227;;H04N21/433;;H04N21/439;;H04N21/44;;H04N21/472;;H04N21/478;;H04N21/4788;;H04N21/63;;H04N21/6543;;H04N21/81;;H04W4/50;;H04W4/80,,19,1,001-019-759-270-089,10.1109/ccnc.2010.5421599,"U.S. Appl. No. 13/602,011, filed Aug. 31, 2012, Cameron A. Marlow.;;U.S. Appl. No. 13/688,736, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,035, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/688,850, filed Nov. 29, 2012, Sean M. Bruich.;;U.S. Appl. No. 13/689,285, filed Nov. 29, 2012, David H. Garcia.;;U.S. Appl. No. 13/689,355, filed Nov. 29, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/688,905, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13/690,769, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,122, filed Nov. 30, 2012, Mark Heynen.;;U.S. Appl. No. 13/692,122, filed Dec. 3, 2012, Colin C. Brennan.;;U.S. Appl. No. 13/691,269, filed Nov. 30, 2012, David H. Garcia.;;U.S. Appl. No. 13/692,675, filed Dec. 3, 2012, Ime Archibong.;;U.S. Appl. No. 13,692,598, filed Dec. 3, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/692,006, filed Dec. 3, 2012, Colin C. Brennan.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013, date of mailing Dec. 11, 2013.;;Martin, R. et al. ""neXtream: A Multi-Device, Social Approach to Video Content Consumption."" Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5.;;U.S. Appl. No. 14/930,072, filed Nov. 2, 2015, Archibong.;;U.S. Appl. No. 15/046,179, filed Feb. 17, 2016, Archibong.;;EPO Germany, Communication-Extended European Search Report dated Apr. 5, 2016; Application No./Patent No. 13833399.2-1905 / 2891322 PCT/US2013057449; Ref. FABOO276-PCT/EP, May 4, 2016.",ACTIVE
76,US,A1,US 2017/0359630 A1,137-828-662-376-655,2017-12-14,2017,US 201715680752 A,2017-08-18,US 201715680752 A;;US 201615175159 A;;US 201213692675 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming through Social Networking,"In particular embodiments, one or more computer systems of a social-networking system determine available media content from one or more content sources and query a social graph of a social-networking system for social content associated with a user of the social-networking system. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system determine, using the social content and the available media content, a plurality of social coefficients for the user, determine, based on the determined social coefficients, recommended media content for the user, and provide the recommended media content for display in a programming guide on a display device.",FACEBOOK INC,ARCHIBONG IME;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;HAUGEN AUSTIN;;HEYNEN MARK;;KRAUSZ BRIAN;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2021-10-28),https://lens.org/137-828-662-376-655,Patent Application,yes,0,7,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N21/81;;G06F3/048;;G06F3/0481;;G06F15/16;;G06F17/30;;G06Q30/02;;G06Q50/00;;H04L12/58;;H04L29/06;;H04L29/08;;H04N21/23;;H04N21/234;;H04N21/235;;H04N21/258;;H04N21/278;;H04N21/41;;H04N21/4227;;H04N21/433;;H04N21/434;;H04N21/439;;H04N21/44;;H04N21/472;;H04N21/478;;H04N21/4788;;H04N21/482;;H04N21/488;;H04N21/63;;H04N21/6334;;H04N21/6543;;H04W4/50;;H04W4/80,,0,0,,,,ACTIVE
77,US,A1,US 2014/0067961 A1,162-433-074-565-329,2014-03-06,2014,US 201213692675 A,2012-12-03,US 201213692675 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming Through Social Networking,"In particular embodiments, one or more computer systems of a social-networking system determine available media content from one or more content sources and query a social graph of a social-networking system for social content associated with a user of the social-networking system. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system determine, using the social content and the available media content, a plurality of social coefficients for the user, determine, based on the determined social coefficients, recommended media content for the user, and provide the recommended media content for display in a programming guide on a display device.",ARCHIBONG IME;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;HAUGEN AUSTIN;;HEYNEN MARK;;KRAUSZ BRIAN;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN,ARCHIBONG IME;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;HAUGEN AUSTIN;;HEYNEN MARK;;KRAUSZ BRIAN;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2012-12-04),https://lens.org/162-433-074-565-329,Patent Application,yes,9,48,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04L12/58;;H04W4/50;;H04W4/80,709/205,0,0,,,,ACTIVE
78,US,B2,US 9386354 B2,153-416-029-049-527,2016-07-05,2016,US 201213692675 A,2012-12-03,US 201213692675 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, one or more computer systems of a social-networking system determine available media content from one or more content sources and query a social graph of a social-networking system for social content associated with a user of the social-networking system. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system determine, using the social content and the available media content, a plurality of social coefficients for the user, determine, based on the determined social coefficients, recommended media content for the user, and provide the recommended media content for display in a programming guide on a display device.",ARCHIBONG IME;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;HAUGEN AUSTIN;;HEYNEN MARK;;KRAUSZ BRIAN;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN;;FACEBOOK INC,ARCHIBONG IME;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;HAUGEN AUSTIN;;HEYNEN MARK;;KRAUSZ BRIAN;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2012-12-04),https://lens.org/153-416-029-049-527,Granted Patent,yes,108,16,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,G06F3/00;;G06F3/048;;G06F3/0481;;G06F13/00;;G06F15/16;;G06F17/30;;H04L12/58;;H04L29/06;;H04N5/445;;H04N21/23;;H04N21/258;;H04N21/41;;H04N21/4227;;H04N21/433;;H04N21/439;;H04N21/44;;H04N21/472;;H04N21/478;;H04N21/4788;;H04N21/63;;H04N21/6543;;H04N21/81;;H04W4/50;;H04W4/80,,18,1,001-019-759-270-089,10.1109/ccnc.2010.5421599,"U.S. Appl. No. 13/602,011, filed Aug. 31, 2012, Cameron A. Marlow.;;U.S. Appl. No. 13/688,736, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,035, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/688,850, filed Nov. 29, 2012, Sean M. Bruich.;;U.S. Appl. No. 13/689,285, filed Nov. 29, 2012, David H. Garcia.;;U.S. Appl. No. 13/689,355, filed Nov. 29, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/688,905, filed Nov. 29, 2012, Ime Archibong.;;U.S. Appl. No. 13/690,769, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/690,892, filed Nov. 30, 2012, Ime Archibong.;;U.S. Appl. No. 13/691,122, filed Nov. 30, 2012, Mark Heynen.;;U.S. Appl. No. 13/692,122, filed Dec. 3, 2012, Colin C. Brennan.;;U.S. Appl. No. 13/691,269, filed Nov. 30, 2012, David H. Garcia.;;U.S. Appl. No. 13/692,598, filed Dec. 3, 2012, Gregory J. Badros.;;U.S. Appl. No. 13/692,006, filed Dec. 3, 2012, Colin C. Brennan.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013.;;Martin, R. et al. ""neXtream: A Multi-Device, Social Approach to Video Content Consumption."" Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5.;;U.S. Appl. No. 14/930,072, filed Nov. 2, 2015, Archibong.;;U.S. Appl. No. 15/046,179, filed Feb. 17, 2016, Archibong.",ACTIVE
79,US,B2,US 9743157 B2,048-108-406-849-407,2017-08-22,2017,US 201615175159 A,2016-06-07,US 201615175159 A;;US 201213692675 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, one or more computer systems of a social-networking system determine available media content from one or more content sources and query a social graph of a social-networking system for social content associated with a user of the social-networking system. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system determine, using the social content and the available media content, a plurality of social coefficients for the user, determine, based on the determined social coefficients, recommended media content for the user, and provide the recommended media content for display in a programming guide on a display device.",FACEBOOK INC,ARCHIBONG IME;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;HAUGEN AUSTIN;;HEYNEN MARK;;KRAUSZ BRIAN;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2021-10-28),https://lens.org/048-108-406-849-407,Granted Patent,yes,174,1,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,G06F3/00;;G06F3/048;;G06F3/0481;;G06F13/00;;G06F15/16;;G06F17/30;;G06Q30/02;;G06Q50/00;;H04L12/58;;H04L29/06;;H04L29/08;;H04N5/445;;H04N21/23;;H04N21/234;;H04N21/235;;H04N21/258;;H04N21/278;;H04N21/41;;H04N21/4227;;H04N21/433;;H04N21/434;;H04N21/439;;H04N21/44;;H04N21/472;;H04N21/478;;H04N21/4788;;H04N21/482;;H04N21/488;;H04N21/63;;H04N21/6334;;H04N21/6543;;H04N21/81;;H04W4/50;;H04W4/80,,8,1,001-019-759-270-089,10.1109/ccnc.2010.5421599,"EPO Germany, Communication—Extended European Search Report dated Apr. 5, 2016; Application No./Patent No. 13833399.2-1905 / 2891322 PCT/US2013057449; Ref. FABOO276-PCT/EP, May 4, 2016.;;U.S. Appl. No. 15/046,179, filed Feb. 17, 2016, Archibong.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013, date of mailing Dec. 11, 2013.;;Martin, R. et al. “neXtream: A Multi-Device, Social Approach to Video Content Consumption.” Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5, 2010.;;U.S. Appl. No. 15/283,908, filed Oct. 3, 2016, Archibong.;;U.S. Appl. No. 15/295,497, filed Oct. 17, 2016, Badros.;;U.S. Appl. No. 15/376,902, filed Dec. 13, 2016, Campbell.;;U.S. Appl. No. 15/393,449, filed Dec. 29, 2016, Garcia.",ACTIVE
80,US,A1,US 2016/0286284 A1,188-520-360-426-708,2016-09-29,2016,US 201615175159 A,2016-06-07,US 201615175159 A;;US 201213692675 A;;US 201213602011 A,2012-08-31,Sharing Television and Video Programming Through Social Networking,"In particular embodiments, one or more computer systems of a social-networking system determine available media content from one or more content sources and query a social graph of a social-networking system for social content associated with a user of the social-networking system. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system determine, using the social content and the available media content, a plurality of social coefficients for the user, determine, based on the determined social coefficients, recommended media content for the user, and provide the recommended media content for display in a programming guide on a display device.",FACEBOOK INC,ARCHIBONG IME;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;HAUGEN AUSTIN;;HEYNEN MARK;;KRAUSZ BRIAN;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2021-10-28),https://lens.org/188-520-360-426-708,Patent Application,yes,2,12,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,H04N21/81;;H04L12/58;;H04L29/06;;H04N21/23;;H04N21/258;;H04N21/41;;H04N21/478;;H04N21/482;;H04N21/63;;H04W4/50;;H04W4/80,,0,0,,,,ACTIVE
81,US,B2,US 10142681 B2,154-046-323-532-537,2018-11-27,2018,US 201715680752 A,2017-08-18,US 201715680752 A;;US 201615175159 A;;US 201213692675 A;;US 201213602011 A,2012-08-31,Sharing television and video programming through social networking,"In particular embodiments, one or more computer systems of a social-networking system determine available media content from one or more content sources and query a social graph of a social-networking system for social content associated with a user of the social-networking system. The social graph includes nodes and edges connecting the nodes. The nodes include user nodes that are each associated with a particular user of the social-networking system. The one or more computer systems of the social-networking system determine, using the social content and the available media content, a plurality of social coefficients for the user, determine, based on the determined social coefficients, recommended media content for the user, and provide the recommended media content for display in a programming guide on a display device.",FACEBOOK INC,ARCHIBONG IME;;CAMPBELL COLIN CAMERON BRENNAN;;DANIEL ROBERT;;GARCIA DAVID HARRY;;HAUGEN AUSTIN;;HEYNEN MARK;;KRAUSZ BRIAN;;TOKSVIG MICHAEL JOHN MCKENZIE;;TSENG ERICK;;WONG YOON KEAN,META PLATFORMS INC (2021-10-28),https://lens.org/154-046-323-532-537,Granted Patent,yes,209,0,83,83,0,H04L65/1089;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/632;;H04N21/6543;;H04N21/44226;;H04N21/41265;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;G06Q30/0277;;G06Q50/01;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;H04N21/632;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/613;;H04L65/612;;H04W4/50;;H04W4/80;;G06F16/58;;G06F16/4387;;H04N21/44218;;H04N21/23424;;H04N21/458;;H04N21/4316;;H04N21/2668;;H04N21/25866;;H04N21/4227;;H04N21/4334;;H04N21/47214;;H04N21/4788;;H04N21/6543;;H04L65/1089;;G06F16/532;;H04N21/41265;;H04N21/44226;;H04L51/52;;H04L65/75;;H04L65/612;;H04L65/613;;H04L67/535;;H04L2101/622;;H04L65/403;;G06F15/16;;H04L51/10;;H04L65/60;;G06F3/0481;;G06F3/048;;H04N21/258;;H04N21/812;;H04N21/478;;H04N21/632;;H04N21/23;;H04N21/4394;;H04N21/44008;;H04N21/8133;;H04N21/4821;;H04N21/4344;;H04L67/10;;H04L67/02;;G06Q30/0277;;G06Q50/01;;H04N21/23418;;H04N21/235;;H04N21/278;;H04N21/4884;;H04N21/6334;;H04L67/306;;H04N21/4147;;H04N21/43635;;H04N21/43637;;H04N21/4402;;H04N21/84;;H04N21/8547;;H04N21/252;;H04N21/25891;;H04N21/26258;;H04N21/41407;;H04N21/4532,G06F3/00;;G06F13/00;;G06F15/16;;G06F17/30;;G06Q30/02;;G06Q50/00;;H04L12/58;;H04L29/06;;H04L29/08;;H04L29/12;;H04N5/445;;H04N21/234;;H04N21/235;;H04N21/25;;H04N21/258;;H04N21/262;;H04N21/278;;H04N21/41;;H04N21/414;;H04N21/4147;;H04N21/4227;;H04N21/433;;H04N21/434;;H04N21/4363;;H04N21/439;;H04N21/44;;H04N21/4402;;H04N21/45;;H04N21/472;;H04N21/4788;;H04N21/482;;H04N21/488;;H04N21/63;;H04N21/6334;;H04N21/6543;;H04N21/81;;H04N21/84;;H04N21/8547;;H04W4/50;;H04W4/80,,8,1,001-019-759-270-089,10.1109/ccnc.2010.5421599,"EPO Germany, Communication—Extended European Search Report dated May 4, 2016; Application No./Patent No. 13833399.2-1905 / 2891322 PCT/US2013057449; Ref. FABOO276-PCT/EP.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; Interational Application No. PCT/US2013/057449; International filing date: Aug. 30, 2013, dated Dec. 11, 2013.;;Martin, R. et al. “neXtream: A Multi-Device, Social Approach to Video Content Consumption.” Consumer Communications and Networking Conference (CCNC), 2010 7th IEEE, 2010. 1-5.;;U.S. Appl. No. 15/495,508, filed Apr. 24, 2017, Archibong.;;U.S. Appl. No. 15/498,015, filed Apr. 26, 2017, Archibong.;;U.S. Appl. No. 15/612,169, filed Jun. 2, 2017, Garcia.;;U.S. Appl. No. 15/618,816, filed Jun. 9, 2017, Marlow.;;U.S. Appl. No. 15/653,616, filed Jul. 19, 2017, Bruich.",ACTIVE
82,US,B1,US 11444610 B1,039-930-673-520-411,2022-09-13,2022,US 202017085958 A,2020-10-30,US 202017085958 A;;US 201962951759 P,2019-12-20,Variable frequency multiplier,"A variable frequency multiplier circuit for frequency multiplying an input signal provided by an ultra-low phase noise signal source includes a tone generator configured to generate a multiple tones from the input signal; a signal separating circuit configured to separate the multiple tones into tones of interest and idler tones, where the tones of interest are separated into one or more groups and outputted from the signal separating circuit, and the idler tones are terminated; an amplification circuit configured to amplify each group of the tones of interest to optimize small and large signal responses; and a switched filter bank configured to selectively connect a selected tone from the tones of interest to a circuit output.",KEYSIGHT TECHNOLOGIES INC,GRICHENER ALEX;;EDALATI NAVEED;;WEBER LEONARD M;;QIN XIAOHUI;;AVELLA RYAN MICHAEL;;MASSIE DAVID;;HORSBURGH STUART;;BLATTER CAMERON;;BRENNAN NICHOLAS;;HARRIMAN MICHAEL JOHN;;FERRARA ANDY;;STATHAM HARRISON;;HOVLAND SCOTT A,KEYSIGHT TECHNOLOGIES INC (2020-10-28),https://lens.org/039-930-673-520-411,Granted Patent,yes,6,0,1,1,0,H03K5/00006;;H03G5/165;;H03F3/19;;H03F2200/165;;H03F2200/171;;H03F2200/294;;H03F2200/451;;H03K5/00006;;H03F3/19;;H03G5/165;;H03F2200/165;;H03F2200/451;;H03F2200/171;;H03F2200/294,H03K5/00;;H03F3/19;;H03G5/16,,0,0,,,,ACTIVE
